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“And now, I said, let me show in a figure how far our nature is enlightened or unenlightened: --
Behold! human beings living in a underground cave, which has a mouth open towards the light 
and reaching all along the cave; here they have been from their childhood, and have their legs 
and necks chained so that they cannot move,  and can only see before them, being prevented by 
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them, over which they show the puppets.”
The Republic, Book VII, Allegory of the Cave
Plato
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Abstract
Fullerene C60 science can been broadly divided into the study of three areas: (i) its 
reactivity that permits the obtention of modified fullerene derivatives, which can 
typically found  (ii) biological and (iii) material applications.
The main goal of this thesis is the synthesis and characterization of a library of 
monoadducts, bisadducts and hexakisadducts of fullerene C60 containing different 
generations of PAMAM dendron. On this purpose we have firstly studied the 
functionalization of fullerene C60 by means of 1,3-dipolar cycloaddition. On this 
purpose, we moved from the classic conditions by employing MW irradiation as the 
heating source, combined with ionic liquids as the solvent phase in order to obtain 
remarkable differences in the reactivity and the polyaddition selectivity.
In a second stage we have been dealing with the separate synthesis of four different 
generations of PAMAM dendron and different fulleropyrrolidine moieties including: 
monoadduct and five bisadducts isomers  to finally attach them via amidation. We have 
complete this library with the employment of the Bingel-Hirsch reaction to attach 
twelve units of a PAMAM first generation dendron to the carbon cage to obtain a Th 
symmetric hexakisadduct. As a result, a variety of fullerene derivatives with an 
enhanced water solubility was obtained, opening the door to their utilization for 
biological applications.  Thus, we can distinguished between those containing terminal, 
positive-charged amines that can be used to efficiently complex oligonucleotides and 
those that contains one or more terminal-free carboxylic acid that can be used as 
anchor points for further functionalization.
Concerning to those potentially used for transfection, the broad range of examples 
described in this thesis will permit to examine the role of the dendron moiety, the 
fullerene, and the distribution of the positive charges around the fullerene sphere, as 
key points into the complexation and transfection processes. Furthermore, 
complexation studies of some of these derivatives has been performed, all of them 
exhibiting a high affinity towards DNA complexation, demonstrating the great 
potential of these derivatives for transfection.
In the last part of this thesis, we have focused on the synthesis of  two porphyrin-
dendrofullerene dyads with or without an amide linker. Since the water solubility 
usually goes hand in hand with a good number of charges we have incorporated an 
asymmetric tryspyridilporphyrin conferring three more positive charges to the final 
structure, that provides an additional solubility to the final molecule. This system is of 
the most interest since electron transfer processes could be studied in polar media. In 
addition, electrostatic interactions could be further exploited with negative charged 
systems to build up high complex systems.
Abstract
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Riassunto
Lo studio del Fullerene C60 si concentra essenzialmente su tre aspetti principali: (i) la 
reattività, che porta all’ottenimento di potenziali derivati applicabili in (ii) campo 
biologico e nella (iii) ricerca di nuovi materiali. 
Lo scopo principale di questo lavoro di tesi è la sintesi e la caratterizzazione di una 
libreria di monoaddotti, bisaddotti ed esa-addotti del fullerene C60 modificati con 
diverse generazioni di dendron PAMAM.
A questo proposito è stata inizialmente studiata la funzionalizzazione del fullerene C60 
tramite la cicloaddizione 1,3-dipolare sfruttando l’irradiazione microonde combinata 
con liquidi ionici come mezzo solvente. L’ottimizzazione di questo approccio sintetico 
ha permesso di ottenere importanti risultati sul piano della resa e della selettività della 
poli-addizione.
In una seconda fase ci si è concentrati sulla sintesi separata di quattro diverse 
generazioni di dendron PAMAM e di varie unità fulleropirrolidiniche comprendenti: 
un monoaddotto e cinque isomeri di bisaddotto da legare ai dendroni attraverso 
reazioni di ammidazione. Questa libreria è stata completata con la sintesi di un esa-
addotto simmetrico di tipo Th, ottenuto legando dodici unità di dendrone PAMAM di 
prima generazione alla sfera fullerenica tramite la reazione di Bingel-Hirsch. 
Come risultato, è stata prodotta una batteria di derivati fullerenici dotati di notevole 
solubilità in acqua e di conseguenza di forte interesse per applicazioni biologiche. In 
particolare, all’interno della libreria si può distinguere una prima serie di derivati 
costituita da ammine terminali cariche positivamente, efficacemente impiegabili per la 
complessazione di oligonucleotidi, a cui se ne affianca una seconda contenente uno o 
più gruppi carbossilici terminali sfruttabili come punti di ancoraggio per successive 
funzionalizzazioni.
Nel corso della tesi si fa particolare riferimento all’applicabilità dei derivati come 
vettori per il trasferimento di geni attraverso la parete cellulare, sostenuta da studi di 
complessazione in gel elettroforesi da cui è emersa una forte affinità di alcuni campioni 
delle serie col DNA.  
Nell’ultima parte di questa tesi verrà trattata la sintesi di due diadi porfirino-
dendrofullereniche con e senza linker ammidico. Al fine di aumentare il numero di 
gruppi carichi dell’intera struttura e, con essi, la conseguente solubilità in acqua, è stata 
incorporata una tris-piridilporfirina recante tre azoti piridinici carichi positivamente.
Il sistema così progettato è di forte interesse in quanto consente lo studio di processi di 
trasferimento elettronico in solventi polari. Inoltre, le cariche positive possono essere 
ulteriormente sfruttate per interagire elettrostaticamente con gruppi carichi 
negativamente, formando strutture supramolecolari più complesse e introducendo 
nuovi risvolti applicativi.
Riassunto
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Chapter 1
Introduction
“The roots of knowledge are bitter, but its fruit is sweet”
Aristotle
1.1 Fullerene C60, the most beautiful molecule in the world
Periodic Table of the Elements contains 118 chemical elements but a whole discipline is 
dedicated to the study of one of them, carbon, to its combinations with hydrogen and 
other carbon  atoms and, to a lesser extent, with  heteroatoms. Carbon’s prevalence can 
be briefly explained by means of a casual combination of a low/intermediate 
electronegativity (2.5) and the presence of 4 electrons in its valence shell. Thus, covalent 
bond is widely preferred with up to four atoms by means of single, double and triple 
bond, giving part to an amazing variety of molecules that represents more than 90% of 
all known chemical compounds. Thus, it is not difficult to understand why structures 
containing only carbon are so appealing for the scientific community. 
Before 1985, mainly three carbon allotropes were known: amorphous carbon, graphite, 
and diamond. In 1985, a new era of carbon allotropes was opened thanks to the 
discovery of Harold Kroto, Robert Curl 
and Richard Smalley, later on recognized 
with the Nobel prize in 1996 (Figure 1.1). 
The fullerene family was identified when 
traces of molecules containing only 60 
and 70 carbon atoms were detected by 
mass spectroscopy during a simulation of 
the high-heat conditions of a red giant’s 
atmosphere, devoted to study the 
production of carbon clusters.1 Later on, 
the fullerene family increased 
continuously and the most recent 
recognition of a new fullerene structure is 
dated 2010, with the isolation of C90.2 
However, C60 remains in a privileged 
position since (i) it is the most abundant, (ii) it can be produced in bulky quantities and 
with affordable coast, (iii) it is relatively inert  in standard  conditions (iv) it is high 
symmetric. 
C60 possesses an unequalled beautiful structure that reminds the geodesic dome of the 
american architect Buckminster Fuller, built on the occasion of the Expo ’67 in Montreal 
(Figure 1.2, panel A).
The structure of fullerene C60 consists of 20 hexagons and 12 pentagons fused together 
into a hollow carbon sphere (Figure 1.2, panel B). Initially, C60 was considered as a 
“super aromatic molecule”, but X-ray diffraction revealed rather a polyenic structure.3
Figure 1.1 1996 Nobel Prize winners in 
Chemistry: Harold Kroto, Robert Curl and 
Richard Smalley.
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A  B
Figure 1.2 Panel A: the geodesic dome; Panel B: Some of the most representative examples of 
the nanocarbon family: C60 (left), graphene (right) and carbon nanotubes (bottom).
As a consequence of this peculiar structure, fullerene C60 presents a strong apolar 
character that renders it absolutely insoluble in all the polar solvents, and sparingly 
soluble in the other organic solvents. Commonly, toluene, carbon disulfide and 
ortodichlorobenzene are used to dissolve C60, that gives solutions with a characteristic 
magenta color. 
1.2 Fullerene C60 reactivity
C60 presents two types of bonds: (i) those joining two hexagons (6,6 junctions, 1.38 Å); 
and (ii) those at the junction of a pentagon and a hexagon (5,6 junctions, 1.45 Å). The 
deviation from planarity of the 
double bonds, due to its 
geometrical constraints, results in 
an enhancement of the reactivity.4 
The main driving force for the 
reactivity of fullerenes is therefore 
the relief of strain associated with a 
change in hybridization at the 
reacting carbons on the spherical 
surface from sp2 to sp3 (Figure 1.3). 
From the chemical point of view, 
C60 can be mainly considered as an 
electrophilic reagent.5 
The demonstration that C60 reacts readily with diazo compounds opened the access to 
many functional derivatives, which were familiarly called “fulleroids” (Figure 1.4).6 It 
was later discovered that “fulleroids” convert to methanofullerenes using different 
reaction conditions (Figure 1.4).
bent sp2 carbons sp
3 carbons
Figure 1.3 After reaction has occurred on the surface 
of C60, a change in the hybridization from sp2 to sp3 
occurs at the involved carbon atoms. 
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Several other approaches for the covalent functionalization of C60 have been developed. 
Depending on the type of reaction, fullerene C60 reactions have been divided in 
cycloadditions, nucleophilic additions and radical functionalization.
In the following paragraphs we will give a general overview on the variety of reactions 
that can be efficiently used to attached several functionalities to C60, focusing on the 
two most employed methodologies in fullerene chemistry: the Bingel-Hirsch reaction 
and the 1,3-dipolar cycloaddition.
1.2.1 Cycloadditions
[1+2] cycloadditions take place with divalent species such as carbene (Figure 1.5, route 
a), nitrenes7 and silylenes8 to obtain a huge variety of methanofullerene or 
heteroanalogues. In the addition of nitrenes, “azafulleroids” and 
azamethanofullerenes, precursors of azafullerenes (C59N), are obtained.9
Alkynes and alkenes (Figure 1.5, route b) can undergo [2+2] cycloaddition reactions 
either photochemically or thermally.10 Moreover, C60 oligomers have been prepared by 
solid state synthesis in the presence of KCN to give dimers,11 or under high pressure to 
obtain polymers.12
Also [4+2] cycloadditions take place at 6,6 junctions. Diels-Alder reactions with 1,3 
dienes have been described (Figure 1.5, route d).13 The main drawback is the stability of 
the cycloadduct versus the retro-Diels-Alder reaction, that strongly depends on the 
electronic nature of the diene substituents.
RR'C=N2  +  C60
- N2
+
!
methanofullerene "fulleroid"
N
N
R'
R R R'
R
R'
 Figure 1.4 Cycloaddition reaction 
between diazo compounds and C60.
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1.2.1.1 1,3-dipolar cycloaddition
C60 can react with dipoles to yield cycloadducts at the 6,6 junctions. The 1,3-dipolar 
cycloaddition of azomethine ylides is a powerful and widely used methodology since 
it was introduced by Prato and coworkers (Figure 1.5, route c),14 because of the 
versatility of the reaction and the stability of the resulting fulleropyrrolidines.15
In this reaction, the ylide can be generated in situ by thermal ring opening of aziridines 
or by decarboxylation of the iminium salts derived from the condensation of !-
aminoacids and aldehydes or ketones. In the first example sarcosine, formaldehyde 
Figure 1.5 Examples of well-established C60 functionalization protocols (a) [1+2] 
cycloaddition; (b) [2+2] thermal cycloaddition; (c) [3+2] cycloaddition with azomethine 
ylides;  (d) [4+2] Diels-Alder cycloaddition; (e) Bingel-Hirsch Reaction; (g) Rh-catalyzed 
arylation. For relevant references, see text.
R1 R2
R1
R2
O
O Me
H
O
OH
NHR1
R2
O
H
N
R1
R2
O O
O
O
Ar H
ArB(O
R)
2
R
h C
atalyst
O
O
O
O
O
OO
O
Br
NaH
(a)
(b)
(c)
(d)
(e)
(f)
CARBENE ADDITION
[2+2] CYCLOADDITION
[3+2] CYCLOADDITION
[4+2] CYCLOADDITION
ORGANOMETALLIC ADDITION
CYCLOPROPANATION
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and C60 were reacted together to give the corresponding N-methyl fulleropyrrolidine 
(Figure 1.6 ).
The retrocycloaddition of fulleropyrrolidines has been recently described by using high 
temperatures (180ºC) while trapping the ylide intermediate with a metal and a 
dipolarophile in order to shift the equilibrium to the retrocycloaddition.16 The required 
harsh conditions demonstrate the high stability of the fulleropyrrolidines. 
In an outstanding work, it has been possible to physically visualize fulleropyrrolidines 
attached in the vicinity of single walled carbon nanotube surface or in their internal 
cavity by using High Resolution Transmission Electron Microscopy (HRTEM) (Figure 
1.7).17
H
N
OH
O
+ CH2O
heating
-CO2
-H2O
N C60
N
Me
Figure 1.6 The 1,3-dipolar cycloaddition leading 
to N-methyl fulleropyrrolidine.
Figure 1.7 HRTEM images of fulleropyrrolidines (C60-C3NH7) attached to 
the surface of SWCNTs (a-c) Image simulations of C60 derivatives (d-f) 
Corresponding atomic simulations (g-i).
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1.2.2 Nucleophilic additions
1.2.2.1 Bingel reaction
The nucleophilic addition of bromomalonates to C60, the so-called Bingel or Bingel-
Hirsch reaction,18 has been widely used in the design of new fullerene derivatives. The 
original conditions involved the treatment of diethyl bromomalonate with NaH in the 
presence of C60 but many other modifications of the Bingel reaction have been 
developed (Figure 1.5, route e).19 
Thus, a strong base is used in order to abstract the acidic malonate proton, generating a 
carbanion, which reacts with the electron deficient fullerene double bond. This in turn 
generates a carbanion which displaces bromine in a nucleophilic aliphatic substitution 
to give an intramolecular cyclopropane ring closure (Figure 1.8).
Although methanofullerenes formed in the Bingel reaction are normally stable, the 
retro-Bingel reaction20 has been described both electrochemically21 and under mild 
chemical conditions.22
1.2.2.2 Other nucleophilic additions
Organometallic compounds, such as organocopper,23 cyanide anions,24 organolithium 
or Grignard reagents25 can give nucleophilic reactions to C60 with interesting results 
but strong drawbacks such as (i) low monoaddition selectivity (ii) low compatibility 
with other functional groups and (iii) high load requirement of organometallic 
reagents. 
Variations of the well-known organolithium addition have permitted the synthesis of 
complex multifullerene derivatives.26 New arylation and alkenylation reactions to C60 
have been performed by using Rh as catalyst and organoboron compounds (Figure 1.5, 
route f).27
Figure 1.8 Mechanism of the Bingel-Hirsch reaction.
O
O
O
O
H Br
B
O
O
O
O
Br
O
O
O
OBr
O
O
O
O
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Other approaches have been also developed, involving zwitterions derived from 
dimethyl acetylene dicarboxylate (DMAD) and 4-dimethyl aminopyridine (DMAP) at 
room temperature (Figure 1.9). The proposed mechanism goes through (i) addition of 
the zwitterionic intermediate to the electrophilic fullerene, (ii) attack of the fullerene 
anion on the carbonyl carbon of the ester group and (iii) replacement of the DMAP 
group with a methoxy group.28
1.2.3 Radical functionalization
Radical functionalization has been less explored than the other derivatization methods 
previously described as a consequence of the high reactivity of radicals towards C60. As 
a matter of fact, a complex mixture of polyadducts is obtained, while the monoaddition 
has been only observed by mass spectroscopy and electron spin resonance (ESR).29 
Nonetheless in the last years, exciting results have been obtained. The well-known acyl 
radical reactions in organic chemistry have been successfully applied to fullerene. 
Thus, a single addition to the fullerene has been obtained, using a variety of aldehydes 
as acyl radicals precursors and tetrabutylammonium decatungstate [(n-Bu4N)4W10O32, 
TBADT]. In a similar fashion, the direct addition of ethers to the fullerene has been 
recently achieved by a photochemically assisted free-radical approach, (Figure 10, top).
30 Another example is given by the straightforward and general procedure to prepare 
dioxolanes on a 6,6 junction from aldehydes and ketenes. The reaction proceed via 
radical addition to C60 promoted by Fe3+ salts (Figure 1.10, bottom).31
Figure 1.9 Fullerene zwitterions-mediated functionalization.
+
O O
O O
+
N
N
Toluene
rt, 2h
O
O
O
OO
O
O
O N
N
C60
Introduction
13
1.2.4 Multiple additions
The addition of an organic residue to a 6,6 junction of C60 leads to monoadduct, but, 
depending on the reaction conditions, can also give a complex mixture of multiadducts 
(Figure 1.11). There are 8, 46 and 262 possible regioisomers for the bis, tris and tetrakis-
additions of a symmetrical 
addend, respectively. 
The second addition to a 
fullerene monoadduct is 
controlled by the frontier 
molecular orbitals,32 while the 
control over the regiochemistry 
of multiple additions is only 
achieved in a few cases,33 where 
the steric hindrance plays a main 
role. 
1.2.4.1 Fulleropyrrolidine 
bisadducts
The double functionalization of 
the carbon cage can take place in eight different positions. If the second addition 
proceeds on the same hemisphere, cis-isomers are obtained while when the second 
Figure 1.10 Radical functionalization of fullerene. Top: photochemically assisted 
addition of acyl radicals to C60. Bottom: Preparation of 1,3 dioxolanes using Fe3+ salts.
Figure 1.11.  A typical HPLC profile of a crude of 
reaction of 1,3-dipolar cycloaddition.
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addend locates in the opposite hemisphere trans isomers are given. When the 
intermediate position is preferred, equatorial isomer is given (Figure 1.12).
This is clearly the reason why multiaddition has been generally disregarded since a 
hard and time-consuming purification is required in most of the cases to obtain pure 
bisadducts in low yields. However, from the chemical point of view multiadducts are 
of a great interest since the attachment of more than one unit dramatically decrease the 
aggregation observed on the analogue monoadducts.34
Focusing on the isolation of fulleropyrrolidines bisadducts, big efforts have been done 
to understand the behaviour of multiadditions in the last years. Thus, by controlling 
the stoichiometry of the reagents and the reaction conditions mono-, bis-, tris, etc., are 
formed with a moderate selectivity.
This methodology was followed in order to achieve the isolation and full analytical 
characterization of the whole series of the N-methyl pyrrolidine bisadducts (trans-1, 
trans-2, trans-3, trans-4, equatorial, cis-3, cis-2 and cis-1).35 Earlier work made possible the 
partial characterization of some of the patterns,36 while cis-3, cis-2 and cis-1 
fulleropyrrolidine isomers were isolated for the first time. Moreover, the same strategy 
was applied in order to synthesize, isolate and characterize nine different trisadducts.37 
1.2.4.2 Bingel-Hirsch multiadducts
A  very ingenious approach to facilitate the isolation of a wide range of polyadducts 
was reported by Diederich et al,38  who introduced the so called tether-directed remote 
multifunctionalization, considered as one of the most powerful tools to control 
Trans 1 Trans 2 Trans 3 Trans 4
Equatorial Cis 3 Cis 2 Cis 1
Figure 1.12. Relative positions of the addends in C60. bis-adducts.
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multiaddition in the Bingel reaction. In this case, a combination of cyclopropanation 
and Diels-Alder reaction with a careful control of length, rigidity and geometry of the 
tethers allows the obtaining of bis, tris and hexakisadducts. By controlling the length 
and geometry of the tether, equatorial, cis-2,39  or even trans-240  and trans-141 can be 
almost exclusively obtained. Variations of this methodology and incorporation of 
macrocycles helps the formation of regioselective trisadducts and bisadducts.42
Concerning hexakisadducts, those with a Th symmetrical octahedral addition pattern 
are almost routinely synthesized by following the original procedure introduced by 
Hirsch43  and further improved by Sun.44 
1.2.5 Non-covalent functionalization 
Supramolecular chemistry allows the preparation of functional architectures by means 
of non-covalent interactions, including hydrogen bonding, !-!, and metal coordination. 
For example, C60 derivatized with pyridyl groups can spontaneously coordinate to zinc 
and ruthenium tetraphenyl porphyrins.45 Other examples include the functionalization 
of fullerenes with multiple hydrogen bond motifs self-recognized.46 On the other hand, 
fullerene can participate directly in the self-assembly process through interactions with 
its curved !-system. C60 can form inclusion complexes with bis-porphyrin hosts47 and 
with extended-tetrathiafulvalene tweezers (exTTF).48
Atoms, molecules, or ions can be trapped inside the cavity of a fullerene cage to form 
endohedral fullerenes. H2, N2, and a wide variety of noble gases and transition metal 
atoms have been successfully encapsulated.49 Physical methods for the preparation of 
endohedral fullerenes are tedious and with a clear lack of efficiency, reaching isolated 
yields of only 1%.50 Recently, a new creative concept has been developed, called 
“molecular surgery” to introduce guests inside the fullerene sphere (Figure 1.13). The 
procedure starts with a ring opening or a ring expansion generally induced by 
cycloadditions or radical-oxidating reactions in order to open a “hole” in the sphere 
and insert the desired species into the cage. After the encapsulation, the reconstitution 
of the cage has been achieved at high temperatures.51
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1.2.6 Water-soluble fullerene derivatives
As already discussed, pristine C60 is insoluble in water which is the main drawback 
that limits its compatibility with biological media and consequently its possible 
biological applications: pristine C60 could be potentially toxic to humans since, among 
others, it has been observed oxidative damage in the brain lipids of fishes, when 
exposed to fullerene’s aggregates in water.52 In order to overcome this problem, two 
main strategies have been proposed: (i) to partially mask the apolar fullerene surface, 
and (ii) to covalently modify the aromatic cage. 
In the first approach, several methodologies have been successfully applied including: 
(a) fullerene complexation with cyclodextrins or calixarenes53 (b) co-solvation with 
polyvinylpyrrolidone in organic solvents;54 (c) inclusion into suspensions55 and (d) 
incorporation into artificial lipid membranes.56 Although promising results have been 
obtained following these approaches, it is also of great interest to maintain the intrinsic 
hydrophobicity of the fullerene sphere for some biological applications.
Regarding the covalent functionalization, 
several examples are available in the literature 
describing adducts with improved water-
solubility thanks to the presence of sugars.57  For 
instance, the addition of 2-azidoethyl tetra-O-
acetyl-!-D-mannopyranoside to C60 resulted in 
two different water-soluble isomers that were 
separated and characterized.58 
Following this strategy, the same 
cycloaddition reaction was employed to 
prepare a bisadduct (Figure 1.14) that 
forms bilayer vesicles.59 These liposome-
like structures could act as neuroprotective 
Figure 1.13.  “The molecular surgery” approach: hole generation by provoking "  and ! 
bond scission, insertion of the guest molecule, and reconstruction of the fullerene 
structure. 
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Figure 1.14. Fullerene-sugar 
derivative that form bilayer vesicles.
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agents owing to the fullerene intrinsic superoxide dismutation ability. Moreover, 
the vesicles are endowed with an internal cavity exploitable as a reservoir where a 
drug could be encapsulated and eventually slowly released into the cells. 
A similar approach was used for the construction of the so-called fullerene sugar 
balls, in which the fullerene sphere is partially or totally surrounded by sugar 
units. Spherical micelles with a diameter of 5 nm were observed by TEM.60 Very 
recently, Nierengarten and coworkers reported the synthesis of a fullerene 
hexakisadduct, in which the whole sphere is covered by suitable sugar residues 
coupled to a polyfunctionalized fullerene by click chemistry, generating globular 
polytopic ligands.61
The development of new methods to solubilize fullerene is a very active field that 
currently involves not only organic chemistry but also other disciplines, such as 
biochemistry. In fact in a recent work C60 derivatives were covalently attached to 
large biological structures, viral nanoparticles (VNPs), obtaining VNP-C60 hybrids 
with high solubility and biocompatibility.62 The cellular uptake of these constructs 
was demonstrated using labelled derivatives, prepared using click chemistry as the 
key step. Both VPNs and C60 retained their biological properties. It is most likely 
that the cell internalizing driving force is exerted by the viral portion while the 
fullerene acts as the cargo, exploitable, for example, in photodynamic therapy.
A valid route to obtain water-soluble C60 derivatives is also the conjugation of amino 
acids. Fullerene substituted phenylalanine derivatives,63 (Figure 1.15) dipeptides from a 
fullerene amino acid or multifullerene peptides64 are among the most representative 
examples.
Thus, the procedures described in sections 
1.2.1-1.2.4 have been systematically used to 
attach different polar appendages in order to get 
biocompatible fullerene derivatives.
Dendritic architectures are among the most 
interesting addends that can be coupled to 
fullerene, since a variety of functional groups can 
be massively introduced in a controlled manner, 
from an initial growing core, and successively 
attached to the fullerene sphere by means of the methods previously discussed.
Bettreich and Hirsch developed the first pioneer work concerning dendrofullerenes,in 
which a second generation Newkome-type dendron containing 18 carboxylic groups 
was conjugated to fullerene C60 (Figure 1.16). As a consequence, this compound is 
characterized by one of the  highest solubility for a fullerene derivative in water (34 
mg/mL at pH 7.4).65
Figure 1.15. Molecular structure of a 
phenyalanine-C60-amino acid 
derivative.
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After this encouraging results, the group of Hirsch has largely contributed to the 
development of the dendrofullerene science. Special attention has been focused on the 
attachment of chromophores mainly for the studies of donor-acceptor systems that 
posses a high solubility in polar solvents as methanol and water due to the presence of 
a dendron in the structure.66 
1.3 Biological Applications of fullerene derivatives
The synthesis of water-soluble fullerene derivatives, though not straightforward, 
permetted to explore the use of fullerene based compounds in various biological and 
biomedical fields, including neuroprotection, antioxidation, DNA photocleveage, 
antibacterial and antiviral activity, and immunomodulation.67 Herein we will mainly 
focus on: drug and oligonucleotide delivery. 
1.3.1 Drug delivery systems based on C60
C60 can be considered as an interesting scaffold for drug delivery since it can be 
multifunctionalized, forms nanoparticles and/or acts as a drug absorbent,68 and, 
moreover, its lipophilicity can be exploited to cross cell membranes.
Several groups have directed their efforts to the synthesis of appropriate fullerene 
derivatives able to bind and to deliver drugs intracellularly.
Few years ago, paclitaxel, one of the most promising drug against cancer,69 was 
covalently attached to the fullerene sphere (Figure 1.17, top) via an ester bond, 
permitting the paclitaxel to retain its pharmacological activity. Indeed, the 
hydrolysis of the ester function resulted in the consequent release of the drug. 
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Figure 1.16. A water soluble dendrofullerene.
Introduction
19
Moreover, it was demonstrated that this conjugate has a significant anticancer 
activity in vitro when administrated with a liposome formulation even though the 
IC50 was 1.6 times higher than the analogous formulation containing the drug 
alone.70 
In a similar approach doxorubicin, another effective anticancer agent, was attached 
to the fullerene moiety (Figure 1.17, bottom). While the drug itself is sparingly 
soluble in water, the conjugation to fullerene increased its solubility, thus 
rendering doxorubicin more available for bioapplications.71  Following the 
incubation with cells, this construct was localized into the cytoplasm and, to a less 
extent, into the nucleus, where instead the free drug mainly accumulates. Despite 
this difference, the activity of doxorubicin was preserved.
Polyhydroxylated fullerenes, called fullerenols or fullerols, have also emerged as 
very promising candidates for delivering anticancer drugs.72 Indeed, these 
structures, although not perfectly defined in the number and the position of the 
hydroxyl groups, present the remarkable advantage of high solubility in polar 
solvents if compared to many other C60 derivatives. Moreover, the functional 
groups can bind bioactive units, obtaining so far a high drug loading as the result 
of a multifunctionalized structure. A fullerenol model has been used to link 
doxorubicin and cis-platin. In the latter case the multifunctionalization implied 
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Figure 1.17.  Molecular structures of paclitaxel- (top) and 
doxorubicin-fullerene C60 conjugates (bottom).
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also the cyclopropanation reaction thus introducing the carboxylic acids as anchor 
points for the ligation of the platin-based complex.73 
C60 has been used to deliver not only anticancer drugs, but also other bioactive 
molecules like warfarin, a coumarin anticoagulant drug.74 The fluctuations of the 
concentration of warfarin in the blood, due to a rapid discontinuation, can provoke 
damages as thrombosis. It has been recently concluded that the biological profile of 
the warfarin can be modulated by its conjugation to fullerene.
In another example, erythropoietin (EPO), a hormone mainly produced by kidneys, 
was linked to fullerene and carbon nanotubes.75  The usual administration route of 
EPO is the intravenous injection, but its biological activity can be dramatically 
reduced since it is quite sensitive to the enzymatic degradation into the intestine. 
One interesting approach to optimize the EPO administration consisted in 
absorbing the molecule on porous materials containing fullerene. The 
pharmacokinetic parameters of these preparations were studied, and EPO 
bioavailability was strongly improved when fullerene was used, being almost three 
times higher than the bioavailability obtained by intraperitoneal administration.76
Another methanofullerene with two terminal carboxylic acids was used as counter-
ions to modulate the cellular uptake of polyarginines.77 This derivative behaves as 
an efficient activator of oligo/polyarginines in egg yolk phosphatidylcholine 
membrane, confirming its ability to cross phospholipidic barriers and easily 
penetrate into the cells. However, it was observed that the efficiency of this 
delivery strongly depends on the type of membrane.78 
Recently, it has been observed that fullerenes have the 
ability to penetrate through the skin, paving the way 
to new transdermal administration systems. The 
interaction with human epidermal keratinocytes was 
also analyzed to evaluate cytokine production and 
pro-inflammatory response in the presence of 
fullerene derivatives. Cytokine activity and cell 
viability were found to depend on the concentration 
of the fullerene derivatives.79 In another study, a 
fullerene-based peptide was synthesized and its 
ability to penetrate through flexed and un-flexed skin 
was analyzed.80 The experiments, carried out on 
porcine skin, revealed that mechanical flexion 
increased the penetration by compromising the 
permeability barrier of epidermis.
The first example of fullerene-immunoconjugates was 
reported in 2006, by using a novel multifunctionalized 
water-soluble C60 derivative as fullerene scaffold 
(Figure 1.18). C60 was modified by the Bingel-Hirsch 
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Figure 1.18. Molecular 
structure of the fullerene 
polyadducts developed to link 
antibodies to generate 
fullerene immunoconjugates.
Introduction
21
reaction affording the activated compound sketched on Figure 1.18, ready for the 
covalent attachment of the antibody (Ab) ZME-018 via the disulphide bridge exchange. 
This Ab specifically targets gp240 antigen, which is present in more than the 80% of the 
human melanoma cells. This protein is well-known as targeting agent toward 
melanoma and has already been used to deliver therapeutic agents into this type of 
cancer cells. Therefore, the strategy based on the use of fullerene scaffold is potentially 
advantageous since multiple attachment of different drugs on the 
polyfunctionalized fullerene cage could be performed, developing targeted, single-
dose “drug cocktails”.81
1.3.2 Nucleic acid delivery
New advanced approaches in the treatment of genetic diseases are based on cellular 
delivery of foreign nucleic acids, including DNA, RNA, siRNA, and plasmid DNA 
(pDNA).82
In the last years, the attention has been focused on the development of efficient 
methods to deliver nucleic acids. A good methodology has to meet four basic criteria: 
(i) tight binding of the nucleic acid sequences, (ii) protection of the genetic material 
from the  the nucleases’ degratation in the intercellular comparments, (iii) overcoming 
of  different cell barriers, and (iv) absence of undesired side effects.83  
After the first transfection strategies based on liposomes,84 several systems have been 
devised, classified in viral and non-viral vectors. Viral methods take advantage of the 
ability of viruses to inject their genetic material inside a host cell, but normally a high 
immune response is triggered. Alternatively, the non-viral approaches are based on 
the use of cationic systems like polymers or dendrimers,85  silica nanoparticles,86 
gluco-nanoparticles87 or carbon nanotubes.88 Concerning the non-viral approach, it 
is still necessary to overcome the low efficiency and/or the acute immune response 
often observed in most of the tested systems.
In this context, fullerenes derivatives containing one or more positive charge on 
their cage have been explored as nucleic acid delivery carrier.89  This field was 
pioneered by Nakamura’s group, who synthesized a double-handed fullerene 
transfection derivative with four positive charges (Figure 1.19).90 The derivative 
resulted in binding and delivering double-stranded DNA into cells with efficiency 
comparable to commercial reagents. 
Furthermore, after verifying the protein expression for a long period, it was 
observed that the pDNA-fullerene complex was stable into the cytoplasm.91 
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In order to understand the morphology of complexes between cationic fullerenes 
and pDNA, AFM analyses were performed. This derivative was able to fold a 
supercoiled DNA molecule into a single-molecule complex with the adhesion of 
DNA double strands  displaying only a small increase of the DNA volume.92 This is 
certainly an advantage as other DNA-condensing agents based on lipids or 
dendrimers create larger and less structurally defined aggregates.
The cytotoxicity and in vitro transfection efficiency of a series of fullerene 
conjugates were tested, evidencing some structural requirements for the design of 
efficient transfection fullerene derivatives.93 Transfection efficacy is supposed to be 
strongly related not only to the applied protocols and/or cell types but also to the 
dimension of the DNA-vectors. The latter characteristic is intimately related to the 
structure of the carriers. In fact, different forces are implied in the interaction 
among nucleic acids and fullerene derivatives and the predominant interactions 
are due to the electrostatic charges between the phosphates and the ammonium 
groups, while hydrophobic interactions, hydrogen bonding, and van der Waals 
forces play a secondary role. When the complexation is based only on the charge 
interactions, the obtained constructs are bigger and generally less effective. Taking 
into consideration these important parameters, a library of aminofullerenes 
presenting slight variations on the same structural motif was synthesized. All 
cationic fullerenes were able to condense DNA into aggregates in the nano/
micrometer scale, while only few of them were active in the delivery.93 
In addition, a different approach to obtain cationic fullerenes that can complex 
pDNA for gene delivery has been reported. Two types of multifunctionalized C60 
(Figure 1.20) were prepared by the 1,3-dipolar cycloaddition, thus obtaining a 
mixture of polyadducts which were methylated using an excess of iodomethane. 
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Figure 1.19. Top: AFM images of intact 
multiple DNA molecules R(reagent/base pair 
ratio)=0 (a) and multiple fullerene DNA 
condensates R=2.6 (b). Scale bars = 200 nm 
Bottom: Molecular structure of the cationic 
fullerene able to bind and transfer pDNA.
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The cationic poly-N,N-dimethyl fulleropyrrolidinium salts were used to evaluate 
their capacity to condense pDNA using surface plasmon resonance. A strong 
interaction between both units was measured with an association constant in the 
submicromolar range. These derivatives present the advantage of being totally 
water-soluble, compared to Nakamura’s compound, where potentially toxic DMF 
or DMSO was added as co-solvent, to completely solubilize it.94
Contrary to what hypothesized at the beginning, Remy et al. observed that systems 
with an isotropic distribution of positive charges could be also efficiently 
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Figure 1.20.  Top: Molecular structures of 
polycationic fullerenes derivatives.  Bottom 
right:  Confocal microscopy images of Jurkat 
cells incubated with FITC-fullerene 
derivative (green fluorescence) showing the 
internalization into the cells.
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employed as transfecting agents.95   Several 
generations of polycationic dendrimeric fullerene 
hexakisadducts were tested as potential vectors, 
finding them able to complex DNA into stable 
and positively charged polyplexes. 
Finally, the first in vivo gene delivery experiment 
with fullerene derivatives has been recently 
reported. Thus, a cationic tetraamino-fullerene 
(Figure 1.21), with a high water-solubility, was 
used to complex pDNA, and its efficiency and 
toxicity were compared to Lipofectin.96 No acute 
toxicity was reported for the fullerene complex in 
comparison to Lipofectin administration. The in 
vivo delivery of insulin-2 gene corresponds to an 
increased plasma insulin level and a reduced blood glucose concentration, 
demonstrating the high potential of fullerene derivatives as gene delivery carriers.
1.4 Materials applications of fullerene derivative
A large number of C60 derivatives have been synthesized yielding new materials with 
exciting properties. In fact these derivatives can be organic electronic devices, super-
conductors, liquid crystals and hybrids or are really interesting for electron transfer 
and non-linear optic properties. Inhere the discussion will be focused on for donor-
acceptor and photovoltaics examples.
1.4.1 Donor-acceptor systems
The research on donor-acceptor systems involving fullerenes has attracted the attention 
trying to simulate the photosynthetic system and transforming light into chemical 
energy. In the natural photosynthetic reaction centre, several photoactive units are 
coupled together, so that several photoinduced electron transfer events take place after 
irradiation, giving a long distance and long-lived charge separated state in which the 
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Figure 1.21. Molecular structure 
of the first fullerene-based 
transfection vector for in vivo 
experiments.
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energy is stored (Figure 1.22). The 
easiest approach to an artificial 
model consists of two different units 
(dyad), an electron-donor and an 
electron-acceptor, linked together by 
a covalent or non-covalent spacer.  
C60 have been widely used as an 
electron-acceptor because of its high 
electron affinity and small 
reorganization energy.97 A large 
number of example of dyads have 
been reported on the last years and 
the field has been extensively 
reviewed,98  and, since the overall 
lifetime of the radical pairs depends on the distance and orientation between the donor 
and the acceptor, a series of C60 dyads with various electron donors including 
porphyrins,99 phthalocyanines and their metalated analogs100 tetrathiafulvalene (TTF),
101 ruthenocene and ferrocene102 have been prepared, also using different donor-
acceptor geometries. 
Several dyads have been reported to give charge separated states with lifetimes over 
the !s. For instance, the ferrocene-fullerene dyad (Figure 1.23, left) gives radical pairs 
with lifetime of 2.5 !s,103 while for an exTTF-C60 dyad (Figure 1.23, centre) 174 ns were 
measured,104 The longest radical-ion pair lifetime for a fullerene derivatives, a Zn 
chlorin-C60 (Figure 1.23, right), has been reported by Fukuzumi , and resulted on  120 s 
at -150ºC.105 
Figure 1.23 From left to right: Ferrocene, exTTF,  and chlorin C60 dyads.
Figure 1.22 Schematic representation in an 
energy diagram of the processes of separation 
(CS), shift and recombination charge.
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Another example is given by the phtalocyanine-C60 dyad (Figure 1.24) containing a 
polar triethylenglycol (TEG) chain that self-aggregates into nanostructured 
nanotubules and, as consequence, an  enhancement on the charge separation lifetimes 
up to 1 ms.106 
Figure 1.24. Structure of  a phtalocyanine-C60 dyad and TEM image showing 
nanotubular aggregates formed in water solution.
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1.4.1.1 Porphyrin-C60 dyads
Porphyrin-C60 dyads are among the most investigated systems.107 Porphyrins (P) can 
be  covalently introduced at position 2 of fulleropyrrolidines in the 1,3-dipolar 
cycloaddition reaction.108 These structures usually exhibit photoinduced electron 
transfer (PET) with charge separated state (CSS) with lifetime up to 230 !s at 25ºC. 
Multiple rigid spacers based on amides, diazo derivatives109 and rigid chiral binaphtyl 
compounds110 have been linked to C60 not only by means of the 1,3-dipolar 
cycloaddition, but also using the Diels-Alder cycloaddition,111 and the Bingel reaction,
112 as in the case of a double-bridged P used to synthesize the P-C60 dyad involving a 
trans-2 addition pattern (Figure 1.25).
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This derivative is an hybrid between the covalent and 
the non-covalent interaction approach, in fact its 
photophysical studies showed a good electronic 
coupling and the ultra-fast formation of a CSS that can 
be considered as a reference point for !-stacked P-
fullerene ensembles, even though there is covalent link.
113 Also non-covalent interactions are used to build up 
the dyads, as Van der Waals forces, !-stacking 
interactions, axial coordination or hydrogen bonding. 
The affinity exhibited between fullerenes and 
porphyrins has been demonstrated by X-ray structures 
of co-crystals of different fullerenes and Ps,114 and by observing upfield shifts in 1H and 
13C experiments in toluene when in solution. In other developed approaches P-based 
molecules host C60 inside their cavities, allowing a supramolecular control of the 
electronic properties. For instance, P jaws,115 a kind of bis-P systems, can successfully 
interact with the curved !-system of C60 and, in some cases, light-induced electron 
transfer was observed.116 
Fullerene derivatives containing a pyridyl substituent 
can bind metalloporphyrins by axial coordination, as the 
herein reported complex (Figure 1.26), that 
spontaneously assembles in solution when mixing a 
fulleropyrrolidine bearing a pyridine moiety with Zn(II) 
tetraphenyl porphyrin (ZnTPP). Intramolecular PET was 
observed in dichloromethane leading to a radical-pair 
with a lifetime of 8.6 !s.117 The formation of 1:1 
complexes of C60, functionalized with a pyridyl group, 
and a variety of metalloporphyrins have been observed 
both in solution and in the solid state.118 
Furthermore, when P and C60 are functionalized with 
complementary hydrogen bond motifs, dyads can be 
also assembled in solution.119 A P-fullerene dyad 
(Figure 1.27) was assembled through a two-point 
amminidium-carboxylate binding motif with a high association constant of 107M-1. 
The photophysical studies showed a radical-ion pair states with a lifetime of 10 !s, 
comparable to those of the covalent dyads ones (!1 !s).120 
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Figure 1.25  A double-bridged 
Porphyrin linked to C60.
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Another example has been recently reported, in which a fullerene derivative containing 
a Hamilton receptor was synthesized and assembled with a ZnP resulting into the 
dyad (Figure 1.28). The association constant was in the order of 105 M-1, thanks to the 6-
fold hydrogen-bonding motif. The photophysical measures revealed a radical-ion 
lifetime of 3.1 ns.121
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Figure 1.27. A P-C60 dyad assembled by means of H-
bonding.
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Figure 1.28 A fullerene derivative containing a Hamilton 
receptor assembling a porphyrin to conform a dyad.
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1.4.1.2 Polyads
Donor-acceptor systems are not limited to one single electron transfer between two 
chromophores. In fact, as already mentioned, the photosynthetic reaction centre is 
comprised of a series of electron donors and acceptors that promote an energy transfer 
(ET) cascade. Following the same fashion, fullerene derivatives have been coupled to 
several photo- and electroactive units carefully selected and arranged, mimicking the 
multistep ET nature of the photosynthetic reaction centre. C60 containing various units 
of porphyrins have been synthesized, principally triads and tetrads. Porphyrin (H2P), 
Zinc Porphyrin (ZnP) and Ferrocene (Fc) with different structures have been linearly 
arranged and attached to C60 to investigate their properties. A ZnP-H2P-C60 triad was 
reported122 in which energy transfer from the ZnP to the H2P followed by an electron 
transfer from the excited H2P to C60 was observed. Fc-ZnP-C60 and Fc-H2P-C60 triads 
with a terminal ferrocene unit were prepared, giving two consecutive electron transfer 
processes, in which an electron was transferred from the porphyrin to C60 and then 
from Fc to the P.122  The combination of these two systems gives rise to  a tetrad (Figure 
1.29) in which a sequence of energy and multistep electron transfer events permitted to 
give a very high lifetime (380 !s). 
Also multicomponent polyads, based on linear123 and branched124 multi-P polyads, 
including a Fc-multi-P pentad, have been synthesized.125 In parallel, multinuclear Pc-
C60 polyads have been prepared by covalent or non-covalent interactions. One 
interesting example is the supramolecular triad  of axially coordinated 
subphthalocyanine-triphenylamine-ZnP, which presents a long-lived charge-separated 
state of 6.6 !s (Figure 1.30).126
Figure 1.29 A Fc-ZnP-H2P-C60 tetrad.
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Multiple donor–acceptor systems 
containing TTF have been also 
explored. These include P-C60 
triads bearing terminal TTF and 
exTTF moieties. Series of triads 
based on terminal exTTF or P 
linked to C60 through 
oligophenylene vinylene (OPV) 
molecular wires of different 
lengths have been recently 
reported (Figure 1.31). After light 
irradiation, electron transfer 
occurred leading to up to a 
distance between charges of 40 Å. 
Analogous systems have been prepared with Ps connected to C60 through 
oligothiophene,127 OPE128 and combination of oligothiophene and OPV.
Figure 1.30 A subphthalocyanine-ZnP-C60 triad.
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Figure 1.31 An exTTF- C60 dyad containing an OPV linker.
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1.4.2 Photovoltaics
The excellent electron-accepting properties of fullerenes have been exploited in the 
preparation of organic solar cells, which are considered a possible 
alternative to silicon solar cells. [6,6]-Phenyl-C61-butyric acid 
methyl ester (PCBM) (Figure 1.32) was first synthesized by Wudl 
group129  and is the most widely used C60 derivative in plastic 
solar cells, together with the C70 analog PC71BM.130
Bulk-heterojunction photovoltaic cells are prepared from blends 
of soluble fullerene acceptors with polymers as electron 
donating materials, typically poly(3-hexylthiophene) (P3HT) or 
copolymers with thiophene units. This type of cells display a 
high power conversion efficiency, which ranges from 5 to 7.4%.
131 Many fullerene derivatives have been used in combination 
with different polymers, mainly methanofullerenes, [2+4] 
cycloadducts and fulleropyrrolidines. As methanofullerenes, PCBM is consider the 
most successful acceptor due to an excellent electron mobility. In addition, PCBM 
posses a good miscibility with conjugated polymers and  a large number of structural 
variations in the PCBM structure have been performed, opening the door to a big 
number of fullerene-based solar cells systems with continuously improved efficiencies.
132 In a very recent work, a number of blends containing P3HT and various PCBM 
derivatives  were tested as solar cells, founding a power conversion efficiencies in a 
range from 0.02% to 4.1% as a consequence of the different solubilities of the PCBM 
derivatives. This fact strongly affects the morphologies of its composite with P3HT and 
consequently the resulting efficiency.133  Electron tomography technique was used in 
order to study the 3D morphology of blends of P3HT and PCBM and the influence on 
the power efficiency of the final system.134
Concerning to [2+4] cycloadducts an impressive 6.5% efficiency has been recently 
achieved with a bulk-heterojunction polymer solar cell consisting on a blend of P3HT 
as an electron donor and an indene-C60 bisadduct (Figure 1.33). In addition the results 
were found to be highly reproducible and independent to the active layer thickness in 
the range of 100-300 nm.135
    Fulleropyrrolidines have been used as well as electron 
acceptor for the construction of solar cells, presenting 
lower power conversion efficiencies but promising 
results.136 For instance a novel cyanine-fullerene 
dyads have been used to build up a double-layer 
device obtaining an energetic conversion efficiency 
of 0.1% (Figure 1.34)137 while a 0.02% was found for 
phthalocyanine-fulleropyrrolidine dyad thin films.
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Molecular structure 
of PCBM.
Figure 1.33 Indene-C60 
bisadduct.
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In a similar way, !-conjugated oligomer-tetrafullerene and 
P3HT were used to build a photovoltaic device exhibiting 
a quantum efficiency of 15%.139 Other functionalized 
fullerenes can be useful in order to design efficient solar 
cells. Endohedral fullerenes, as acceptor materials, have 
been used in combination with P3HT, observing 4% 
power conversion efficiency.140 Nonetheless, trannulenes 
(18!-annulenic fluorofullerenes) have been recently used 
as photoactive materials for solar cells in combination 
with polyfluorene polymers.141
The large number of examples reported in literature and 
the stimulating results obtained so far confirm the 
photovoltaic field as one of the most realistic and 
developed applications for fullerene C60.
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Figure 1.34 A cyanine-C60 
dyad.
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Chapter 2
Results and discussion
!It would be possible to describe everything scientifically, but it would make no sense; it would be without 
meaning, as if you described a Beethoven symphony as a variation of wave pressure” 
Albert Einstein
2.1 Control over the 1,3-dipolar cycloaddition
The first part of this thesis has been focused on the deepened study of the main C60 
derivatization method herein used, the 1,3-dipolar cycloaddition of azomethine ylides, 
in order to gather more useful information to be applied in the synthesis of 
dendrofullerenes, described in the next sections. The main goals of this part in fact 
were (i) the obtention of a protocol to increase the reaction yields and decrease the 
reaction time both in the mono and the polyaddition (ii) the control on the multiple 
addition in order to simplify the polyadduct mixture usually obtained when the 1,3-
dipolar cycloaddition is performed following conventional protocols, with special 
attention on the bisadduct formation.
As already discussed in the introduction, the addition of azomethine ylides to fullerene 
C60 is a widely recognized and applied method for functionalizing C60. The formidable 
success of this reaction can be explained by its selectivity in the attack on the [6,6] 
bonds and the easily introduction of many substituents/functional groups. In addition, 
the 1,3-dipolar cycloaddition can be conveniently accelerated when assisted  by 
microwave (MW) irradiation as demonstrated in a large number of examples reported 
in literature.143 Another advantage of this functionalization methodology is the quasi-
irreversibility of the 1,3-dipolar cycloaddition, as compared, for instance, with the 
electrochemical21, photochemical and thermal instability of methanofullerene,22 Diels-
Alder cycloadducts144  or isoxazolinofullerenes.145
Nonetheless, Prof. Martin et al. have recently described how to obtain quantitative 
retrocycloaddition in fulleropyrrolidine derivatives. In this outstanding work, thermal 
and catalytic conditions were tested on five different fulleropyrrolidines. When the 
derivatives were heated to reflux in o-DCB for up to 24 hours, no changes were 
observed, while the addition of maleic anhydride resulted in the retrocycloaddition. 
The addition of a metal catalyst in combination with maleic anhydride was the key to 
obtain the quantitative retrocycloaddition in most of the cases.16 Noteworthy, 
prolonged heating of the fulleropyrrolidines, in the presence of either a dipolarophile 
excess and/or a Lewis acid catalyst, is required for quantitative conversion. Further 
studies on the mechanism of the retrocycloaddition  revealed that the 
fulleropyrrolidine thermal treatment regenerates the 1,3-dipole, which is efficiently 
trapped by the dipolarophile. In addition, it was proved that the nature of the 
substituent on the pyrrolidine nitrogen atom has great impact on the 
retrocycloaddition process: the N-methyl or the unsubstituted pyrrolidinofullerenes 
efficiently undergo the retrocycloaddition reaction while the N-benzoyl derivatives are 
stable if treated in the same experimental conditions.146
We have decided to deepen the study of the 1,3-dipolar cycloaddition and 
retrocycloaddition introducing the use of microwave irradiation, as heating source, and 
ionic liquids (ILs) as cosolvents to achieve a very efficient flash-thermal activation in 
conjunction with a strong activation of polar/ionic intermediates or reactants. Both 
features are associated with the electrolytic nature of ILs, and turn out to play a key 
role in the reactions under examination.147
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Ionic liquids are normally composed by bulky cations and anions, reason why the 
lattice energy is small than in a conventional ionic solid, so resulting into compounds 
with a low melting point (Figure 2.1). ILs have been successfully used as alternatives to 
molecular solvents, for a variety of organic transformations. Recognized advantages 
are their tunable properties, polar character, non volatility, thermal resistance, 
complementarity with water or 
other green media, and liquid 
electrolyte behaviour. Concerning 
their use with fullerenes, only few 
examples are reported in literature 
and solvophobic aggregation effects, 
dominating at low temperatures, 
discourage their use with C60.148 
We started synthesizing seven 
different fulleropyrrolidine 
monoadducts 1-7 (Figure 2.2) 
containing different substituents. All 
of them were efficiently prepared by 
refluxing the correspondent 
aminoacid and aldehyde with 
fullerene C60 in toluene, following 
the classic procedure described in literature.15
Figure 2.1. Comparison between a normal ionic 
solid and an ionic liquid species.
Figure 2.2. Molecular structure of the seven fulleropyrrolidine monoadducts under 
investigation.
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Thus, 2 mg of monoadduct 1-7 were suspended by sonication in 0.5 mL of 1-methyl-3-
n-octylimidazolium tetrafluoroborate ([OMIM]BF4) and later on heated by applying 
MW-irradiation (50 W) and controlling the temperature profile (Tbulk=180ºC) by 
simultaneous cooling with compressed air. The parallel cooling of the system allows a 
higher level of microwave power and the applied air flow is crucial in order to find a 
protocol applicable to a broad panorama of reactions. 
As a result, in these conditions (Scheme 2.1), the retrocycloaddition is achieved 
quantitatively in 5-10 minutes (Table 2.1). The reaction can be conveniently 
monitorized by HPLC of the extracted mixture since pristine C60 quickly precipitates 
from the reaction mixture that contains only IL media, avoiding in this way further 
reactions.
Scheme 2.1. Synthetic protocols for direct and retrocycloaddition of 
azomethine ylides to C60. Reagents and conditions; cycloaddition: 
R1CHO, R2NHCH2CO2H, toluene at reflux temperature; 
retrocycloaddition: ionic liquid, MW irradiation (50 W), 5–10 min.
R2
N
R1
1: R1=H; R2= CH3
2: R1=C6H13; R2=CH3
3: R1= p-CH3O-C6H4; R2= CH3
4: R1= R2= CH3
5: R1= COOC2H5; R2= CH3
6: R1=
N
R2= CH3
7: R1=H; R2= p-HO-C6H4
cycloaddition
retrocycloaddition
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entry FP Conv (%) t(min) R Conditions
a 1 >99 10 21 180ºC, 50W
b 2 >99 5 19 180ºC, 50W
c 3 >99 5 8 180ºC, 50W
d 4 45 10 1 180ºC, 50W
e 5 >99 5 70 180ºC, 50W
f 6 >99 5 87 180ºC, 50W
g 7 >99 5 119 180ºC, 50W
Table 2.1. MW assisted retrocycloaddition of fulleropyrroldines 1-7 in 1-methyl-3-n-
octylimidazolium tetrafluoroborate [OMIM]BF4.
As already discussed, in molecular solvents, the lack of substituents on the pyrrolidine 
ring as compound 1  has been shown to severely inhibit the retrocycloaddition. This 
calls for a stabilization of the incipient azomethine ylide in order for the reaction to 
proceed to an appreciable extent. Indeed, our conditions permit to conclude that the 
impact of the IL is remarkable as N-methyl fulleropyrrolidines bearing either aromatic 
or aliphatic substituent undergo >99% of cycloreversion. The only exception is the 
pyrene derivative 7,  the solubility of which is low in IL media, rendering difficult the 
conversion to C60.
Encouraged by these results, we decided to investigate the role of the ILs in the 
retrocycloaddition, demonstrating that in presence of IL the addition of either a further 
dipolarophile acceptor or a Lewis acid catalyst becomes unnecessary (Table 3.2). To 
confirm this conclusion, control experiments were carried out using FP 2, lowering the 
MW irradiation power to 12 W while introducing either maleic anhydride (Table 3.2, 
entry b) or AlCl3 (Table 3.2, entry c) in the reaction mixtures.
entry FP Conv (%) t(min) Conditions
a 2 76 15 100ºC, 12W
b 2 71 45 100ºC, 12W, maleic acid
c 2 83 45 100ºC, 12W, AlCl3
Table 2.2. MW assisted retrocycloaddition of fulleropyrrolidine 2 in 1-methyl-3-n-
octylimidazolium tetrafluoroborate [OMIM]BF4.
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The key role played by the ionic medium has been further addressed by introducing 
the use of o-DCB as co-solvent and varying the IL nature for the retrocycloaddition of 
fulleropyrrolidine 2 which has been chosen as reference. Noteworthy, phases with ILs 
as dominating component (IL:o-DCB=3:1) preserve the activating effect already 
discussed, although slowing down the overall reaction rate. The latter turns out to be 
almost suppressed when the organic solvent is the main component in the mixture 
(IL:o-DCB=1:3)  (Table 2.3, entries a-f). This observation speaks in favor of a specific 
effect exerted by the IL medium as a bulk which happens to be denatured when 
diluted in o-DCB. In addition, as expected, IL with a different nature, like the 1-
methyl-3-n-butyl imidazolium analogue ([BMIM]BF4), affords sluggish reactions (Table 
2.3, entries g and h) while quantitative cycloreversion is obtained only when in the 
presence of Al-containing counterpart ([BMIM]AlCl4), (Table 2.3, entry i), featuring 
Lewis acid properties.
entry FP IL W (Tbulk/ºC) Conv. (%) t (min) Solvent mixture
a 2 [OMIM]BF4 12(100) 68 45 IL:o-DCB=3:1
b 2 [OMIM]BF4 50(180) 82 45 IL:o-DCB=3:1
c 2 [OMIM]BF4 12(100) 25 45 IL:o-DCB=3:1
d 2 [OMIM]BF4 50(180) 43 45 IL:o-DCB=3:1
e 2 [OMIM]BF4 12(100) 0,02 45 IL:o-DCB=1:3
f 2 [OMIM]BF4 50(180) 5 45  IL:o-DCB=1:3
g 2 [BMIM]BF4 12(100) 0,9 45 IL:o-DCB=1:3
h 2 [BMIM]BF4 50(180) 3,7 45 IL:o-DCB=1:3
i 2 [BMIM]AlCl4 12(100) >99 45 IL:o-DCB=1:3
Table 2.3. MW assisted retrocycloaddition of fulleropyrrolidine 2 in IL:o-DCB. In all reactions:  2 
mg of fulleropyrrolidine in 0.5 mL IL phase, MW heating, magnetic stirring and cooling by 
compressed air at 40 psi. % of FP 2 conversion to C60 monitored by HPLC analysis.
According to the mechanism proposed by Martín,146 cycloreversion is highly 
influenced by the substituents of the fulleropyrrolidine. Thus, electron-acceptors on the 
!-carbon, or electron-donors on the nitrogen, or both will boost up the progress of the 
retrocycloaddition. On this purpose, a 3:1 mixture of [OMIM]BF4:o-DCB was selected, 
since the solubility of the reagents was satisfactory for all substrates, pinpointing the 
sole stereo-electronic impact of the FP on the process under examination.
Despite the strong reactivity enhancement brought about by the combined use of IL 
media and MW-irradiation, the cycloreversion rates remain significantly tuned by the 
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substituents on the pyrrolidine ring. This is clearly visualized from the reactivity ratios 
(R) calculated for FP 1-7, on the basis of estimated initial rates, and referenced to the 
slowest reacting pyrene derivatives 4. The reactivity trend results in the series 
4<3<1<2<5<6<7 with R in the range 8-120 (Figure 2.3).
 
The electron-donating substituent on the nitrogen site turns out to strongly influence 
cycloreversion. On the other hand, the poor reactivity of the pyrene derivative 4 is 
confirmed and it is likely attributed to detrimental steric/aggregation effects.
2.1.1 Selective control over the multiaddition
We focused our attention also on the use of MW-activated IL phases to accelerate the 
thermal azomethine ylide cycloaddition, providing an additional tool for tuning the 
selectivity outcome on the polyadduct distribution (Scheme 2.2). 
Figure 2.3. Time evolution of fulleropyrrolidines 1–7 retrocycloaddition in 
[OMIM]BF4:o-DCB=3:1 (0.5 ml) under MW irradiation,  12 W, with cooling air 
at 40 psi, Tbulk = 100 ºC. Estimated initial rates are as follow: R0(4) = 2.3x10-4 
mmol L-1s-1; R0(3) = 1.9x10-3 mmol L-1s-1; R0(2) = 4.7x10-3 mmol L-1s-1; R0(1) = 
4.7x10-3 mmol L-1s-1; R0(5) = 1.6 x10-2 mmol L-1s-1; R0(6) = 2.7 x10-2 mmol L-1s-1.
!
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Prior to this, the best solvent composition was set for the model synthesis of FP 2, by 
changing the relative IL:o-DCB ratio and optimizing the overall C60 conversion as 
exposed in Table 2.4.
entry [OMIM]BF4:o-DCB Conv. (%) Mono-
FP(%)
Selectivity W Solvent 
Vol (ml)
a 1:0 - - - 12 0,5
b 4:1 18 6 0,5 12 0,5
c 2:1 21 9 0,8 12 0,5
d 1:1 64 22 0,5 12 0,5
e 1:2 58 21 0,6 12 0,5
f 1:3 60 30 1 12 0,5
g 1:3 64 44 2,2 12 1
h 1:9 52 38 3,0 12 1
i 0:1 15 15 - 20 1
Table 2.4.  Effect of [OMIM]BF4:o-DCB ratio on the yield and selectivity of mono- and poly-FPs 
2, obtained by MW-assisted reaction of C60 with sarcosine and heptaldehyde. In all reactions: 
C60 0.14 mmol; sarcosine 0.28 mmol; heptaldehyde 0.56 mmol; Tbulk=100ºC, under magnetic 
stirring and simultaneous cooling by compressed air. Fullerene conversion was monitored by 
HPLC analysis. % of mono-FP 2 monitored by HPLC analysis.  Selectivity expressed as mono-
FP/poly-FP ratio.
CH3NHCH2COOH
N
Me
CH3(CH2)5CHO
CH3NHCH2COOH
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CH3(CH2)5CHO
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Scheme 2.2.  Azomethine ylide cycloadditions to C60 yielding mono 2 and polyadducts under 
MW irradiation, in IL:o-DCB mixtures.
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For this purpose, in all the cases [OMIM]BF4  was used as ionic liquid since gives finer 
fullerene dispersions than other imidazolinium-based ILs. Interestingly, under MW 
irradiation at 12 W, Tbulk=100ºC for 10 min, the change in solvent composition in favor 
of o-DCB leads to a steady increase of the overall yield and of the mono-substitution 
selectivity (Table 2.4, entry f). This latter turned out to be remarkably affected by the 
relative solubility of reagents and products in the solvent system, which is mainly 
controlled by the IL content and by the C60 concentration.
In addition, the selectivity reverts in favor of the monoadduct upon dilution (Table 2.4, 
entries g and h). For the IL-free reaction, which lacks the ionic absorbing component, 
the accelerating effect of MW irradiation, even when the MW power was increased up 
to 20 W, is very poor (Table 2.4, entry i). The results reported herein indicate that also in 
this case the phase IL:o-DCB=1:3 gives the best results, guaranteeing both a fast 
reaction and a convenient selectivity control, which, possibly, depends on clustering/
aggregation phenomena.
Yield optimization was also investigated by varying the relative ratio of the 
azomethine ylide precursors, sarcosine and heptaldehyde, and their additional 
recharge during the reaction that, in turn, was carried out at different C60 
concentrations (Table 2.5, entries a-f).
Under the optimal conditions for monoaddition, the yield of fulleropyrrolidine 2  levels 
off at 40% with no major effects of reagent recharging. Such limiting yield is probably 
attributable to equilibrium constraints, which dictate the observed product 
distribution, as a result of the thermally activated retrocycloaddition involving mono 
and polyfulleropyrrolidines.
Entry Sarcosine/heptaldehyde Conv (%) Mono-FP (%) Selectivity V (mL)
a 1/1 34 16 0,9 0,5
b 2/4 60 30 1 0,5
c 10/20 95 4 0,04 0,5
d 2/4 58 42 2,9 1
e 4/8 69 44 1,8 1
f 2/4+2/4 72 41 1,3 1
Table 2.5.  In all reactions 0.14 mmol of C60, [OMIM]BF4:o-DCB=1:3; MW irradiation at 12 W, 10 
min, Tbulk=100ºC, under magnetic stirring and simultaneous cooling by compressed air. 
Fullerene conversion monitored by HPLC analysis.  Selectivity expressed as:  Mono-FP/Poly-FP 
ratio.
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Interestingly, a fast and quantitative conversion to polyadducts became accessible with 
an excess (10/20-fold) of sarcosine and heptaldehyde when exposed to reagents and to 
MW irradiation (Table 2.5, entry c).
2.1.2 Selective control over the bisaddition
Due to such efficient activation, we decide to study how the reaction selectivity is 
affected by these conditions. Thus, 1,3-dipolar cycloaddition of sarcosine and p-
formaldehyde to fullerene C60 was performed to examine the possible changes in FP 1 
bisadduct distribution under equilibrium regime (Scheme 2.3).
Scheme 2.3. Azomethine ylide cycloadditions to [60]fullerene, yielding monoadduct 1 and 
polyadducts under MW irradiation, in IL:o-DCB mixtures.
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We decided to use a higher concentration of C60 compared to the precedent 
experiments in order to favor the formation of bisadducts. In a first approach the 
reaction mixture was irradiated for 10 minutes at 12 W using o-DCB as solvent, and 
analyzed by HPLC (Figure 2.4a). As a matter of fact a complex mixture of bisadducts 
and polyadducts can be distinguished in the HPLC chromatogram, similar to this that 
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can be found when heating in classic 
conditions. In contrast, the introduction 
of ionic liquid as co-solvent is key to 
obtain a simpler trace, with higher 
concentration of trans-1, trans-2, trans-3 
and equatorial bis-FP 1 (Figure 2.4b).
Motivated by the possibility to get a 
better selectivity we decide to deal with 
the analysis of the time of irradiation and 
its effect on the bisadduct distribution. 
When the sample was irradiated for 20 
minutes, a consequent increase on 
trans-1, trans-2, trans-3 and equatorial 
peaks was observed in the 
chromatogram, while the intensity of 
fullerene and the monoadduct peaks 
decreased. However the presence of an 
irregular baseline in the chromatogram 
indicates the formation of undesired 
higher polyadducts and other 
decomposed species which difficult the 
purification procedure.
Considering the previous restrictions, we 
have irradiated a mixture containing 
exclusively C60, monoadduct 1 and its 
respective bisadducts (Figure 2.5a) at 12 W for 5 minutes using a mixture of IL:o-
DCB=1:3 as solvent.
Thus, we found a remarkable change in the HPLC profile where only monoadduct, 
trans-1, trans-2, trans-3 and a low peak of C60 were present. No traces of trans-4, cis 1-3 
and equatorial were found (Figure 2.5b).
Figure 2.4. HPLC chromatograms of 
crude of reactions (a) classical heating, o-
DCB (b) MW irradiation, IL:o-DCB=1:3 
mixture. solvent
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In order to quantify the variation on the bisadduct distribution by using only IL:o-DCB 
we have irradiated a mixture of C60, p-formaldehyde and sarcosine solved in o-DCB for 
5 minutes,  avoiding in this way the formation of undesired higher polyadducts. The 
results obtained are collected in Table 2.6 in which it can be observed (i) an expected 
decreasing on the monoadduct peak area as a result of a more efficient heating 
provided by the presence of the IL, and  (ii) a clear increasing on the formation of 
trans-1, trans-2 and trans-3 isomers.
Figure 2.5. HPLC chromatograms of a mixture containing C60, 
monoadduct 1 and its bisadducts before MW irradiation in a 
mixture IL:o-DCB=3:1 (a) and after irradiation (b).
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Retention time 
(min)
Derivative Area (%)[a] Area (%) [b]
27 mono 71 44
30 trans-1 0,42 6,6
32 trans-2 6,2 16,8
34 trans-3 8 16,5
37 cis-1 0,1 -
43 trans-4 4,2 4,8
54 equatorial 6,1 7,5
66 cis-2 2,1 3,4
Table 2.6.  Variation on the yield of bisadduct formation expressed as HPLC peak area 
percentage. Reactions: 0.014 mmol of fullerene, 0.055 of p-formaldehyde and 0.028 mmol of 
sarcosine at 12 W. Unreacted C60 % area is not included. [a]2 mL of dichlorobenzene,  2.5 minutes 
[b]1.5 mL of o-dichlorobenzene and 0.5 mL of 
OMIM, 5 minutes.
These results are greatly advantageous 
when the isolation of some of the 
bisadducts is desired, but hard to explain 
exclusively by means of different 
aggregation behaviours.
In order to clarify these results, we have 
also performed DFT calculation on all the 
FP 1 bisadducts, reported in Figure 2.6.
The formation of such products results from 
the reaction between the LUMO of the m-
FP 1 and the HOMO of the ylide, whose 
difference in energy (14.1 Kcal/mol, Figure 
2.7) is much lower than that calculated 
between HOMO and LUMO (138.7 Kcal/
mol). The FP LUMO displays an electron 
density which should favor equatorial, 
cis-2, trans-3 bisadducts.
Figure 2.6. Isomeric C60 bisadducts.
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To assess the thermodynamic stability of the products under equilibrium regime, we 
have calculated the relative energy of the bisadduct derivatives, which have been 
reported in Figure 2.8.
The less stable isomers resulted to be the 
cis (1-3) and trans-4, followed by the 
trans-1 in agreement with the HPLC 
results, where the first four cited isomers 
have not been detected, while only a 
minor amount of trans-1 appeared.
These preliminary results partially explain 
the different changes of the HPLC profile 
commented above. It seems to be the 
collection of two different effects: the 
thermodynamic stability of the bisadducts 
and the different aggregation properties 
provided by each isomer as a result of the 
different ratio between fullerene covered 
surface/fullerene naked surface. 
The optimization of this technique is of 
extreme interest since different factors, as 
stoichiometry, steric factors and power of 
irradiation can play an important role in 
order to obtain higher yields of conversion 
Figure 2.7.  Energy level for HOMO e LUMO of m-FP 1 and  ylide.
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Figure 2.8. Energy of bis-FP 1, with 
respect to equatorial,  the most stable 
bisadduct. 
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and selectivity in the bisadduct formation.
2.2 Synthesis of dendrofullerene derivatives for gene and 
drug delivery
With the purpose of creating new efficient oligonucleotide and drug delivery efficient 
vectors based on fullerene cores we decided to focus our efforts on the synthesis of new 
monoadduct and bisadducts containing polyamidoamine (PAMAM) dendron 
functionalities. The possibility to attach a second unit of the dendron moiety to the 
fullerene sphere represents a chance to increase the biocompatibility of the final 
compounds while increasing the number of potential oligonucleotide or drugs unit to 
the system. In addition, a comparison on the transfection performance among the 
bisadduct isomers would be extremely advantageous to extract several considerations 
for the future design of more efficient systems.
PAMAM dendrimers were firstly studied by Tomalia in 1985, who described the 
synthesis of a new type of macromolecules defined as “starbust dendrimers”.149 One of 
the central core used by Tomalia et al is the ethylendiamine to which is possible to grow 
the dendrimer via Michael addition by using methylacrylate and later on the 
correspondent product is reacted again with an amine (like ethylendiamine). The 
repetition of this sequence brings out the different generations of the PAMAM 
dendrimer (Figure 2.9). 
Morphologic studies carried out on the first generation of the dendrimer show a non-
defined structure while by increasing the dendrimer generation, a spheric structure is 
appreciated.150 One of the most valuable characteristics of these dendrimers is the high 
!
Figure 2.9. PAMAM dendrimers.
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solubility that they exhibite in polar solvents as MeOH and water, that renders them 
very interesting for biological applications, mainly as drug-delivery vectors. Indeed, 
several contributions have been done in this line proposing a mechanism called “click-
in”.151 According to it, the drug will be placed on the inner cavity of the dendrimer, 
stabilized by ionic weak interactions and hydrogen bonding with the internal amide 
groups. 
One of the most exciting examples concerns to a third generation PAMAM dendrimer 
that has been used as a drug carrier of ibuprofene. Up to 78 molecules of ibuprofene 
can be loaded thanks to the interactions of the carboxilic groups of the drug with the 
terminal amine groups of the dendrimer. In addition, it has been demonstrated that 
80% of the complexed ibuprofene can be internalized in to the cell in one hour while 
the naked ibuprofene alone needs 3 hours.152
PAMAM dendrimers are also very appealing as gene delivery carriers. Terminal 
amines of these dendrimers can be positively charged and bind by means of ionic bond 
the negative charged fractions of the oligonucleotides. The complex PAMAM-
oligonucleotide could potentially penetrate the cellular membrane and release the 
oligonucleotide into the nucleus.153
2.2.1 Synthesis of a fullerene moiety containing a terminal 
carboxylic acid
Prior to tackle the synthesis of the different generations of dendrons, we have focused 
on the preparation of mono and bisadducts of fulleropyrrolidine containing carboxylic 
acid functions that can be further used as anchor points for PAMAM dendrons.
On this purpose, the amino acid 9 was synthesized as reported in literature.154 Thus, 
commercial available ß-alanine tert-butyl ester was reacted with benzyl bromoacetate 
that selectively alkylates the amine giving a mixture of unreacted, mono alkylated and 
bis alkylated derivatives. This mixture was purified by chromatographic column in 
order to obtain the desired monoalkylated derivative 8. A further hydrogenation in 
presence of Pd/carbon mixture as catalyst permitted to obtain the unprotected amino 
acid 9.
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To obtain the monoadduct 10, amino acid 9 was dissolved in toluene with p-
formaldehyde and C60 and refluxed for two hours, until no further progress on the 
reaction was detected by thin layer chromatography (TLC).  As a result, a complex 
mixture of polyadducts, monoadduct and unreacted fullerene was obtained and 
further purified by column chromatography to achieve compound 10 with a 45% yield.
However, as exposed in the introduction, polyadducts are extremely appealing, for 
example to decrease the inherent aggregation of fullerene derivatives. With this aim, 
we decided to isolate some of the bisadducts of 10, but the polyadduct mixture 
obtained in the described conditions (reflux, 2h) contained only a small quantity of the 
desired bisadducts and amounts of tris and higher polyadducts, as observed by Electro 
Spray Ionization (ESI) analysis (Figure 2.10).
Figure 2.10 ESI spectra of the crude of the mixture of 10 in classic conditions.
Scheme 2.4. Synthesis of ß-aminoacid 9 and 1,3-dipolar cycloaddition on C60 in classic 
conditions. (i) NEt3, dioxane, r.t., 4 h (ii) H2, Pd/C, EtOH, r.t., 12 h (iii) toluene, reflux, 2 h.
O
O
Cl
+ Br
O
O
(i) O
O
N
H O
O
(ii)
O
O
N
H O
OH
O
O
N
H O
OH + CH2O + C60
(iii)
N
O
O
N
O
O
n
n= 2,3,4,5
+
98
10
9
H3N
n=1 n=2
n=3
N
O
O
n
Chapter 2
49
Shorter times of reaction yielded a bigger quantity of unreacted C60 but, at the same 
time, remarkably decreased the number of major polyadducts, facilitating the 
purification of five of the eight isomers: trans-1, trans-2, trans-3, trans-4 and equatorial 
(Figure 2.11).
However, this method resulted 
into very low quantities of 
bisadducts with yields between 
0.4-2% (see experimental part). 
At this point, the acquired 
knowledge on the control on 
bisaddition (see Paragraph 
2.1.2) was of extreme utility in 
order to obtain good quantities 
of bisadducts 11a-e (Scheme 
2.5). Thus, when the reaction 
was done under MW 
irradiation and using a mixture 
OMIM[BF4]:o-DCB= 3:1, a very 
much simpler mixture of C60, 
monoadduct, trans-1, trans-2, 
trans-3 and equatorial was 
obtained. By combining both 
methods, we were able to isolate reasonable quantities of five different bisadducts: 
trans-1, trans-2, trans-3, trans-4 and equatorial (Scheme 2.5, 11a-e). They have been 
characterized by UV-Vis absorption measurements, which are in perfect agreement 
with the previous works,35 and by 1H and 13C NMR.
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Scheme 2.5.  Optimized conditions to obtain fulleropyrrolidine bisadducts in classical conditions 
(i) o-DCB, p-formaldehyde, reflux, 45 min or (ii) MW, OMIM[BF4]:o-DCB=3:1,  120ºC, 10 min, 20 
W.
Figure 2.11. Symmetry patterns of the eight possible 
bisadducts.
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Also in this case, the pyrrolidine proton NMR spectra, together with the number of the 
carbon signal s from the 13C spectra, confirm the identity of the isomers. In fact, as 
shown in Figure 2.11 the trans-1 presents only one singlet (8H) while in the carbon sp2 
region only 8 signals of the fullerene cage are present, as expected for a D2h geometry. 
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!"#$%&'($)
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11b trans-2
11c trans-3
11d trans-4
11e equatorial 
Figure 2.11. UV spectra (left), pyrrolidinic 1H signals (centre) and fullerene sp2 
13C signals. signals of bisadducts 11a-e.
Chapter 2
51
In the case of C2 symmetry, as for trans-2 and trans-3, the pyrrolidine protons resound 
as 4 doublets of intensity 2H while the sp2 C are 28. Although the trans-4 and the 
equatorial belong to the Cs group, characterized by the presence of a plane of symmetry, 
in the case of trans-4 the pyrrolidine proton signals are still 4 doublets while in the 
equatorial they resound as two singlets and two doublets. Also they differ in the sp2 
carbon region of the NMR spectrum where the trans-4 present 30 peaks and the 
equatorial’s signals are 29.
Monoadduct 10 and bisadducts 11a-e can be easily deprotected from the t-butyl group 
in acidic condition (mixture of DCM/TFA 1:1) to obtain 12 and 13a-e  respectively 
(Scheme 2.6). In the case of bisadducts, longer time of reaction was needed than for the 
monoadduct, in order to achieve the complete deprotection of both carboxylic acid 
functions.
2.2.2 Synthesis of 0.5, 1, 1.5 and 2 G PAMAM dendrons
To prepare PAMAM dendron, we have firstly developed the synthesis to afford 
straightaway the first generation of dendron 18, as sketched in Scheme 2.7. 
Scheme 2.6. Deprotection of monoadduct 10 and bisadducts 11a-e. (i) TFA/DCM, 
r.t., 2-24 h.
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Scheme 2.7. Synthesis of the first generation of PAMAM dendron. (i) CHCl3, r.t, overnight (ii) 
MeOH, r.t, Ar, 24 h, methyl acrylate (iii) MeOH, r.t., Ar, 7 days, ethylenediamine (iv) DCM, r.t, 
48 h, Boc2O (v) MeOH, r.t., Pd/C (10%), 24 h.
Commercially available ethylenediamine was used as the central core for the growing 
of the dendron. In this fashion, one of the two amines was protected with a CBz group 
by treatment with N-(benzyloxy carbonyloxy)succinimide. Thus, a large excess of 
ethylenediamine was used in order to avoid the double protection, obtaining 
compound 14. Consecutively, the very reactive methyl acrylate was added to 14 for a 
contemporary double aza-Michael reaction, resulting into bis-methyl ester derivate 15. 
The attempts of reacting compound 16  with N-Boc ethylenediamine to afford 17 
resulted in very low yields of the desired product, despite various conditions were 
studied, by changing temperature, number of reagent equivalents, and time of reaction.
Thus, an excess of ethylenediamine was added to a solution of 15 and stirred for five 
days, when eventually the presence of a new compound (the desired product 16) was 
revealed. After two more days no further progression was observed and the reaction 
was stopped. Terminal amines were protected by treatment with di-tert-butyl 
dicarbonate leading to a mixture of unreacted, mono and bis-protected dendron, 
efficiently separated by chromatography to afford pure 17. Last, benzyl group was 
easily removed by hydrogenation using Pd/C as catalyst giving 18 quantitatively.
2.2.1.1 Synthesis of the 0.5 G generation
The dendron 0.5 G generation, containing two terminal carboxylic acids protected with 
methyl group, can be easily achieved by following the same pathway described in the 
Scheme 2.7, to achieve 15. After hydrogenation, the CBz group was selectively removed 
from compound 15  to obtain compound 19 (Scheme 2.8).
However, we decided to synthesize the tert-butyl analogue of compound 15, since the 
hydrolysis of methyl esters coupled on to the fullerene has been only reported in a few 
cases, using harsh conditions. For this purpose, tert-butyl acrylate was efficiently used 
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instead of methyl acrylate in order to induce the double Michael addition to the amine. 
Longer time of reactions, with lower yields, were needed to obtain 20, since tert-butyl 
acrylate is much less reactive than the methyl analogue. Once more, catalytic 
hydrogenation permitted to obtain quantitatively compound 21.
Scheme 2.8. Synthesis of dendron 0.5 generation.  (i) MeOH, r.t., Pd/C (10%),  24 h (ii) MeOH, 
r.t., Ar, 24 h, tert-butyl acrylate (iii) (i) MeOH, r.t., Pd/C (10%), 24 h.
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2.2.1.2 Synthesis of the 1.5 and 2 G generation
Motivated by the facility to obtain the first generation by the synthetic strategies 
described before, we decide to face the synthesis of the second generation by following 
the same protocol, as reported in Scheme 2.9. In this fashion, consecutive addition of 
methyl acrylate to 17 yielded 22, further treated with an excess of ethylenediamine to 
afford 23, the main core of the second generation. As for the 1G derivative, addition of 
a solution of Boc anhydride was performed, but eventually, even if the presence of the 
bis Boc-protected derivative was revealed by mass spectroscopy, the complexity of the 
mixture (extremely rich in mono-Boc protected compound), did not allow the 
separation of the mixture. Several conditions were tested in order to optimise the 
reaction conditions, including classical and MW-assisted heating up to 80ºC and 
addition of water, among others, but no significant changes were observed. This fact 
can be possibly explained by the formation of intramolecular hydrogen bonding that 
partially cover one of the amine groups as reported from other groups.155
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Scheme 2.9.  Attempt of synthesis of the second generation PAMAM dendron (i) MeOH, r.t, Ar, 
24 h, methyl acrylate (ii) MeOH, Ar, 7 days, ethylenediamine (iii) DCM, r.t, 24-168 h, Boc2O.
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In order to achieve the second generation of the dendron and to maintain the 
consistence with the 
protective group strategy 
(other protecting groups as 
acetyl worked with success 
on compound 23), we 
proceed as depicted in the 
Scheme 2.10. Compound 17 
was reacted with tert-butyl 
acrylate to afford 24 that 
w a s s u c c e s s f u l l y 
hydrolyzed in acidic media 
to obtain 25. Thus, a very 
much reactive derivative 
towards the amide-bond 
formation was obtained, 
that was successfully 
reacted with N-Boc 
ethylenediamine. This 
reaction was further 
optimized using distilled N-
Boc ethylenediamine.
By using hydrogenation in 
presence of catalyst, the 
benzyl group was 
selectively removed in 
compounds 24 and 26 to 
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Scheme 2.10. Synthesis of the protected second generation 
dendron 26. Reaction conditions: (i) MeOH, r.t, Ar, 24 h, t-
butyl acrylate (ii) MeOH/TFA, 24 h (iii) N-Boc 
ethylendiamine, DCM, r.t., 7 days.
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obtain the 1.5 and 2 generations of the PAMAM dendron (27 and 28 respectively) 
(Scheme 2.11) .
2.2.1.3 Coupling reactions with C60 monoadduct
Having the fullerene mono and bisadduct derivatives bearing carboxylic functionalities 
and the four different generations of dendron derivatives with an unprotected amine, 
we proceeded to the their coupling via amidation. In principle, the activation of the 
carboxylic groups by using conventional activating agent procedures followed by the 
addition of the amine would make possible the formation of the desired derivatives.
The coupling reaction was firstly optimized using the first generation dendron 12 and 
the monoadduct 12 (Scheme 2.12). It was observed that the use of a 10 equivalents of 
EDC and DMAP and the use of pyridine as solvent resulted into a better performance 
of the reaction. In addition, when very strict anhydrous conditions were used the yield 
boosted up. As a result, a satisfactory 80% of yield was obtained, recovering in a good 
quantity the first generation dendrofullerene 29.
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Scheme 2.12. Coupling reaction between deprotected fullerene monoadduct 12 and first 
generation dendron 18 to afford 29. (i) EDC, DMAP, Ar, anhydrous pyridine , r.t., 12 h.
These experimental conditions were applied to the coupling between the monoadduct 
12  and the other generations of the PAMAM dendron, as reported in Scheme 2.13, 
obtaining dendrofullerenes 30, 31 and 32. Noteworthy, the coupling of 12  with 0.5 G 
(21) and 2G (28) generations gave the low yields, probably due for 21 to its low 
solubility in pyridine, and, in the case of 28, to the formation of intramolecular 
hydrogen bonds inducing steric effects in the proximity of the free amine.
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Scheme 2.13.  Coupling between 0.5G, 1.5 and 2G dendrons and monoadduct 12. (i) 21, EDC, 
DMAP, anhydrous DMF, 80ºC, 12 h (ii) 27,  EDC, DMAP, anhydrous pyridine, room 
temperature, 36 h (iii) 28, EDC, DMAP, anhydrous pyridine/CHCl3, 0ºC, 12 h.
In Figure 2.12, the 1H-NMR spectra between 2-4 ppm of 29, 30, 31, 32 are reported. This 
part of the spectra present the PAMAM signals and the differences in spectrum 
complexity are evident, starting from a the very simple spectrum for 29, in which only 
five triplets are observed, to a the very complex multiplet region for 32.
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Figure 2.12.  From bottom to top, 1H-NMR 
spectra between 2 and 4 ppm of 29 (a), 30 
(b), 31 (c), 32 (d), showing the signals 
corresponding to the dendron moiety.
(a)
(b)
(c)
(d)
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All the purified bisadducts were successfully coupled to the first generation dendron, 
giving derivatives 33a-e (Scheme 2.14).
Scheme 2.14. Coupling between bisadducts 13a-e and first generation PAMAM dendron. (i) 18, 
EDC, DMAP, HOBt, Ar, anhydrous DMF/CHCl3, 50ºC, 12-60 h.
The deprotection of all mono and bis dendrofullerenes was performed by TFA 
treatment, obtaining 34, 36 and the trifluoroacetic salts of 35, 37, 38a-e (Scheme 2.15).
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Scheme 2.15. Deprotection of all dendrofullerene derivatives (i) TFA/DCM, r.t., 4-48 h.
2.2.2 Aggregation studies 
Dynamic Light Scattering (DLS) has been used to determine the presence and the 
size of aggregates in water solution, at neutral pH, of monoadduct 35 and bisadducts 
38d and 38e, which resulted highly soluble in aqueous media (Figure 2.13).
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Monoadduct 35  presented already aggregation at a concentration of 10-5 M as detected 
by the UV spectra and DLS, with an almost identical curve profile at 10-4 and 10-3 M, 
concentration at which part of 35 precipitated and should be removed by 
centrifugation.
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Figure 2.13.  Water solution of 35, 38d and 38e (10-3M) after centrifugation.
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 Bisadducts solutions at 10-6, 10-5, 10-4 M exhibited a non aggregation profile in the UV 
spectra, confirmed by DLS where only temporally small aggregates were observed 
with an average hydrodynamic ratio of <10 nm in which no Gaussian curve could be 
satisfactory fitted, meaning the absence of relevant aggregation in the solution.
To find aggregation in bisadducts 38d 
and 38e it was necessary to increase the 
concentration up to 10-3 M. The two 
isomers behave differently as expected 
considering the different distribution of 
the hydrophilic and hydrophobic 
portions on the fullerene surface. 
Indeed, the equatorial isomer presents 
two types of clusters, the smallest with 
average hydrodynamic ratio of 7 nm 
(32.7%) while the largest has an 
average hydrodynamic ratio of 300 nm 
(Figure 2.14). 
Trans-4 isomer presents only larger 
aggregates with an average 
hydrodynamic ratio of 192 nm (60%) 
and 807 nm (38%) (Figure 2.14). 
These results perfectly match with 
what observed in the UV spectra, 
(Figure 2.15) where the UV features of 
the trans-4 isomer appear broad, 
specially the two typical small bands at 
620 and 710 nm, while the equatorial’s 
were still perfectly define.
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Figure 2.14 DLS spectra of monoadduct 35 and 
bisadducts 38d and 38e.
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These considerations where further demonstrated by analytic measurement of the 
maximum solubility of these derivatives, obtained by the UV of the saturated solution 
in neutral water. Monoadduct 35 presents a discrete solubility of 1.02 mg/mL while 
10.02 mg of trans-4 isomer 38d can be solved in 1 mL of neutral water. Interestingly, the 
equatorial isomer 38e is much more soluble than its trans-4 analogue with a remarkable 
solubility value of 23.90 mg/mL, confirming in this manner the precedent obsevations.
2.2.3 Complexation studies
As already discussed in the section 1.3.2, cationic fullerene derivatives possess the 
ability to efficiently condensate nucleic acids and deliver it into the cell.
In this part, we have focused on proving the  great potential of these derivatives as 
siRNA transfection vectors by performing complexation studies with siRNA, 
eventually analyzed by agarose gel electrophoresis as imaged in Figure 2.16. 
Although all the tested compounds are able to complete complex siRNA, remarkable 
differences can be found among them. Thus, as expected, monoadduct 35 needed the 
highest N/P ratio (15) to achieve full complexation. In addition, the different 
distribution of the positive charges around the apolar carbon cage, strongly 
influenciates the performance of the different bisadducts. Trans-1 and trans-2 isomers 
Figure 2.15 UV spectra of solutions 10-4M of compounds 38d 
and 38e  in water.
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fully complex siRNA with  a N/P ratio of 1 while trans-3 requires a higher value (2.5). 
In addition, trans-4 and equatorial presented  the worst values among the bisadducts 
isomers since N/P of 5 and 7.5, respectively, were needed.
Figure 2.16 Electrophoretic motility of dendrofullerenes 35 and 38a-e, reconstituted at 1 mg/
mL in 5% dextrose complexed with siRNA. Various N/P (+/-) ratios of the four conjugates were 
complexed to a fixed 0.5 µg of siRNA. Full complexation for every fullerene derivative is 
highlighted in white.
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2.2 Synthesis of dendrofullerene hexakisadducts for gene 
and drug delivery
After successfully synthesizing the series of dendritic monoadducts 34-37 and 
bisadducts 38a-e, we have focused our attention on the synthesis of Th-symmetrical 
hexakisadduct, herein referred as hexakisadduct for brevity (Figure 2.17), 
incorporating the 1G dendron 18 into its structure. From the practical point of view, the 
hexakisadduct of fulleropyrrolidine has been never reported as pure compound, since 
it would demand an enormous effort in order to separate it from the reaction mixture. 
Thus, we have decided to switch to the Bingel-Hirsch reaction, where several examples 
of Th-symmetrical fullerene hexakisadducts have been reported. The preparation of 
fullerene hexakisadducts has been introduced and largely developed by Prof. Hirsch,43 
but the original procedure was conveniently modified by Sun et al, 44 who described 
how the use of a large excess of the bromination agent (normally CBr4) and the base 
(DBU) resulted into simpler mixtures of isomers and increased 
yields.
To prepare the hexakisadduct coupled to 1G PAMAM dendron 
18, two different strategies were proposed, (i) the earlier 
attachment to six malonyl units containing a linker and 
two terminal carboxyl acids and subsequent coupling of 
the desired dendron moiety and (ii) the conjugation of 
the dendron moiety to the malonyl unit and subsequent 
nucleophilic addition to the fullerene.
In a first stage, we face the synthesis of a proper linker 
between the C60 and the dendron moieties (Scheme 2.16). Thus, when a mixture of 
succinic anhydride, N-hydroxysuccinimide, DMAP and tert-butyl alcohol was refluxed 
in toluene for 24 hours in the presence of NEt3, compound 39 was easily obtained and 
crystalized. It was further reduced by using BH3- DMS to obtain 40.
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Scheme 2.16. Synthesis of 42. (i) DMAP, t-BuOH, toluene, NEt3, reflux, 24 h (ii) BH3-DMS, THF, 
N2, r.t., 0ºC (iii) malonyl dichloride, anhydrous DCM, 12 h (iv) formic acid, DCM, 6 h.
Figure 2.17.  Structure of the 
fullerene cage with the Th-
sym metr i ca l hexak i s 
positions in red.
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Compound 40 was easily reacted with the malonyl chloride in anhydrous conditions to 
give 41, later deprotected by  formic acid to yield 42.
To find the most appropriate conditions for the coupling, we started the exploration 
using, instead of 1G PAMAM dendron, the 2,2!-(ethylenedioxy)bis(ethylamine). Its 
monoBoc derivative 43  was easily obtained by using Boc anhydride. Several conditions 
for the next step were tested, varying temperature and number of equivalents of DCC 
and DMAP. The optimum was achieved when 42 (1 eq), 43 (2.2 eq) and DMAP (2.2 eq) 
were dissolved in anhydrous DCM, cooled to 0ºC and subsequently DCC was added in 
small portions, to obtain 44. The Bingel-Hirsch reaction on fullerene was performed 
following the conditions described by Sun: a large excess of CBr4 and DBU was used to 
induce nucleophilic addition of 43 to the C60 in the presence of DMA, used as 
templating agent. The mixture was allowed to react for 5 days to successfully obtain 44 
(Scheme 2.17). When scale-up reactions were performed (more than 10 mg of 
fullerene), the purification process was remarkably difficult and the isolation of the 
hexakisadduct was only possible using preparative HPLC technique.
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Scheme 2.17. Synthesis of hexakisadduct 45. (i) MeOH, r.t, 24 h,  Boc2O (ii) EDC, DMAP, CHCl3, 
24 h, 0ºC (iii) CBr4, DMA, DBU, anhydrous o-DCB, r.t., Ar, 5 days.
We decided to explore also the second strategy. Thus compound 41 was allowed to 
react for 3 days with C60  using the  conditions described before, to afford 46 as a pale 
yellow solid. In this case, both small-scale and large-scale nucleophilic 
cyclopropanation permitted the isolation of 46 by chromatographic silica column.
NH2
O
O
NH2 NH2
O
O
NHBoc
(i)
42
COOHO
O
O
O
HOOC
43
+ (ii)
O
O
O
O
NH
O
O
NHBoc
O
BocHN
O
O
H
N
O
44
(iii)
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
NH
O
O
BocHN
O
NH
O O
NHBoc
O
HN
O
O
NHBoc
O
HN
O
O
NHBoc
O
HN
O
O
NHBoc
OHN
O
O
NHBoc
O
HN
O
O
BocHN
OH
NO
OBocHN
O
NH
O
O
BocHN
O
NH
O
O
BocHN
NH
O O
NHBoc
O
O
NH
O
O
NHBoc
O
45
Chapter 2
67
The 12 tert-butyl ester groups were successfully hydrolyzed by addition of TFA to the 
pure solid of 46 to afford 47, which contains 12 carboxylic acid residues and, from the 
following coupling reaction using 43, a very complex mixture could expected. Indeed, 
only the use of 100 equivalents of EDC and DMAP permitted to properly activate all 12 
carboxylic acids and to obtain compound 45 in good yields (Scheme 2.18).
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Scheme 2.18. Synthesis of hexakisadduct 45 via coupling. (i) CBr4, DMA, DBU, anhydrous o-
DCB, r.t., Ar, 3 days (ii) TFA/DCM, 1 day (iii) 43, EDC, DMAP, N2, anhydrous DCM , 0ºC, 12 h.
So, both strategies were satisfactory when applied with the 2,2!-
(ethylenedioxy)bis(ethylamine).  Taking into account this results, a simply coupling 
between dendron 18  and the hexakisadduct 47 was performed using a large excess of 
coupling agent to obtain compound 49. However, although the presence of 49 was 
detected by MALDI spectroscopy, the reaction crude consisted of a very complex 
mixture of compounds, highly difficult to purify. 
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This remarkable difference on the reactivity between dendron 18  and 43 can be 
ascribed to a combination of steric factors and formation of intramolecular hydrogen 
bonds.
On the other hand, these steric factors were not relevant in the coupling between 42 
and the first generation dendron 18, resulting into compound 48. Sun’s procedure was 
again used to afford the hexakisadduct containing 12 units of dendron 18. In addition 
to longer reaction times, a lower yield (15% ) for 49  compared to 45 was obtained 
(Scheme 2.20).
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Scheme 2.20. Synthesis of the symmetric hexakisadduct containing 12 units of 1G  PAMAM 
dendron (i) 18, EDC, DMAP, r.t., 0ºC, 24 h (ii) 47,   CBr4, DMA, DBU, Ar, anhydrous o-DCB, r.t., 8 
days.
The 1H-NMR and 13C spectra of 49  in CDCl3 are reported in Figure 2.18 with their 
respective assignments for each signal. Interestingly, in the 13C-NMR spectra only two 
sp2 carbon signals are observed as expected for a D2h symmetry. Noteworthy, it is also 
possible to observe the quaternary equivalent sp3 carbons of the fullerene at 79 ppm 
(Figure 2.18, bottom, q) and the one corresponding to the malonyl portion (Figure 2.18, 
bottom, p).
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The use of mild acid media provided by the addition of TFA to 45 and 49 resulted into 
hexakisadduct 50, containing 12 positive charges, and dendron hexakisadduct 51, with 
36 positive charges respectively (Scheme 2.21).
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CDCl3.
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Scheme 2.21. Deprotection of hexakisadducts 45 and 49 (i) TFA/DCM, r.t., 24-48 h.
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2.3 Loading chromophores on dendrofullerene derivatives
The attachment of chromophores, as porphyrins, to fullerene derivatives with an 
enhanced solubility in water, as dendrofullerenes, is of interest not only for biological 
purposes,   i.e. DNA photocleavage, but also for materials science, for example with the 
possibility to build dyads apt to give electron transfer and charge separation states in 
polar media, resembling processes that can be found in nature, as the photosynthesis.
With this aim, we started with the synthesis of an asymmetric porphyrin where three 
meso positions were occupied by pyridine substituents while the fourth meso position 
contained a methyl ester group, potential anchor point for the conjugation. This 
structure provides three potential positive charges conferring additional solubility to 
the final derivative.
The synthesis of the mentioned porphyrin has already been described in literature,156 
and we used the classic  Rothemund method. The use of pyrrole and two aldehydes 
gave a statistic mixture of the possible six isomers 52a-f (Scheme 2.22)  which were 
efficiently separated by column chromatography. The major drawback of this approach 
is the low yield (2%) obtained for porphyrin 52e, reason why large scale-up reactions 
were mandatory to obtain a good quantity of 52e to work with.
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Scheme 2.22. Synthesis of porphyrin 52. (i) propionic acid, reflux, 90 min.
The ester function of porphyrin 52e was then  easily converted into the corresponding 
carboxylic acid (compound 53, Scheme 2.23) by  hydrolysis in strong basic media. 
Derivative 52e was also reduced by using LiAlH4 to yield 54 and a subsequent Swern 
oxidation afforded the aldehyde porphyrin 55. So, derivatives 54 and 55 can be used 
respectively in a coupling reaction with a fullerene derivative bearing amine or 
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hydroxyl groups and in the cycloaddition reaction, in presence of C60 and a proper 
amino acid.
Thus, to prepare an analogue of 1G 
dendrofullerene 29 bearing the tris(4-
pyridyl) porphyrin we performed the 
cycloaddition with amino acid 9, C60 
and p-nitrobenzaldehyde to obtain 
56. This compound presents two 
potential anchor points, since the 
deprotection of the tert-butyl group 
will afford a free carboxylic acid and 
the nitro group can be reduced to 
amine. The reduction of the nitro 
group has been widely describe in 
literature, where three main 
procedures has been reported: (i) 
reflux in acetic acid in the presence of 
iron (ii) use Samarium diiodide as 
selective reductive agent (iii) catalytic 
hydrogenation in the presence of 
PtO2 or Nickel Raney. The first 
procedure was immediately 
disregarded due to the required harsh 
conditions, while samarium diiodide 
seemed to not work properly with 
fullerene derivatives. On the other 
hand, it has been reported that catalytic 
hydrogenation in presence of fullerene 
can reduce the fullerene double bonds. In order to find a convenient nitro reduction 
protocol, we used a simpler fullerene derivative (compound 57, scheme 2.24), prepared 
using sarcosine instead of amino acid 9, p-nitrobenzaldehyde and C60. 
Compound 57 was hydrogenated in the presence of PtO2 as catalyst, and the reaction 
was monitored by TLC. After three hours the  amine fulleropyrrolidine 57 were 
required to obtain 58 in good yields (80%, see scheme inserted into Figure 2.19) , while 
longer times  of reaction  led to the formation of unknown fullerenic species. In the  1H-
NMR spectra  (Figure 2.19) it is possible to appreciate the differences of the signals 
corresponding to the phenyl ring  of the nitro derivative of 57 and the amino analogue 
58, whose spectrum shows also a broad singlet at 3.8 ppm, integrating two protons, 
corresponding to the amine group.
Scheme 2.23. Modification of functional 
groups in porphyrin 52e. (i) THF/MeOH, 
KOH 40%, 1h (ii) LiAlH4, THF, r.t., 2h (iii) 
oxalyl chloride, DMSO, -70ºC.
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Scheme 2.24. 1,3-dipolar cycloadditions to afford 
fulleropyrrolidines 56 (top) and 59(bottom) with a 
lateral p-nitro group. (i) toluene, reflux, 1 h.
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Figure 2.19.  1H-NMR spectra of nitro derivative 57 (bottom) 
and amine derivative 58 (top). (i) toluene, H2, Pd/C, r.t.,  3 
h.
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Thus, compound 56 was first hydrolyzed in acidic media to give 59 that was 
successfully coupled with the first generation PAMAM dendron 18, obtaining 60. The 
reduction of the nitro group to amine was performed following the previously 
described procedure obtaining the amine derivative 61 (Scheme 2.25). The latter was 
coupled with porphyrin 53 in the presence of EDC and DMAP as activating agents, but 
derivative 62 was obtained in very low yields in all the tested conditions. The best 
result (yield 10%) was get using 10 equivalents of both EDC and DMAP. 
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Scheme 2.25. Synthetic strategy to obtain for the porphyrin attachment to dendrofullerene 61 
via amide linkage. (i) TFA/DCM, r.t., 2h (ii) 18, EDC, DMAP, Ar, anhydrous pyridine, r.t., 12h 
(iii) toluene, H2, Pd/C, r.t.,  12h (iv) EDC, DMAP, Ar, anhydrous DMF, 24h.
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Compound 63 was characterized by both 1H and 13C-NMR. In the 1H-NMR spectrum 
reported in Figure 2.20, the signals corresponding to the porphyrin can be clearly 
observed between 7 and 9 ppm, the fulleropyrrolidine ring protons are at 4.3 and 5.2 
ppm, and from 2-4 ppm it is possible to observe the dendron signals. At -3 ppm there is 
also a broad singlet corresponding to the characteristic protons at the endo- positions of 
the porphyrin (2 H).
Even though the preparation of the dendrofullerene dyad was achieved, the low yield 
obtained in the process induced us to explore a more appealing synthetic strategy.
In this second approach, derivative 55 was allowed to react with amino acid 9 and C60 
in a mixture of toluene/DMF to obtain compound 63. The advantage of this procedure 
was clearly to recover the unreacted porphyrin by simple column chromatography. 
Furthermore, the hydrolysis of the t-butyl ester yielded 64 that was efficiently coupled 
with the first generation PAMAM dendron 19, obtaining 65.
Figure 2.20. 1H-NMR spectrum of derivative 63 in CDCl3.
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Scheme 2.26. Synthesis of a P-C60 dyad 63 via 1,3-dipolar cycloaddition (i) DMF, reflux, 3h (ii) 
TFA/DCM, 1 h, r.t. (iii) EDC, DMAP, Ar, DMF anhydrous, 24 h, r.t.
Thus, with two different synthetic paths,  the tris(4-pyridyl)porphyrin was successfully 
linked to a first generation dendrofullerene to obtain derivatives 62 and 65, which 
differ in the presence of a short linker present in the case of 62, while in the case of 65 
the porphyrin is direct attached to the fullerene functionalization. 
As last stage, we  have methylated both P-C60 dyad 62 and 65. Firstly, we treated both 
compounds with a large excess of CH3I using a small quantity of DMF until their 
complete solubilization leaving by reflux under stirring. The reaction was screened by 
reversed-phase HPLC, observing no further progression after 72 hours within the 
presence of a single peak in the chromatogram.  When the reaction is performed at 
room temperature, it was possible to observe the presence of an additional peak in the 
chromatogram, the not methylated N-pyrrolidinic compound, as revealed by ESI. 
Compounds 66  and 67 were not isolated, but  to the crude of reaction was directly 
passed an HCl gas flow for 5 minutes to obtain 68 and 69. The final compounds 
presented a discrete solubility in DMSO that permitted to characterize them by 1H-
NMR technique and confirm the grade of methylation, as sketched on Scheme 2.27.
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Scheme 2.27  Methylation  and subsequent Boc-deprotection of compounds 62 and 65. 
Conditions: (i) Methyl Iodide/CHCl3, reflux, 72h (ii) HCl gas, DMF, 15 min
Surprisingly, global yields in both synthetic pathways are very similar, 7 synthetic steps 
are needed in the case of 69 with 9% yield, while 5 synthetic steps were required for 68, 
with a 8.9% yield. However,  it has to be considered the possibility to simply recovered 
the unreacted porphyrin 55 on the crude of 63, that eventually confirms the second 
pathway as the most advantageous one.
As expected, both compounds 68 and 69 were found to be highly soluble in water, 
presenting very low aggregation as revealed by the UV-Vis spectrum (Figure 2.21). 
Although broader, the absorption profile of 68 and 69 in neutral water present the same 
profile of its precursor when dissolved in CHCl3  being perfectly distinguishable the 
Soret Band at 420 nm and the Q bands region from 470 to 650 (Figure 2.21).
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Figure 2.21. Comparison between UV 
spectra of compound 62 and 65 in CHCl3 
and 68 and 69 in neutral water.
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Chapter 3
Conclusions
“Science is built up with facts,  as a house is with stones. But a collection of facts is no more a science than 
a heap of stones is a house.” 
Henri Poincaré
In conclusion, during this thesis we have synthesized, isolated and characterized a 
broad range of fullerene derivatives containing dendron moieties that can found 
potential uses in biological applications such as drug and gene delivery. In concrete, we 
have focused most of our efforts on to the obtention of bisadducts of fulleropyrrolidine 
incorporating two units of the dendron moiety, which implies a substantial decreasing 
in the aggregation behavior and an increased biocompatibility. In order to achieve this, 
we have firstly studied the 1,3-dipolar cycloaddition in special conditions: using a 
combination of ionic liquids and MW irradiation, obtaining remarkable differences into 
the reactivity and selectivity as compared with the classic conditions. 
Thanks to this, we have been able to obtain five bisadducts isomers that were further 
conjugated with a first generation PAMAM dendron, obtaining five analogue systems 
with a completely different distribution of the polar appendage around the carbon 
cage. This could have several implications, reason why we have performed solubility 
and aggregations studied by DLS technique confirming different aggregation and 
solubility behaviours. Furthermore, the ability of these derivatives to complex siRNA 
has been demonstrated by electrophoretic analysis concluding very satisfactory results 
for all the compounds, revealing at the same time interesting differences between the 
dendrofulleropyrrolidine bisadducts.
Motivated by the chance to enrich this library of compounds, we have synthesized a 
Th-symmetric a dendritic hexakisadduct by using the Bingel-Hirsch procedure. In this 
case, an homogeneous distribution of the positively charged dendritic appendage 
around the fullerene sphere is obtained, that could involve different results as a 
transfection vector.
The third part of this thesis has been devoted to the attachment of a porphyrin unit to a 
monoadduct dendrofullerene by two different pathways: including a short amide 
linker or not. In addition to the synthetic exercise, the final structures obtained are 
porphyrin-fullerene dyads, multipositively charged with a remarkable solubility in 
water and the possibility to assemble with other complementary negatively charged 
structures in order to further develop more complex systems.
Conclusion
81
Chapter 4
Experimental Part
“Facts are the air of scientists. Without them you can never fly.” 
Linus Pauling
4.1 Materials and methods
Reagents and solvents
All reagents have been purchased from Sigma-Aldrich, Fluka and J. T. Backer.  Solvents were 
used as received without further purification, unless specified. Deuterated solvents were 
purchased from Cambridge Isotope Laboratories. Fullerene C60 has been acquired from Bucky-
USA.
NMR experiments
1H-NMR and 13C-NMR spectra were recorded on a Varian Gemini-200 (200 MHz) or a Varian 
INOVA (500 MHz) at Università degli Studi di Trieste or on a Bruker Avance-300 (300 MHz) or a 
Bruker Avance-400 (400 MHz) at Friedrich-Alexander-University Erlangen-Nuremberg. 
Chemical shifts are expressed as ppm (parts per million) with respect to the solvent signal and 
multiplicity of the peaks with the following abreviations: s (singlet),   d (doublet), dd (doublet of 
doublets), t (triplet), m (multiplet), q (quadruplet), b(broad).
Mass spectroscopy
Electrospray (ES-MS) experiments were recorded on a Perkin-Elmer API1 at 5600 eV at 
University of Trieste and  MALDI-TOF or HR-MALDI-TOF measurements were made with an 
AXIMACFR plus instrument (Kratos Analytical) or a Shimadzu AXIMA Confidence at 
Friedrich-Alexander-University Erlangen-Nuremberg. 
HPLC analyses
HPLC analyses of section 3.1 were conducted at Università degli studi di Padova with a 
Cosmosil Buckyprep column (5 µm particles) and toluene as mobile phase (flow = 1 ml min).
HPLC analyses of Section 3.2 were conducted with a Phenomenex Prodigy 5 µm silica or a Luna 
5 µm silica using the following program for bisadducts 10a-e:
A: t=0 min, toluene 100%, flow 0 mL/min; 
B: t =3 min, toluene 100%, flow 1 mL/min; 
C: t = 33 min, toluene/ethyl acetate 90/10, flow 1 mL/min; 
D: t =83 min, toluene 100%, flow 1 mL/min; 
E: t =85 min, toluene 100%, flow 0 mL/min.
Purity of final or key compounds was checked using Phenomenex Prodigy 5 µm silica or a Luna 
5 µm silica columns for normal phase and a Luna 5 µm column for reverse phase using adapted 
elution programs in each case.
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MW synthesis
MW synthesis with ionic liquids were carried at Università degli studi di Padova in a CEM-
Discover-Coolmate monomode microwave apparatus with simultaneous monitoring of 
irradiation power, pressure and temperature.  During the high-power experiments, interruption 
of MW irradiation and sonication was necessary to homogenize the sample and improve the 
yields.
 
Dynamic light scattering measurements
DLS measurements were performed in a Malvern ZS apparatus with the following 
specifications:  sampling time=120 s, refractive index of medium (water)= 1.33, refractive index 
of particles= 1.40, viscosity= 1.0150 cP, T=20ºC.
UV Measurements
UV-Vis-NIR measurements were recorded on a Varian 5000 UV-Vis-NIR spectrometer.
IR Spectroscopy
FT-IR spectra have been registered with a FT-IR Perkin Elmer system 2000.. 
Thin Layer chromatography (TLC)
Reactions have been followed by silica gel thin layer chromatography 60 F254 purchased from 
Merck. Non-colored compounds were detected by UV lamp or by oxidation with a solution of 
KMnO4.
Chromatographic separation
Chromatographic separations have been performed with silica gel 40-63 µm from Merck, unless 
differently specified.
Gel electrophoresis
siRNA-dendrofullerene complexes were prepared by mixing 0.5 mg of siRNA in 30 mL of 5% 
dextrose with the dendrofullerene at different charges ratio. 0.5 mg of free siRNA was used as a 
conrtol.  Complexes were incubated for 30 minutes at room temperature to allow complete 
complexation to occur. siRNA complexes or siRNA alone were mixed with orange dye solution 
(1:10 dilution) and loaded onto 1% w/v agarose/TBE gel containing ethidium bromide (0.5 
mg/mL). The gel was run for 45 min at 70 mV (BioRad, UK). The gel was then photographed 
under UV light using GeneGenius system (PerkinElmer Life and Analytical Sciences, USA)
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4.2 Synthetic procedures
Synthesis of 1
In a 50 mL flask, fullerene C60 (87 mg, 0.12 mmol), formaldehyde (3 mg, 0.12 mmol) and 
sarcosine (11 mg, 0.12 mmol) were solved in 10 mL of toluene and sonicated for 15 
minutes. The mixture was refluxed for 30 min and the solvent removed under reduced 
pressure. The solid sample was separated on silica chromatographic column by using 
toluene to remove first the unreacted fullerene, and then toluene/ethyl acetate 95:5 to 
isolate the monoadduct. The solvent of the collected fractions was evaporated at 
reduced pressure, then 1 mL of chloroform was added to the solid residue, the solution 
was filtrated to remove the solid impurities and precipitated using distilled methanol 
to afford 1 as a brown solid  (18 mg, yield 84% on recovered C60).
Characterizations were in accordance with literature.14,15
1H-NMR (200 MHz, CDCl3): ! 4.73 (s, 4H), 2.82 (s, 3H).
Synthesis of 2
In a 50 mL flask, fullerene C60 (87 mg, 0.12 mmol), heptaldehyde (25 mg, 0.22 mmol) 
and sarcosine (53 mg, 0.60 mmol) were solved in 10 mL of toluene and sonicated for 15 
minutes. The mixture was refluxed for 20 min and the solvent removed under reduced 
pressure. The solid sample was dissolved in toluene and separated by silica 
chromatographic column  by using toluene to remove first the unreacted fullerene and 
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1
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then toluene/ethyl acetate 9:1 to isolate the monoadduct. The solvent of the collected 
fractions was evaporated at reduced pressure, the residue was dissolved in 1 mL of 
CS2, filtrated to remove the solid residues and precipitated using distilled methanol 
and petroleum ether to afford 2 as a brown solid (22 mg, 92% expressed on recovered 
C60).
Characterizations were in accordance with literature.14,15
1H-NMR (200 MHz, CDCl3): ! 4.72 (d, J=9.0 Hz, 1H), 4.53 (d, J=9.0 Hz, 1H), 4.20 (s, 1H), 
2.80 (s, 3H), 2.50 (t, J=7.4 Hz, 2H), 2.25-1.80 (m, 8H), 1.75 (t, J=7.0 Hz, 2H).
Synthesis of 3
C60 (87 mg, 0.12 mmol), p-methoxybenzaldehyde (27 µL, 0.22 mmol) and sarcosine (53 
mg, 0.60 mmol) were solved in 10 mL of toluene and sonicated for 15 minutes. The 
mixture was refluxed for 30 min and the solvent removed under reduced pressure. The 
reaction mixture was separated by silica chromatographic column using toluene to 
remove first the unreacted fullerene and then toluene/ethyl acetate 9:1 to isolate the 
monoadduct. The solvent of the collected fractions was evaporated at reduced 
pressure, the residue was dissolved in 1 mL of CHCl3, filtrated to remove the solid 
residues and precipitated using distilled methanol and petroleum ether to afford 3  as a 
brown solid.
Characterizations were in agreement with literature.14,15
1H-NMR (200 MHz, CDCl3): ! 7.52 (d, J=2.1 Hz, 2H), 7.30 (d, J=2.0 Hz, 2H), 4.81 (d, 
J=8.9 Hz, 1H), 4.60 (d, J=8.9 Hz, 1H), 4.18 (s, 1H), 3.20 (s, 3H), 2.81 (s, 3H). 
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Synthesis of 4
In a 50 mL flask, fullerene C60 (87 mg, 0.12 mmol), a 50% solution of  ethyl glyoxalate in 
toluene (48 µL, 0.22 mmol) and sarcosine (53 mg, 0.60 mmol) were solved in 10 mL of 
toluene and sonicated for 15 minutes. The mixture was refluxed for 3 h and the solvent 
removed under reduced pressure. The solid sample was separated on silica column 
chromatography by using toluene to remove first the unreacted fullerene and then 
toluene/ethyl acetate 95:5 to isolate the monoadduct. The solvent of the  collected 
fractions was evaporated at reduced pressure, added 1 mL of CHCl3, filtrated to 
remove the solid residues and precipitated in distilled methanol and petroleum ether 
to afford 4 as a brown solid (15 mg, 91% yield on recovered C60).
Characterizations were in agreement with literature.14,15
1H-NMR (200 MHz, CDCl3): ! 4.81 (d, J=8.9 Hz, 1H), 4.72 (d, J=8.9 Hz, 1H), 4.33 (s, 1H), 
3.22 (s, 3H), 2.80-2.73 (m, 5H).
Synthesis of 5
In a 50 mL flask, fullerene C60 (87 mg, 0.12 mmol), isonicotinaldehyde (62 µL, 0.22 
mmol) and sarcosine (53 mg, 0.60 mmol) were solved in 10 mL of toluene and 
sonicated for 15 minutes. The mixture was refluxed for 3 h and the solvent removed 
under reduced pressure. The solid sample was separated on silica column 
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chromatography by using toluene to remove first the unreacted fullerene and then 
toluene/ethyl acetate 90:1 to isolate the monoadduct. The solvent of the  collected 
fractions was evaporated at reduced pressure, added 1 mL of CHCl3, filtrated to 
remove the solid residues and precipitated in distilled methanol and petroleum ether 
to afford 5 as a brown solid (15 mg, 80% on recovered C60).
Characterizations were in agreement with literature.14,15
1H-NMR (200 MHz, CDCl3): ! 8.82 (m, 2H), 8.20 (m, 2H), 5.2 (d, J=8.9 Hz, 1H), 4.92 (d, 
8.9 Hz, 1H), 4.50 (s, 1H), 3.28 (s, 3H).
Synthesis of 6
In a 50 mL flask, fullerene C60 (87 mg, 0.12 mmol), formaldehyde (3 mg, 0.12 mmol) and 
N-(4-hydroxyphenyl)glycine (20 mg, 0.12 mmol) were solved in 10 mL of toluene and 
sonicated for 15 minutes. The mixture was refluxed for 30 min and the solvent 
removed under reduced pressure. The solid sample was separated on silica column 
chromatography by using toluene to remove first the unreacted fullerene, and then 
toluene/ethyl acetate 9:1 to isolate the monoadduct. The solvent of the  collected 
fractions was evaporated at reduced pressure, added 1 mL of CS2, filtrated to remove 
the solid residues and precipitated in distilled methanol to afford 1 as a brown solid. 
(15 mg, 77% expressed on recovered C60).
Characterizations were in agreement with literature.14,15
1H-NMR (200 MHz, CDCl3): ! 7.76 (d, 2H, J= 1.5 Hz), 7.52 (d, 2H, J= 1.5 Hz), 4.32 (s, 
4H).
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Synthesis of 7
In a 50 mL flask, fullerene C60 (87 mg, 0.12 mmol), 1-pyrenecarboxaldehyde (28 mg, 
0.12 mmol) and sarcosine (53 mg, 0.60 mmol) were solved in 10 mL of o-
dichlorobenzene and sonicated for 15 minutes. The mixture was refluxed for 2 h and 
the solvent removed under reduced pressure. The solid sample was separated on silica 
column chromatography by using toluene to remove first the unreacted fullerene, and 
then toluene/ethyl acetate 9:1 to isolate the monoadduct. The solvent of the  collected 
fractions was evaporated at reduced pressure and 1 mL of CS2 was added to the solid 
residue, filtrated to remove the solid particles and precipitated in distilled methanol to 
afford 1 as a brown solid. (10 mg, 67% expressed on recovered C60).
Characterizations were in agreement with literature.14,15
1H-NMR (200 MHz, CDCl3): ! 9.29 (m, 2H), 8.32 (m, 4H), 8.10 (m, 3H), 5.41 (d, J=9.1 Hz, 
1H), 5.01 (d, 9.1 Hz, 1H), 4.91 (s, 1H), 3.30 (s, 3H).
Synthesis of 8
A solution of benzylbromoacetate (5.58 mL, 35.3 mmol) in MeOH (20 mL) was added 
via addition funnel to a solution of tert-buthyl-3-amminopropanoate clorhydrate (8.0 g, 
44.0 mmol) and NEt3 (12.2 mL, 88.0 mmol) in MeOH (300 mL). The mixture was leaved 
under magnetic stirring at room temperature for 12 hours. The solvent was removed 
under reduced pressure, the crude was ridisolved in 100 mL of CHCl3 and extracted 
with brine (x3). The organic phase was dried by adding anhydrous Na2SO4. Column 
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chromatography in silica gel was required using first Petroleum ether and then Ethyl 
acetate/Petroleum ether (1:1), to obtain 8 as a pale yellow oil. (4.2 g, yield 40.5 %)
Characterizations were in agreement with literature.154
1H-NMR ( 200 MHz, CDCl3): ! 7.37-7.33 (m, 5H, CHAr); 5.17 (s, 2H, Ar-CH2); 3.48 (s, 
2H, CO-CH2-NH); 2.87 (t, J=6.0 Hz, 2H,), CH2-CH2-CO); 2.45 (t, 2H, J=6.0 Hz, NH-CH2-
CH2); 2.39 (bs, 1H, NH); 1.44 (s, 9H, Boc). 
Synthesis of 9
To a solution of 8 (4.2 g) in MeOH (150 mL) was added a catalytic amount (400 mg) of 
Pd/C (10% w/w). The solution was leaved by magnetic stirring overnight in an 
hydrogen atmosphere.  The mixture was then filtrated under celite and the solvent 
removed under reduced pressure to obtain 9 as a white solid (2.9, quantitative yield).
Characterizations were in agreement with literature.154
1H-NMR ( 200 MHz, CD3OD): ! 3.50 (s, 2H, NH-CH2-CO); 3.23 (t, J=7.1 Hz, 2H, CO-
CH2-CH2); 2.70 (t, J=7.1 Hz, 2H, CH2-CH2-NH); 1.47 (s, 9H, Boc). 
Synthesis of 10 and 11a-e (classic conditions).
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 A mixture of C60 (2.00 g, 2.80 mmol), 6-tert-butyl hydrogen 3-azahexanedioate (1.13 g, 
5.60 mmol) and p-formaldehyde (0.42 g, 14 mmol) were dissolved in 500 mL of 
ortodichlorobenzene and heated to reflux for 45 minutes. The solvent was removed by 
reduced pressure obtaining a brown solid as a mixture of unreacted C60, monoadduct 
and bisadducts, separated by column chromatography on silica gel using, as eluent, 
toluene / ethyl acetate mixtures: 100/0 (C60), 99/1 (monoadduct, trans-1), 98/2 (trans-2, 
trans-3 and cis-1), 97/3 (trans-4), 96/4 (equatorial). Trans-3  was further separated from 
cis-1 with a second chromatographic column using toluene/ethylacetate/cyclohexane 
(98/1/1) as eluent. Precipitation of the isolated bisadducts from a highly concentrated 
CHCl3 solution with distilled MeOH gave products 10 and 11a-e as brown solids.
Synthesis of 10 and 11a-e (MW conditions).
A mixture of C60 (20 mg, 28 µmol), 6-tert-butyl hydrogen 3-azahexanedioate (11.3 mg, 
56 µmol) and p-formaldehyde (5 mg, 120 µmol) were suspended with a Vortex on a 
mixture of 2 mL of o-DCB/OMIM [BF4] 3:1 and sonicated for 20 min. Then, the reaction 
was heated under MW irradiation at 120ºC for 10 min. The resulting crude was 
extracted with water (5mLx3) to remove the ionic liquid and purified by column 
chromatography on silica gel using as eluent toluene / ethyl acetate mixtures: 100/0 
(C60), 99/1 (monoadduct, trans-1), 97/3 (trans-4), 96/4 (equatorial). Precipitation of the 
isolated bisadducts from a highly concentrated CHCl3 solution with distilled MeOH 
gave products 10 and 11a-e as brown solids.
10 monoadduct: classic: Yield 1.11 g (45%). MW: 40 mg (60 %)
1H-NMR (200 MHz, toluene[d8]): ! 3.92 (s, 4H, CH2 pyrrolidine), 3.10 (t, J= 8.9 Hz, 2H, 
N-CH2), 2.69 (t, J= 8.9 Hz, 2H, CH2-CO), 1.51 (s, 9H, tBu).
13C-NMR (50 MHz, CDCl3 + CS2): ! 171.22, 154.68, 147.12, 146.07, 145.85, 145.51, 145.25, 
145.10, 144.37, 142.92, 142.45, 142.01, 141.90, 141.71, 139.78, 139.99, 136.10, 80.65, 70.46, 
67.62, 50.25, 35.40, 28.17.
MS ESI m/z: found 892.1 (M+1), 914.1 (M+Na); calculated 891.88.
UV/vis (toluene, "/nm): 325, 433, 704.
FT-IR (KBr): # (cm-1) 2971, 2922, 2776, 2327, 1726, 1628, 1454, 1427, 1389, 1364, 1344, 
1247, 1219, 1150, 1115, 1043, 895, 846, 768, 703, 597, 574, 561, 553, 542, 526, 478.
 
11a (trans-1): classic: Yield 13.00 mg (0.5%). MW: Yield  5 mg, 15%
 1H-NMR (400 MHz, CDCl3): ! 4.70 (s, 8H, CH2 pyrrolidine), 3.53 (t, J = 8.9 Hz, 4H, N-
CH2), 2.97 (t, J = 8.9 Hz, 4H, CH2-CO), 1.61 (s, 18H, Boc).
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 13C-NMR (125 MHz, CDCl3): ! 171.93, 153.78 (8C), 147.90 (4C), 146.38 (8C), 145.66 (8C), 
144.43 (8C), 142.53 (4C), 140.95 (8C), 136.73 (8C), 81.13, 68.63 (4C), 68.14 (4C), 50.58 (2C), 
35.52 (2C), 28.49 (6C).
 MS ESI m/z: found 1064.5 (M+1), calculated 1063.76.
 UV/vis (toluene, "/nm): 320, 458, 491, 668.
 FT-IR (KBr): # (cm-1) 2971, 2816, 1721, 1553, 1534, 1470, 1453, 1424, 1391, 1343, 1142, 
1022, 768.
11b (trans-2): classic: Yield 48.10 mg (1.6%).
 1H-NMR (400 MHz, CDCl3): ! 4.67 (d, J = 9.1 Hz, 2H, CH2 pyrrolidine), 4.49 (d, J = 9.1 
Hz, 2H, CH2 pyrrolidine), 4.36 (d, J = 9.1 Hz, 2H, CH2pyrrolidine), 4.33 (d, J = 9.1 Hz, 
2H, CH2 pyrrolidine), 3.43 (t, J = 6.9 Hz, 4H, CH2-N), 2.90 (t, J = 6.9 Hz, 4H, CH2-CO), 
1.58 (s, 18H, Boc).
 13C-NMR (75 MHz, CDCl3): ! 171.50, 158.48 (2C), 152.81 (2C), 152.62 (2C), 152.00 (2C), 
147.97 (2C), 147.26 (2C), 146.65 (2C), 146.58 (2C), 145.97 (2C), 145.83 (2C), 145.60 (2C), 
145.21 (2C), 145.19 (2C), 144.89 (2C), 144.70 (2C), 143.75 (2C), 143.34 (2C), 143.20 (2C), 
142.12 (2C), 142.08 (2C), 142.03 (2C), 141.93 (2C), 141.07 (2C), 141.05 (2C), 139.17 (2C), 
139.12 (2C), 134.09 (2C), 133.32 (2C), 80.42, 68.76 (2C), 68.59 (2C), 67.32 (2C), 67.12 (2C), 
49.85 (2C), 35.05 (2C), 27.81 (6C).
 MS ESI m/z: found 1063.6 (M+1), calculated 1063.76.
 UV/vis (Toluene, "/nm): 431, 477, 724.
 FT-IR (KBr): #  (cm-1) 2976, 2359, 1715, 1555, 1455, 1420, 1390, 1350, 1266, 1141, 1031, 811, 
762
11c (trans-3): classic: Yield 53.20 mg (1.8%).
 1H-NMR (500 MHz, CDCl3): ! 4.42 (d, J = 9.0 Hz, 2H, CH2 pyrrolidine), 4.37 (d, J = 9.0 
Hz, 2H, CH2 pyrrolidine), 4.15 (d, J = 9.0 Hz, 2H, CH2 pyrrolidine), 4.09 (d, J = 9.1 Hz, 
2H, CH2 pyrrolidine), 3.30 (t, J = 7.0 Hz, 4H, CH2-N), 2.81 (t, J = 7.0 Hz, 4H, CH2-CO), 
1.58 (s, 18H, Boc). 
13C-NMR (50 MHz, CDCl3): ! 170.89, 153.30 (2C), 152.11 (2C), 152.92 (2C), 152.16 (2C), 
149.04 (2C), 148.63 (2C), 148.16 (2C), 148.11 (2C), 147.8 (2C), 147.80 (2C), 145.86 (2C), 
145.11 (2C), 145.06 (2C), 144.99 (2C), 144.74 (2C), 144.47 (2C), 143.84 (2C), 143.76 (2C), 
143.73 (2C), 143.33 (2C), 142.32 (2C), 141.57 (2C), 141.11 (2C), 140.86 (2C), 140.69 (2C), 
139.15 (2C), 136.23 (2C), 135.62 (2C), 81.72, 68.22 (2C), 67.91 (2C), 65.67 (2C), 64.96 (2C), 
50.01 (2C), 32.75 (2C), 27.92 (6C). 
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MS ESI m/z: found 1063.6 (M+1), calculated 1063.76.
 UV/vis (toluene, !/nm): 414, 462, 700. 
FT-IR (KBr): " (cm-1) 2933, 2359, 1731, 1674, 1558, 1506, 1463, 1367, 1147, 1008, 769. 
11d (trans-4): classic: Yield 26.00 mg (0.9 %). MW: Yield  8 mg, 22%
 1H-NMR (400 MHz, CDCl3): # 4.33 (d, J = 8.8 Hz, 2H, CH2 pyrrolidine), 4.19 (d, J = 9.1 
Hz, 2H, CH2 pyrrolidine), 4.11 (m, 4H, CH2 pyrrolidine), 3.27 (t, J = 7.0 Hz, 4H, CH2-N), 
2.77 (t, J = 7.0 Hz, 4H, CH2-CO), 1.58 (s, 18H, Boc).
 13C-NMR (125 MHz, CDCl3): # 171.90, 155.04 (2C), 153.04 (2C), 151.83 (2C), 151.29 (1C), 
151.11 (2C), 149.99 (1C), 149.65 (2C), 148.71(2C), 148.34 (2C), 148.05(1C), 147.87 (2C), 
146.63 (2C), 146.60 (2C), 146.51 (2C), 145.95 (2C), 145.40 (2C), 145.35 (2C), 145.04 (2C), 
143.16 (1C), 143.01 (2C), 142.52 (2C), 142.17 (2C), 142.13 (2C), 141.80 (2C), 141.64 (2C), 
139.52 (2C), 139.07 (2C), 136.52 (2C), 135.84 (2C), 131.63 (2C), 81.19, 69.75(2C), 69.52(2C), 
68.17(2C), 67.53 (2C), 50.63 (2C), 35.79 (2C), 28.62 (6C).
 MS ESI m/z: found 1063.6 (M+1), calculated 1063.76.
 UV/vis (toluene, !/nm): 416, 452, 705.
 FT-IR (KBr): " (cm-1) 2924, 2359, 1732, 1559, 1453, 1366, 1258, 1157, 1032, 798.
11e (equatorial): classic: Yield 41.06 mg (1.4%) MW: Yield  9 mg, 23%
1H-NMR (500 MHz, CDCl3): # 4.08 (m (d+s), 4H, CH2pyrrolidine), 4.01 (d, J = 9.8 Hz, 
2H, CH2pyrrolidine), 3.91 (s, 2H, CH2 pyrrolidine), 3.19 (m, 4H, CH2-N), 2.71 (m, 4H, 
CH2-CO), 1.58 (s, 18H, Boc).
13C-NMR (75 MHz, CDCl3): # 171.92, 171.90, 159.42 (2C), 153.96 (2C), 153.42 (2C), 153.13 
(2C), 150.23 (1C), 149.29 (2C), 148.46 (2C), 148.17(1C), 148.16 (2C), 147.64 (2C), 147.63 
(2C), 147.16 (2C), 147.01 (2C), 146.27 (2C), 145.57 (2C), 145.51 (2C), 145.04 (2C), 144.79 
(2C), 144.10 (2C), 143.62 (2C), 142.68 (2C), 142.21 (2C), 142.20 (2C) 142.00 (2C), 141.84 
(2C), 141.16 (2C), 139.60 (2C), 137.12 (2C), 136.00 (2C), 81.18, 81.14, 70.13 (2C), 69.89 
(1C), 69.81 (1C), 67.99 (2C), 67.65 (1C), 67.03 (1C), 50.65 (1C), 50.50 (1C), 35.73 (1C), 
35.72 (1C), 28.63 (6C).
MS ESI m/z: found 1063.6 (M+1), calculated 1063.76.
UV/vis (toluene, !/nm): 399, 423, 750.
FT-IR (KBr): " (cm-1) 2949, 2361, 1714, 1502, 1451, 1363, 1260, 1150, 1036, 842, 757.
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Synthesis of 12 and 13a-e
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10.00 mg (11.22 and 9.40 mmol for 12 and 13a-e respectively) of compound were solved 
in 10 mL of a mixture DCM/TFA (1:1) and stirred for 24 h. The reaction crude was 
diluted with additional 10 mL of DCM and extracted with brine (x2) to remove the 
excess of TFA. The organic phase containing a brown solid in suspension was 
recovered and the solvent removed by reduced pressure obtaining the desired 
unprotected derivative in quantitative yields.
12 (monoadduct): 9.35 mg,
1H-NMR (200 MHz, pyridine[d5]): ! 4.51 (s, 4H, CH2 pyrrolidine), 3.68 (t, J= 7.0 Hz, 2H, 
N-CH2), 3.30 (t, J = 7.0 Hz, 2H, CH2-CO).
The low solubility of 12 did not allow to record the 13C spectrum.
MS ESI m/z: found 834.9; calculated 835.77.
UV/vis (THF, "/nm): 333, 433, 706.
FT-IR (KBr): # (cm-1) 2919, 2360, 1747, 1642, 1429, 1386, 1359, 796, 768, 724, 553, 527.
13a (trans-1): 8.80 mg, 1H-NMR (200 MHz, pyridine[d5]): ! 4.50 (s, 8H, CH2 
pyrrolidine), 3.42 (t, J = 7.0 Hz, 4H, N-CH2), 2.60 (t, 4H, J=6.0 Hz, CH2-CO).
13C-NMR (50 MHz, pyridine[d5]): ! 174.90, 154.48 (8C), 149.82 (4C), 148.13 (8C), 145.50 
(8C), 144.62 (8C), 141.50 (4C), 140.92 (8C), 136.74 (8C), 68.43(4C), 67.96 (4C), 50.20 (2C), 
36.20 (2C).
MS ESI m/z: found 951.4 (M+1), calculated 950.81. UV/vis (pyridine, "/nm): 318, 450, 
480, 666.
FT-IR (KBr): # (cm-1) 2969, 2805, 1720, 1550, 1532, 1470, 1453, 1434, 1386, 1340, 768.
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13b (trans-2): 8.83 mg, 
1H-NMR (200 MHz, pyridine[d5]): ! 4.67 (d, J = 9.0 Hz, 2H, CH2 pyrrolidine), 4.49 (d, J 
= 9.2 Hz, 2H, CH2 pyrrolidine), 4.36 (d, J = 9.2 Hz, 2H, CH2 pyrrolidine), 4.33 (d, J = 9.1 
Hz, 2H, CH2 pyrrolidine), 3.70 (m, J = 7.0 Hz, 4H, CH2-N), 3.03 (m, J = 7.1 Hz, 4H, CH2-
CO). 
13C-NMR (75 MHz, pyridine[d5]): ! 173.30, 159.02 (2C), 152.65 (2C), 152.58 (2C), 152.02 
(2C), 149.25 (2C), 147.26 (2C), 146.45 (2C), 146.18 (2C), 145.92 (2C), 145.76 (2C), 
145.68(2C), 145.21 (2C), 145.19 (2C), 144.99 (2C), 144.69 (2C), 143.44 (2C), 143.36 (2C), 
143.31 (2C), 142.12 (2C), 142.08 (2C), 142.02 (2C), 141.89 (2C), 141.27 (2C), 141.15 (2C), 
139.87 (2C), 139.10 (2C), 133.99 (2C), 133.32 (2C), 68.76 (2C), 68.59 (2C), 67.32 (2C), 65.12 
(2C), 50.05(2C), 36.15 (2C).
MS ESI m/z: found 951.2 (M+1), calculated 950.81.
UV/vis (pyridine, "/nm): 421, 457, 724.
FT-IR (KBr): # (cm-1) 2966, 2459, 1715, 1565, 1453, 1420, 1390, 1350, 1264, 801, 760.
13c (trans-3): 8.82 mg, 
1H-NMR (200 MHz, pyridine[d5]): ! 4.51 (d, J = 9.0 Hz, 2H, CH2 pyrrolidine), 4.45 (d, J 
= 9.0 Hz, 2H, CH2 pyrrolidine), 4.10 (m, 4H, CH2 pyrrolidine),  3.5 (t, J = 7.2 Hz, 4H, 
CH2-N), 2.91 (t, J = 7.2 Hz, 4H, CH2-CO).
13C-NMR (50 MHz, pyridine[d5]): ! 171.52, 154.33 (2C), 153.51 (2C), 152.44 (2C), 152.22 
(2C), 150.87 (2C), 150.62 (2C), 150.43 (2C), 150.10 (2C), 149.62 (2C), 149.53 (2C), 148.92 
(2C), 147.24 (2C), 147.05 (2C), 146.92 (2C), 146.67 (2C), 146.13 (2C), 145.82 (2C), 145.25 
(2C), 145.14 (2C), 144.68 (2C), 143.34 (2C), 142.89 (2C), 142.46 (2C), 142.33 (2C), 142.00 
(2C), 141.46 (2C), 140.28 (2C), 140.00 (2C), 69.58 (2C), 69.30 (2C), 67.00 (2C), 66.29 (2C), 
51.02 (2C), 36.82 (2C). 
MS ESI m/z: found 951.2 (M+1), calculated 950.81.
UV/vis (pyridine, "/nm): 420, 452, 702.
FT-IR (KBr): # (cm-1) 2930, 2370, 1731, 1674, 1558, 1505, 1463, 1367, 769. 
13d (trans-4): 8.78 mg
1H-NMR (200 MHz, pyridine[d5]): ! 4.43 (d, J = 9.1 Hz, 2H, CH2 pyrrolidine), 4.26 (d, J 
= 9.0 Hz, 2H, CH2 pyrrolidine), 4.12 (m, 4H, CH2 pyrrolidine), 3.27 (t, J= 7.2 Hz, 4H, 
CH2-N), 2.77 (t, J= 7.1 Hz, 4H, CH2-CO).
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13C-NMR (100 MHz, pyridine[d5]): ! 173.40, 153.24 (2C), 153.02 (2C), 151.63 (2C), 151.19 
(2C), 150.96 (1C), 149.79 (1C), 148.95 (2C), 148.70 (2C), 148.43 (2C), 148.00 (1C), 147.67 
(2C), 147.37 (2C), 146.92 (2C), 146.88 (2C), 144.85 (2C), 144.34 (2C), 144.12 (2C), 144.01 
(2C), 141.06 (1C), 141.01 (2C), 141.25 (2C), 141.17 (2C), 141.09 (2C), 139.27 (2C), 139.02 
(2C), 137.27 (2C), 136.04 (2C), 134.52 (2C), 133.99 (2C), 131.33 (2C), 67.55 (2C), 66.52 
(2C), 66.17 (2C), 66.22 (2C), 50.44 (2C), 35.42 (2C).
MS ESI m/z: found 951.6 (M+1), calculated 950.81 
UV/vis (pyridine, "/nm): 414, 452, 705. 
FT-IR (KBr): # (cm-1) 2925, 2360, 1722, 1559, 1453, 1366, 1258, 799.
13e (equatorial): 8.84 mg,
1H-NMR (500 MHz, pyridine[d5]): ! 4.12 (m, 4H, CH2 pyrrolidine), 3.91 (s, 4H, CH2 
pyrrolidine), 3.88 (t, J = 9.0 Hz, 4H, CH2-N), 3.16 (t, J = 9.0 Hz, 4H, CH2-CO)
13C-NMR (50 MHz, pyridine[d5]): ! 176.22, 154.32 (2C), 154.11 (2C), 153.96 (2C), 154.00 
(2C), 152.01 (1C), 149.28 (2C), 148.25 (2C), 148.17 (1C), 148.15 (2C), 147.93 (2C), 147.65 
(2C), 147.20 (2C), 146.74 (2C), 145.97 (2C), 145.41 (2C), 145.01 (2C), 144.92 (2C), 144.99 
(2C), 144.29 (2C), 143.88 (2C), 142.77 (2C), 142.50 (2C), 142.46 (2C), 141.80 (2C), 141.63 
(2C), 141.15 (2C), 139.45 (2C), 137.22 (2C), 135.64 (2C), 70.00 (2C), 69.96 (1C), 69.80 (1C), 
67.87 (2C), 67.34 (1C), 67.22 (1C), 50.59 (1C), 30.46 (1C), 30.44 (1C).
MS ESI m/z: found 951.4 (M+1), calculated 950.81.
UV/vis (pyridine, "/nm): 389, 423, 726.
FT-IR (KBr): # (cm-1) 2946, 2361, 1724, 1500, 1451, 1373, 1268, 842, 760.
Synthesis of 14
A solution of N-(benzyloxycarbonyloxy) succinimide (3.00 g, 12 mmol) in CHCl3 (20 
mL) was added drop by drop via syringe pump in 5 h to a solution of ethylendiamine 
(20 mL, 300 mmol) in 150 mL of CHCl3, then the mixture was stirred for 8 hours. The 
crude was washed with 50 mL of brine (x3), 50 mL of saturated NaHCO3 (x3) and 
finally 50 mL of water (x3). The organic phase was dried on Na2SO4, filtered and the 
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O
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solvent removed under pressure obtaining a white solid (1.75 g, 75% yield). The 
characterization was in agreement with literature data.3
1H-NMR ( 200 MHz, CDCl3): ! 7.38-7.34 (m, 5H, CHAr); 5.10 (s, 2H, Ar-CH2 ); 3.33 (bs, 
1H, NH); 3.24 (q, J=6.0 Hz, 2H, NH-CH2); 2.82 (t, J=6.0 Hz, 2H, CH2-NH2); 1.18 (bs, 2H, 
CH2-NH2). 
Synthesis of 15
To a solution of 14 (1.75 g, 9 mmol) in MeOH (50 mL), degassed by bubbling Ar for 15 
minutes, was added drop by drop methylacrylate (2 mL, 22 mmol). The mixture was 
stirred for 24 hours under Ar atmosphere. The yellow oil obtained  after evaporation of 
the solvent was diluted in CHCl3, washed extensively with  50 mL of brine (x10), dried 
on Na2SO4, filtered, and the solvent removed under reduced pressure obtaining a 
colorless oil (3.05 g, 90% yield).
1H-NMR (200 MHz, CD3OD): ! 7.38-7.34 (m, 5H, CHAr), 4.90 (s, 2H, Ar-CH2), 3.11 (m, 
4H, NH-CH2-CH2), 2.80 (s, 6H, O-CH3), 2.63 (m, 8H, N-CH2-CH2-CO).
13C-NMR (50 MHz, CD3OD): ! 175.46, 158.78, 138.41, 129.58, 129.13, 128.99, 70.2, 65.60, 
52.58, 51.40, 51.11, 48.38.
MS ESI m/z: found 367.2 (M+1), calculated 366.18.
FT-IR (KBr): " (cm-1) 3500, 2910, 2852, 2525, 2335, 1694, 1240, 950, 796, 755, 695. 
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Synthesis of 16
A solution of 15 (3.00 g, 8 mmol) in 50 mL of MeOH was added via addition funnel to a 
cooled solution (0ºC) of ethylendiamine (3.50 mL, 50 mmol) in MeOH (10 mL), and 
stirred for 7 days at room temperature under Ar. The crude was washed with 50 mL of 
brine (x5) and 50 mL of saturated NaHCO3 (x5) until removal of the ethylendiamine 
excess. The organic solvent was distilled obtaining a pale-yellow oil (2.36 g, 65% yield) 
used without further purification. An aliquot was purified by silica gel 
chromatography for characterization (CHCl3/MeOH 9:1). 
1H-NMR (200 MHz, CD3OD): ! 7.38-7.34 (m, 5H, CHAr), 4.90 (s, 2H, Ar-CH2), 3.11 (t, 
J=6.0 Hz, 6H, NH-CH2), 2.63 (m, 8H, N-CH2-CH2-CO and CH2-NH2), 2.44 (t, J=6.0 Hz, 
2H, N-CH2-CH2-NH), 2.23 (t, J=6.0 Hz, 4H, CH2-CO).
13C-NMR (50 MHz, CD3OD): ! 175.46, 158.78, 138.41, 129.58, 129.13, 128.99, 67.60, 53.78, 
51.11, 42.41, 41.97, 39.91, 34.82.
MS ESI m/z: found 423.3 (M+1), 445.3 (M+Na), calculated 422.52.
FT-IR (KBr): " (cm-1) 3419, 2954, 2926, 2852, 2525, 2238, 2075,1694, 1635, 1553, 1456, 
1265, 1117, 973, 775, 745, 700. 
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To a cooled solution (0ºC) of 16  (100.00 mg, 0.25 mmol) in CHCl3 (5 mL) a solution of 
Boc2O (285.00 mg, 1.25 mmol) in DCM (5 mL) was added drop by drop and the 
resulting solution was stirred for 2 days. The organic solvent was removed under 
reduced pressure obtaining a mixture of not protected, mono and bis-protected 
derivative that was purified by silica gel chromatography (CHCl3/MeOH 95:5) 
obtaining 6 as a white oil (70.20 mg, 45% yield).
 1H-NMR (400 MHz, CDCl3): ! 7.35-7.31 (m, 5H, CHAr), 7.13 (bs, 2H, CH2-CO-NH), 5.82 
(bs, 1H, Cbz-NH), 5.31 (bs, 2H, NH-Boc), 5.07 (s, 2H, Ar-CH2), 3.34-3.06 (m, 10H, NH-
CH2), 2.66 (t, J=6.0 Hz, 4H, CH2-N-(CH2)2), 2.49 (t, J=6.1 Hz, 2H, CH2-N-(CH2)2), 2.28 (t, 
J=6.1 Hz, 4H, CH2-CO), 1.41 (s, 18H, NH-Boc).
13C-NMR (50 MHz, CDCl3): ! 172.87, 156.41, 136.48, 128.43, 128.13, 128.09, 79.34, 66.57, 
52.67, 50.07, 40.30, 39.77, 38.74, 34.08, 28.40.
MS ESI m/z: found 623.4 (M+1), 645.3 (M+Na), calculated 622.75.
FT-IR (KBr): " (cm-1) 3327, 3068, 3036, 2976, 2934, 2849, 2828, 1695, 1653, 1539, 1438, 
1392, 1366, 1339, 1272, 1253, 1170, 1039, 1027, 1011, 862, 778, 754, 737, 698, 460.
Synthesis of 18
To a solution of 17 (70.00 mg, 0.112 mmol) in MeOH, previously degassed for 10 
minutes by bubbling N2, a catalytic amount of Pd/C (10% w/w) was added. The 
reaction was stirred for 24 hours under H2 atmosphere, them filtered on celite and the 
solvent was removed under reduced pressure, obtaining a white solid in quantitative 
yield (55 mg).
1H-NMR (500 MHz, CD3OD): ! 3.23 (m, 4H, CH2-NH), 3.16 (m, 4H, CH2-NHBoc), 2.99 
(m, 2H, CH2-NH2), 2.72 (m, 6H, CH2-N), 2.36 (t, J=5.0 Hz, 4H, CH2-CO), 1.44 (s, 18H, 
NH-Boc). 
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13C-NMR (500 MHz, CD3OD): ! 175.12, 52.65, 51.13, 43.91, 40.88, 38.80, 34.26.
MS ESI m/z: found 489.4 (M+1); calculated 488.6.
FT-IR (KBr): " (cm-1) 3302, 3072, 2977, 2931, 2872, 2852, 1703, 1694, 1657, 1651, 1538, 
1455, 1392, 1366, 1275, 1252, 1171, 1040, 1027, 1013, 861, 781, 757, 590, 465.
Synthesis of 19
To a solution of 15 (250 mg, 0.273 mmol) in MeOH previously degassed for 10 minutes 
by bubbling N2 was added a catalytic amount of Pd/C (10% w/w). The reaction was 
leaved for 12 hours under H2 atmosphere to finally filtered it in celite and removed the 
solvent under reduced pressure, obtaining a pale yellow oil in quantitative yield (62 
mg).
1H-NMR (200 MHz, CD3OD): ! 7.42 (m, 5H, CHAr), 4.77 (s, 2H, Ar-CH2 ), 3.22-3.06 (m, 
4H, NH-(CH2)2), 2.82 (s, 3H, O-CH3),  2.60-2.40 (m, 8H, N-(CH2)2-CO).
Synthesis of 20
To a solution of 14 (2.00 g, 10 mmol) in MeOH (50 mL) was bubbled Ar for 15 minutes. Later 
on, tert-buthyl acrylate was added in excess drop by drop (5 mL, 34 mmol) leaving it  stirring for 
72 hours under Ar. The yellow oil obtained was rediluted in CHCl3, washed extensively 
with water (x3), saturated solution of NaHCO3 (x3), brine (x3)  dried with Na2SO4, 
filtered, and the solvent removed under reduced pressure obtaining a colorless oil (2.72 
g, 60% yield).
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1H-NMR (200 MHz, CD3OD): ! 7.38-7.34 (m, 5H, CHAr), 4.78 (s, 2H, Ar-CH2 ), 3.14-3.08 
(m, 4H, NH-(CH2)2),  2.58-2.34 (m, 8H, N-(CH2)2-CO), 1.78 (s, 18H, tBu).
13C-NMR (50 MHz, CD3OD): ! 176.02, 158.38, 129.28 (Ar), 129.22 (Ar), 128.79 (Ar), 
128.50 (Ar),  71.03, 60.42 (1C), 50.96 (1C), 48.76 (2C), 47.95 (2C), 27.99 (6C). 
MS ESI m/z: found 451.30 (M+1), calculated 450.27.
FT-IR (KBr): " (cm-1) 3487, 2853, 2512, 2295, 1674, 1200,  786, 755, 689.
Synthesis of 21
To a solution of 20 (1 g, 2.85 mmol) in 20 mL of CHCl3 previously degassed for 10 
minutes by bubbling N2 was added a catalytic amount of Pd/C (10% w/w). The 
reaction was leaved for 18 hours under H2 atmosphere to finally filtered it in celite and 
removed the solvent under reduced pressure, obtaining a colorless oil (602 mg, 89% 
yield).
1H-NMR (200 MHz, CD3OD): ! 3.14 (m, 4H, NH2-(CH2)2),  2.82 (t, J=6.4 Hz, 4H, N-
CH2), 2.63 (t, J=6.4 Hz, 4H, CH2-CO) 1.79 (s, 18H, tBu).
13C-NMR (50 MHz, CD3OD): ! 175.82, 158.36, 71.00, 50.89 (1C), 48.73 (2C), 47.94 (2C), 
27.89 (6C). 
MS ESI m/z: found 233.3 (M+1), calculated 232.14.
FT-IR (KBr): " (cm-1)  3486, 2851,, 1680, 1203,  784, 772, 753, 688.
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O
H
N
N
O
OtBu
OtBuO
O
20
H2N N O
tBu
OtBuO
O
21
Experimental Part
100
A solution of 17 (2g, 4.72 mmol) in 50 mL of MeOH was added drop by drop via 
addition funnel to a solution of methyl acrylate (2.5 mL, 17 mmol) leaving it under 
stirring for  72 hours in Ar atmosphere. The solvent was removed  and the excess of 
methylacrylate removed by coevaporation with toluene (20 mL, x3) giving a  pale 
yellow oil ( 2.42 g, 75% yield).
1H-NMR (200 MHz, CD3OD): ! 3.25-3.18 (m, 12H, NH-(CH2)2), 2.82 (s, 12H, OMe) 
2.64-2.48 (m, 24H, N-(CH2)2-CO and N-(CH2)2-CONH).
13C-NMR (50 MHz, CD3OD): ! 174.92, 158.92,  71.99, 61.20 (4C)   52.67 (1C), 51.08 (2C), 
42.39(1C), 41.52 (2C), 40.91 (2C), 40.48 (2C) 39.67 (4C), 39.24 (2C), 34.77 (2C),
MS ESI m/z: found 736.55  (M+1) calculated 735.42. 
FT-IR (KBr): " (cm-1) 3448, 3440, 2967, 2818,  2506, 2491, 2132, 1072, 1046,  780, 744, 443.
Synthesis of 23
A solution of 22 (1g, 1.36 mmol) in 10 mL of MeOH was added via addition funnel to a 
cooled solution (0ºC) of ethylendiamine (7.0 mL, 100 mmol) in MeOH (10mL), and 
leaved by stirring for 7 days under Ar. The crude of reaction was washed with brine 
(x5) and saturated NaHCO3 (x5) until remotion of the excess of ethylendiamine. The 
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organic solvent was removed under pressure obtaining a yellow oil further purified by 
silica chromatographic column using DCM /MeOH (9:1) as eluent mixture (691 mg, 
60% yield).
1H-NMR (200 MHz, MeOD): ! 7.30-7.28 (m, 5H, CHAr), 5.10 (s, 2H, Ar-CH2), 3.43-3.26 
(m, 12H, NH-(CH2)2) 3.19-2.88 (m, 16 H, CH2-NHBoc)  2.59-2.44 (m, 24H, N-(CH2)2-CO 
and N-(CH2)2-CONH).  
13C-NMR (100 MHz, MeOD): ! 176.13, 138.41 (Ar), 129.36 (Ar), 129.09 (Ar), 128.97 (Ar), 
67.19 (1C),  53.45 (1C), 51.20 (2C),  42.40(1C), 41.78 (2C), 41.44 (2C), 41.42 (2C), 40.90 
(2C), 40.84 (2C), 40.25 (2C), 40.65 (2C) 39.90 (4C), 39.73 (2C), 34.82 (2C). 
MS ESI m/z: 874.6 (M+Na) calculated 851.52.
 
FT-IR (KBr): " (cm-1) 3436, 2965, 2819,  2031, 1552, 1538, 1059, 1078 1016,  746, 733, 452. 
Synthesis of 24
A solution of 17 (1g, 2.36 mmol) in 20 mL of DCM (HPLC grade, 99.9 %) was added 
drop by drop via syringe pump to a solution of tert-buthyl acrylate (2.5 mL, 17 mmol) 
leaving it under stirring for  72 hours under Ar atmosphere. The solvent was removed 
under reduced pressure to give a brown oil, that was firstly filtrated in a silica plug 
using DCM and then purified by cromatographic column on silica using DCM/MeOH 
9:1 as eluent to give a colorless oil ( 876.24 mg, 40% yield)
1H-NMR (500 MHz, CD3OD): ! 7.30-7.28 (m, 5H, CHAr), 5.11 (s, 2H, Ar-CH2), 3.20-3.15 
(m, 12H, NH-(CH2)2), 2.60-2.45 (m, 24H, N-(CH2)2-CO and N-(CH2)2-CONH), 1.77 (s, 
36H, tBu). 
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13C-NMR (125 MHz, CD3OD): ! 175.50, 159.61, 138.40 (Ar), 129.37 (Ar), 129.10 (Ar), 
128.98 (Ar), 72.12, 67.10 (1C),  53.78 (1C), 51.11 (2C),  42.41(1C), 41.97 (2C), 40.62 (2C), 
40.60 (2C) 39.91 (4C), 39.80 (2C), 34.82 (2C), 28.21 (12C). 
MS HR-MALDI-TOF (matrix: THAP) found: 921.5943  M+1) calculated 920.58. 
FT-IR (KBr): " (cm-1) 3456, 2987, 2830,  2510, 2488, 2120, 1060, 1025,  786, 752, 480.
Synthesis of 25
A solution of 24 (100 mg, 0.11 mmol) in 5 mL of DCM/TFA 1:1 was stirred for 4 h until 
no trace of 25 was observed by TLC. The solvent was removed under reduced pressure 
and rests of TFA were removed by addition of  10 mL MeOH and coevaporation. As a 
result, a pale yellow oil was obtained in quantitative yield  (75 mg).
1H-NMR (200 MHz, CD3OD): ! 7.31-7.28 (m, 5H, CHAr), 5.09 (s, 2H, Ar-CH2), 3.30-3.18 
(m, 12H, NH-(CH2)2)  2.60-2.48 (m, 24H, N-(CH2)2-CO and N-(CH2)2-CONH).  
13C-NMR (50 MHz, CD3OD): ! 175.30, 138.42 (Ar), 129.35 (Ar), 129.08 (Ar), 128.98 (Ar), 
67.09 (1C),  53.77 (1C), 51.11 (2C),  42.40(1C), 41.89 (2C), 40.68 (2C), 40.56 (2C) 39.93 
(4C), 39.79 (2C), 34.81 (2C).  
MS ESI found: 697.5  (M+1) calculated 696.33 
FT-IR (KBr): " (cm-1) 3453, 2988, 2829,  2510, 2488,  1058, 1029,  785, 751, 478.
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Synthesis of 26
To a solution of 25 (500 mg, 0.70 mmol) in 10 mL of MeOH was added dropwise 
distilled, filtered a solution of N-Boc ethylendiamine (4.70 g, 29 mmol) in 10 mL of 
MeOH. The resulting mixture was leaved under stirring at room temperature for 7 
days under Ar. The solvent was removed under reduced pressure and the excedent of 
N-Boc ethylendiamine removed by coevaporation with toluene. A final purification 
using a  Sephadex 6-100 resine column yielded 26 as a white sticky solid (200 mg, 22%).
1H-NMR (500 MHz, D2O): ! 7.31-7.28 (m, 5H, CHAr), 5.09 (bs, 2H, Ar-CH2), 3.42-3.25 
(m, 12H, NH-(CH2)2) 3.18-2.80 (m,16 H, CH2-NHBoc)  2.58-2.42 (m, 24H, N-(CH2)2-CO 
and N-(CH2)2-CONH), 1.80 (bs, 36H, Boc). 
13C-NMR (100 MHz, D2O): ! 176.20, 159.22 138.42 (Ar), 129.35 (Ar), 129.08 (Ar), 128.98 
(Ar), 70.77,  67.19 (1C),  53.47 (1C), 51.21 (2C),  42.38(1C), 41.76 (2C), 41.44 (2C), 41.43 
(2C), 40.89 (2C), 40.86 (2C), 40.27 (2C), 40.64 (2C) 39.89 (4C), 39.70 (2C), 34.80 (2C), 27.02 
(12C).
 
MS MALDI-TOF (matrix: DCTB) m/z: 1265.9  (M+1) calculated 1264.78.
 
FT-IR (KBr): " (cm-1) 3446, 2967, 2820,  2500, 2448, 203, 1552, 1538, 1060, 1098 1018,  766, 
742, 478.
25
O
H
N N
O
N
H
NH
O
O N
N
OH
OH
O
O
OH
OH
O
O
N
O
H
N
O
N
H
N
N
O
NH
O
H
N
N
H
O
NH
O
NHBoc
NHBoc
NHBoc
BocHN
H
N
O
O
26
Experimental Part
104
Synthesis of 27
To a solution of 24 (500 mg, 0.54 mmol) in 5 mL of MeOH previously degassed for 10 
minutes by bubbling N2 was added a catalytic amount of Pd/C (10% w/w). The 
reaction was leaved for 12 hours under H2 atmosphere to finally filtered it in celite and 
removed the solvent under reduced pressure, obtaining a colorless oil (341 mg, 70% 
yield).
1H-NMR (200 MHz, CD3OD): !  3.32-3.19 (m, 12H, NH-(CH2)2)  2.67-2.48 (m, 24H, N-
(CH2)2-CO and N-(CH2)2-CONH), 1.90 (s, 36H, tBu). 
13C-NMR (75 MHz, CD3OD): ! 175.50, 159.61, 72.12, 52.80 (1C), 51.09 (2C),  42.39 (1C), 
42.00 (2C), 40.15 (2C), 40.58 (2C) 39.22 (4C), 39.67 (2C), 34.64 (2C), 28.15 (12C). 
MS ESI found: 809.2  (M+Na) calculated 786.55. 
FT-IR (KBr): " (cm-1) 3339, 2965, 2829,  2507, 1059, 1012,  784, 749, 482.
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Synthesis of 28
To a solution of 26 (100 mg, 0.07 mmol) in 5 mL of MeOH previously degassed for 10 
minutes by bubbling N2 was added a catalytic amount of Pd/C (10% w/w). The 
reaction was leaved for 12 hours under H2 atmosphere to finally filtered it in celite and 
removed the solvent under reduced pressure, obtaining a white sticky solid in 
quantitative yield (79 mg).
1H-NMR (200 MHz, D2O): ! 3.50-3.24 (m, 12H, NH-(CH2)2) 3.06-2.82 (m, 16H, CH2-
NHBoc)  2.60-2.44 (m, 24H, N-(CH2)2-CO and N-(CH2)2-CONH), 1.79 (bs, 36H, Boc).
13C-NMR (50 MHz, D2O): ! 176.22, 159.20, 67.20 (1C),  53.43 (1C), 51.18 (2C),  42.08(1C), 
41.66 (2C), 41.43 (4C), 40.85 (2C), 40.81 (2C), 40.44 (2C), 40.61 (2C) 39.79 (4C), 39.70 (2C), 
34.92 (2C), 27.25 (12C).
 
MS ESI m/z: 1131.2  (M+1), 1154.4 (M+23) calculated 1130.74.
 
FT-IR (KBr): " (cm-1) 3436,  2492, 2445, 2031, 1563, 1537, 1100, 1095 1020,  740, 468.
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General procedure for synthesis of 29, 30, 31 and 32
To a solution of 10 mg of fullerene derivative (0.01 mmol)  and EDC (0.10 mmol) in 2 
mL of anhydrous pyridine  was added drop by drop a mixture of 18  , 21, 27 and 28 
(0.10 mmol) for 29, 30, 31, 32 respectively and DMAP (0.10 mmol) and the reaction was 
stirred under Ar atmosphere for 12 hours. The solvent was removed under reduced 
pressure to obtain a brown oil that was purified by column chromatography with silica 
using CHCl3/MeOH (9:1) as eluent. The product was precipitated from a highly 
concentrated solution in CHCl3 by adding distilled MeOH to give a brown solid. 
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29: (11.50 mg, 70% yield)
1H-NMR (500 MHz, CDCl3): ! 8.19 (bs, 1H, NH-CO); 7.20 (bs, 2H, NH-CO), 5.53 (bs, 
2H, NH-Boc), 4.49 (s, 4H, CH2 pyrrolidine), 3.45 (t, J = 6.5 Hz, 2H, CH2-N(CH2)2); 3.37 
(t, J = 6.3 Hz, 6H, NH-CH2); 3.27 (t, J = 5.0 Hz, 4H, CH2-NHBoc); 2.86 (t, J = 6.5 Hz, 2H, 
CH2-N pyrrolidine), 2.74 (bs, 4H, N-(CH2)2), 2.65 (bs, 2H, Npyrrolidine-CH2-CH2), 2.35 (bs, 4H, 
CH2-CONH), 1.43 (s, 18H, NH-Boc). 
13C-NMR (125 MHz, CDCl3): ! 173.02, 156.74, 147.33, 146.29, 146.11, 145.91, 145.56, 
145.48, 145.31, 144.54, 143.14, 142.67, 142.11, 142.04, 141.89, 140.22, 135.98, 79.48 (2C), 
70.52 (2C), 67.42 (2C), 53.07 (1C), 50.82 (2C), 40.45 (1C), 40.15 (2C), 38.10 (1C), 35.06 
(2C), 34.20 (1C), 28.45 (6C). 
MS ESI m/z: found 1306.3 (M+), 1328.3 (M+Na), calculated 1306.38.
UV/vis (DCM, "/nm): 226, 254, 313, 691. 
FT-IR (KBr): # (cm-1) 3370, 2925, 1691, 1648, 1538, 1455, 1365, 1250, 1169, 527. 
30: (2.60 mg, 23% yield) 
1H-NMR (200 MHz, CDCl3/CS2): ! 5.11 (s, 4H, CH2 pyrrolidine), 3.62 (t, J=6.5 Hz, 4H, 
NH-(CH2)2), 3.02 (t,  J=9.1 Hz, 2H, CH2-N pyrrolidine), 2.95 (t, J=6.3 Hz, 4H, N-(CH2)2), 2.88 
(t, J=9.1 Hz, 2H, Npyrrolidine-CH2-CH2), 2.49 (t, J= 6.3 Hz, 4H, CH2-CO), 1.75 (s, 18H, tBu). 
The low solubility of this derivative did not allow to record 13C-NMR spectra. 
UV/vis (CHCl3, "/nm): 230, 262, 316, 690.  
FT-IR (KBr): # (cm-1)  3310,  2920,  1635, 1533, 1342, , 1289,  550.
31: (12.94 mg, 84% yield) 
1H-NMR (500 MHz, CDCl3): ! 4.80 (s, 4H, CH2 pyrrolidine), 3.62-3.40 (m, 12H, CH2-
N(CH2)2 and NH-CH2), 3.38-2.99 (m, 18H, CH2-N pyrrolidine and N-(CH2)2), 2.96-2.80 ( m, 
10H, CH2-CO and Npyrrolidine-CH2-CH2), 1.72 (s, 36H, tBu). 
13C-NMR (125 MHz, CDCl3): ! 173.00, 156.74, 156.72, 147.31, 146.22, 146.08, 146.05, 
145.54, 145.35, 145.06, 144.87, 143.12, 142.45, 142.10, 142.04, 141.76, 140.18, 135.95, 79.52 , 
71.34 , 67.40, 53.05 (1C), 50.82 (2C), 50.62 (2C), 50.30 (2C), 40.43 (1C), 40.13 (2C), 40.10 
(2C), 40.08 (2C), 38.10 (1C), 35.07 (2C), 35.03 (2C), 34.20 (1C), 28.84 (12C).
UV/vis (CHCl3, "/nm): 229, 260, 316, 698. 
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FT-IR (KBr): !  (cm-1)  3312,  3300, 2943, 2922,  1680, 1635, 1533, 1350, 1311, 1289, 1246, 
1169,  649, 523.
32: (3.94 mg, 22% yield) 
1H-NMR (500 MHz, CDCl3): " 4.82 (s, 4H, CH2 pyrrolidine), 3.62-3.41 (m, 20H, CH2-
N(CH2)2 and NH-CH2), 3.38 (t, J=6.5 Hz, 2H, CH2-N pyrrolidine), 3.31-2.98 (m, 24 H, N-
(CH2)2) 2.96-2.40 (m, 10H, CH2-NHBoc and Npyrrolidine-CH2-CH2)  1.45 (s, 36H, NH-Boc).
The low quantity obtained did not permit to record 13C-NMR spectra. 
MS MALDI (matrix: THAP) found 1963.1 (M+), 1328.3 (M+Na), calculated 1961.88. 
UV/vis (CHCl3, #/nm): 228, 260, 315, 695. 
FT-IR (KBr): ! (cm-1) 3360, 3357, 3349, 2923, 2918, 1865, 1853, 1672, 1648, 1630 1534, 
1422, 1353, 1310, 1296 1250, 1168, 753, 650, 527.
Synthesis of 33a-e
To a solution of 10.00 mg of 13a-e (0.010 mmol for 12) and EDC (0.10 mmol) in mixture 
of 1mL of CHCl3/pyridine, was added drop by drop a mixture of 1G-PAMAM 18 (0.10 
mmol) and DMAP (0.100 mmol) and the reaction was stirred under Ar atmosphere for 
12 hours. The solvent was removed under reduced pressure to obtain a brown oil that 
was purified by column chromatography with Al2O3 using CHCl3/MeOH (99:1) as 
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eluent. The product was precipitated from a highly concentrated solution in CHCl3 by 
adding separately ethanol, ethyl ether and cyclohexane to give a brown solid.
33a (trans-1)
Yield 82% (16.62 mg)
1H-NMR (400 MHz, CDCl3): ! 4.70 (s, 8H, CH2 pyrrolidine), 3.80 (t, J = 6.5 Hz, 4H, CH2-
N(CH2)2); 3.62 (t, J = 6.3 Hz, 12H, NH-CH2); 3.57 (t, J = 5.0 Hz, 8H, CH2-NHBoc); 3.01 (t, 
J = 6.5 Hz, 4H, CH2-N pyrrolidine), 2.96 (bs, 8H, N-(CH2)2), 2.52 (bs, 4H, Npyrrolidine-CH2-
CH2), 2.41 (bs, 8H, CH2-CONH), 1.38 (s, 36H, NH-Boc). 
13C-NMR (100 MHz, CDCl3): ! 173.89, 154.62 (8C), 148.88 (4C), 145.44 (8C), 144.32 (8C), 
144.89 (8C), 143.02 (4C), 142.77 (8C), 136.63 (8C), 80.00, 68.59 (4C), 68.12 (4C), 52.98 (2C), 
50.46 (4C), 40.42 (2C), 40.10 (4C), 37.99 (2C), 35.16 (4C), 35.46 (2C), 28.02 (12C).
MS MALDI-TOF (matrix: (DCTB)) m/z: found 1891.8 (M+1), calculated: 1890.82. 
UV/vis (CHCl3, "/nm): 325, 460, 491, 667. 
FT-IR (KBr): # (cm-1) 3365, 2898, 1701, 1650, 1453, 1372, 1259, 770, 530.
33b (trans-2)
Yield 41% (8.22 mg) 
1H-NMR (400 MHz, CDCl3): ! 4.70 (bb, 2H, CH2 pyrrolidine), 4.61 (d, J = 9.1 Hz, 2H, 
CH2 pyrrolidine), 4.42 (bb, 2H, CH2pyrrolidine), 4.38 (bb, 2H, CH2 pyrrolidine), 
3.63-3.51 (m, 16H, CH2-N(CH2)2 and NH-CH2), 3.20-3.12 (m,  24H, CH2-NHBoc, CH2-
NPyrrolidine and N-(CH2)2), 2.30 (m, 8H, CH2-CONH),  1.46 (s, 36H, Boc). 
The low quantity obtained did not permit to record 13C. 
MALDI-TOF (no matrix) m/z: found 1891.7 (M+1), calculated: 1890.82. UV/vis 
(CHCl3, "/nm): 441, 480, 723.
FT-IR (KBr): #  (cm-1) 3070, 2969, 2930,  2816, 2849, 2361, 1700, 1697, 1660, 1649, 1550, 
1549,  1250, 1152, 1000, 795, 563, 452.
33c (trans-3)
Yield 75% (15.20 mg) 
1H-NMR (400 MHz, CDCl3): ! 4.60 (d, 2H, J = 9.3 Hz, CH2 pyrrolidine), 4.51 (d, J = 9.3 
Hz, 2H, CH2 pyrrolidine), 4.45 (d, J = 9.4 Hz, 2H, CH2 pyrrolidine), 4.23 (d, J = 9.4 Hz, 
2H, CH2 pyrrolidine) 3.82-3.71 (m, 16H, CH2-N(CH2)2 and NH-CH2), 3.46-3.35 (m,  24H, 
CH2-NHBoc, CH2-NPyrrolidine and N-(CH2)2), 2.56 (m, 8H, CH2-CONH),  1.72 (s, 36H, 
Boc). 
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13C-NMR (100 MHz, CDCl3): ! 173.21, 154.12 (2C), 153.06 (2C), 152.88 (2C), 152.33 (2C), 
149.76 (2C), 148.99 (2C), 148.34 (2C), 148.10 (2C), 147.61 (2C), 147.52 (2C), 145.92 (2C), 
145.20 (2C), 145.00 (2C), 144.76 (2C), 144.54 (2C), 144.38 (2C), 143.79 (2C), 143.53 (2C), 
143.47 (2C), 143.33 (2C), 142.28 (2C), 141.74 (2C), 141.10 (2C), 140.91 (2C), 140.68 (2C), 
139.26 (2C), 136.23 (2C), 135.11 (2C), 82.42, 69.35 (2C), 68.01 (2C), 66.49 (2C), 63.89 (2C), 
50.11 (2C), 50.08 (4C), 49.78 (4C), 44.18 (4C), 41.23 (4C), 37.21 (2C), 34.11 (2C), 33.02 
(2C), 28.26 (12C).
MALDI-TOF (matrix: pivalic acid) m/z: found 1891.8 (M+1), calculated: 1890.82. 
UV/vis (toluene, "/nm): 418, 461, 700. 
FT-IR (KBr): # (cm-1) 3069, 2975, 2982, 2900,  2852, 2378, 1742,, 1697, 1660, 1617, 1558, 
1368, 1243, 1150, 1061, 698, 540, 498.
33d (trans-4)
Yield 60% (12.00 mg). 
1H-NMR (400 MHz, CDCl3): ! 6.08 (bs, 2H, NH-Boc), 4.35 (dd, J= 9.0 Hz, 4H, CH2 
pyrrolidine), 4.18 (s, 4H, CH2 pyrrolidine), 3.55-3.48 (m, 16H, CH2-N(CH2)2 and NH-
CH2), 3.21 (m, 8H, CH2-NHBoc), 3.05 (m, 12H, CH2-NPyrrolidine and N-(CH2)2), 2.72 
(m, 4H, NPyrrolidine-CH2-CH2), 2.48 (m, 8H, CH2-CONH), 1.45 (s, 36H, NH-Boc). 
13C-NMR (125 MHz, CDCl3): ! 171.95, 150.78 (2C), 149.55 (2C), 149.52 (2C), 149.02 (2C), 
148.19 (1C), 147.69 (1C), 147.64 (2C), 147.41 (2C), 147.26 (2C), 147.23 (1C), 146.10 (2C), 
145.99 (2C), 145.97 (2C), 145.42 (2C), 144.75 (2C), 144.71 (2C), 144.42 (2C), 142.66 (2C), 
142.55 (1C), 142.47 (2C), 141.97 (2C), 141.66 (2C), 141.63 (2C), 141.23 (2C), 141.13 (2C), 
139.02 (2C), 138.14 (2C), 135.71 (2C), 134.99 (2C), 130.84 (2C), 77.53, 69.09 (2C), 68.87 
(2C), 67.14 (2C), 66.47 (2C), 53.23 (2C), 49.77 (4C), 49.76 (4C), 44.79 (4C), 40.06 (4C), 
36.00 (2C), 34.64 (2C), 34.60 (2C) 28.24 (12C). 
MS MALDI-TOF (matrix: DCTB)) m/z: found 1891.9 (M+1), calculated: 1890.82. 
UV/vis (CHCl3, "/nm): 418, 452, 710. 
FT-IR (KBr): # (cm-1) 3069, 2975, 2930, 2924, 2820, 2852, 2359, 1732, 1702, 1697, 1660, 
1653, 1558, 1453, 1368, 1260, 1157, 1032, 798, 560, 464.
33e (equatorial)
Yield 71% (14.00 mg) 
1H-NMR (400 MHz, CDCl3): ! 4.35 (d, J = 9.0 Hz, 2H, CH2 Pyrrolidine), 4.24 (d, J = 9.0 
Hz, 2H, CH Pyrrolidine), 4.13 (bb, 4H, CH2 Pyrrolidine), 3.52-3.21 (m, 36H, CH2-
NPyrrolidine, N-(CH2)2, CH2-N(CH2)2, NH-CH2 and  CH2-NHBoc), 2.72 (bt, 4H, 
NPyrrolidine-CH2-CH2), 2.42 (bb, 8H, CH2-CONH), 1.45 (s, 36H, Boc).
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13C-NMR (125 MHz, CDCl3): ! 173.36, 159.30 (2C), 157.07 (2C), 153.36 (2C), 153.11 (2C), 
150.24 (1C), 149.34 (2C), 148.53 (2C), 148.16 (1C), 147.66 (2C), 147.50 (2C), 147.06 (2C), 
146.19 (2C), 146.16 (2C), 145.65 (2C), 145.46 (2C), 145.14 (2C), 145.11 (2C), 145.06 (2C), 
144.88 (2C), 144.84 (2C), 144.22 (2C), 143.55 (2C), 142.68 (2C), 140.90 (2C), 140.87 (2C), 
139.60 (2C), 139.45 (2C), 137.11 (2C), 135.76 (2C), 79.86, 79.83, 79.80, 70.18 (1C), 70.09 
(2C), 70.06 (2C), 69.77 (1C), 69.68 (1C), 67.71 (1C), 52.38 (1C), 52.30 (1C), 51.23 (2C), 
51.20 (1C), 51.18 (1C), 40.84 (2C), 40.81 (1C), 40.78 (1C), 40.54 (1C), 40.52 (2C), 40.50 
(1C), 38.42 (1C), 38.35 (2C), 38.20 (1C), 35.29 (2C), 35.22 (1C), 35.19 (1C), 34.29 (1C), 
34.26 (1C), 28.89 (12 C). 
MS-MALDI-TOF (matrix: (DCTB)) m/z: found 1891.9 (M+1); calculated: 1890.82. 
UV/vis (CHCl3, "/nm): 390, 424, 720 
FT-IR (KBr): # (cm-1) 3365, 2910, 1688, 1678, 1645, 1530, 1449, 1365, 1248, 1168, 526.
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General procedure for  34, 35, 36, 37 and 38a-e
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5.00 mg of compound (4.2, 3.8, 3.0, 2.5 and 2.6 µmol for 30, 29, 31, 32 and 33a-e 
respectively) were solved in 5 mL of a mixture DCM/TFA (1:1) and stirred for 12 h to 
48 h. The reaction crude was diluted with additional 10 mL of DCM and extracted with 
a solution of saturated NaHCO3 and brine (x2) to remove the excess of TFA. The 
organic phase containing a brownish solid in suspension was recovered and the 
solvent removed by reduced pressure obtaining the desired unprotected derivative in 
quantitative yields.
34: 4.28 mg 
1H-NMR (200 MHz, pyridine[d5]): ! 5.11 (s, 4H, CH2 pyrrolidine), 3.80 (t, J=6.5 Hz, 4H, 
and NH-(CH2)2), 3.25 (t,  J=9.4 Hz, 2H, CH2-N pyrrolidine), 3.11 (t, J=6.3 Hz, 4H, N-(CH2)2), 
2.82 (t, J=9.4 Hz, 2H, Npyrrolidine-CH2-CH2), 2.52 (t, J= 6.3 Hz, 4H, CH2-CO).
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The low solubility of this derivative did not allow to record 13C-NMR spectra. 
MS ESI: found 1020.0 (M-1); calculated 1021.16. 
UV/vis (Pyridine, !/nm): 240, 318, 680.  
35: 2.80 mg, 
MS ESI m/z : found 368.9 (M+); calculated 369.43.
UV/vis (H2O, !/nm) = 260.
36: 4.18 mg
1H-NMR (200 MHz, CDCl3/pyridine[d5]): " 5.10 (s, 4H, CH2 pyrrolidine), 3.82-3.56 (m, 
12H, CH2-N(CH2)2 and NH-CH2), 3.42-3.02 (m, 18H, CH2-N pyrrolidine and N-(CH2)2), 
3.01-2.92 ( m, 10H, CH2-CO and Npyrrolidine-CH2-CH2).
The small quantity obtained did not permit to record 13C spectra.
MS ESI: found 1393.2 (M-1); calculated 1394.35 UV/vis (CHCl3, !/nm): 240,  320, 700.
38a:  3.39 mg, 
MS MALDI (no matrix) m/z : found 254.7. (M+); calculated 254.61,
UV/vis (H2O, !/nm): 320, 459, 489, 665.
38b:  3.38 mg, 
MS MALDI (no matrix) m/z : found 254.6. (M+); calculated 254.61.
UV/vis (CHCl3, !/nm): 440 (broad), 457, 720.
38c:  3.38 mg, 
MS MALDI (no matrix) m/z : found 254.4. (M+); calculated 254.61.
UV/vis (H2O, !/nm): 417 (broad), 461, 708.
38d: 3.39 mg, 
MS MALDI (no matrix) m/z : found 254.6. (M+); calculated 254.61, 
UV/vis (H2O, !/nm) = 415, 450, 705.
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38e: 3.40 mg.
MS MALDI (no matrix) m/z : found 254.6. (M+); calculated 254.61.
UV/vis (H2O, !/nm) = 390, 422, 749.
Synthesis of 39 Tert-butyl 4-hydroxybutanoate
To a mixture of succinic anhydride (30 g, 0.30 mol), N-hydroxysuccinimide (0.30 equiv, 
10 g, 0.09 mol), and DMAP (0.10 equiv, 3.5 g, 0.03 mol) in toluene (150 mL) were added 
tert-butyl alcohol (1.3 equiv, 35 mL, 0.37 mol) and Et3N (0.3 equiv, 0.09 mol, 12.5 mL). 
The suspension was refluxed for 24 h. The solution was cooled and diluted with EtOAc 
(150 mL). The reaction mixture was washed with 10% citric acid and brine, dried over 
Na2SO4, and concentrated to give a brown oil. The oil was recrystallized with ether and 
petroleum ether at -20 °C to give 40 as a white crystal (41 g, 78%).  
Characterizations were in accordance with literature.156a
1H-NMR (300 MHz, CDCl3): " 2.65-2.50 (m, 4 H), 1.45 (s, 9 H).
Synthesis of 40 4-Hydroxybutanoic Acid tert-Butyl Ester
To a solution of acid 4 (21 g, 0.12 mol) in dry THF (183 mL) at 0 °C was added 
BH3‚Me2S (2.0 M, 65.5 mL, 0.131 mol) dropwise. After being stirred at room 
temperature for 24 h, the mixture was cooled to 0 °C. Water (100 mL) and solid K2CO3 
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were added to the reaction mixture. The reaction mixture was extracted with Et2O (200 
mL ! 3), and the combined organic extracts were washed with brine, dried over 
Na2SO4, and concentrated in vacuo. The residue was distilled to give a colorless liquid 
(14.50 g, 74%).
Characterizations were in accordance with literature.156a
1H-NMR (300 MHz, CDCl3): !  3.70 (t, J ) 6.0 Hz, 2 H), 2.40-2.30 (m, 3 H), 1.85 (m, 2 H), 
1.45 (s, 9 H).
Synthesis of 41
Tert-butyl 4-hydroxybutanoate 39 (2.00 g, 12.5 mmol) and pyridine (1.0 mL, 12.5 mmol) 
were 
dissolved in dry CH2Cl2 (20mL) under nitrogen atmosphere and cooled to 0 °C. 
Subsequently, a solution of malonyl dichloride (0.61 mL, 6.22 mmol) in dry CH2Cl2 (20 
mL) was added dropwise under vigorous stirring over a period of 2 hours. The 
reaction mixture was stirred for additionally 2 hours at 0 °C, followed by stirring at 
room temperature overnight. After filtering through a silica gel plug with hexanes/
EtOAc 50:50, the solution was extracted with a saturated solution of NH4Cl (2 x 100 
mL) and NaHCO3 (2 x 100 mL). Purification was achieved by flash 
chromatography on silica gel using a mixture of hexanes/EtOAc = 5:1 as eluent. Finally 
the product fractions were evaporated in vacuum to isolate 41 as a colorless oil. (1.47 g, 
61% based on malonyl dichloride).
Characterizations were in accordance with literature.156b
1H-NMR (300 MHz, CDCl3): ! 4.43 (t, J = 6.4 Hz, 4H, OCH2) 3.31 (s, 2H, O2CCH2CO2), 
2.24 (t, J = 7.4 Hz, 4H, CH2CO2tBu), 1.87 (tt, J = 6.9 Hz, J =6.8 Hz, 4H, CH2CH2CH2), 1.38 
(s, 18H, C(CH)) 
13C-NMR (75 MHz, CDCl3): ! 172.01 (2C, CO2tBu) 166.42 (2C, O2CCH2CO2) 80.51 (2C, 
C(CH3)3), 64.63 (2C, OCH2),41.48 (1C, O2CCH2CO2)31.82 (2C, CH2CO2tBu), 28.17 (6C, 
C(CH3)3),24.03 (2C, CH2CH2CH2).
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MS (FAB, NBA):  found 389 [M +H]+, 333 [M –tBu]+, 277 [M -2tBu]+; calculated= 388.45 
g/mol. 
IR (diamond) ! (cm-1) =2980, 2937, 1725, 1459, 1420, 1393, 1366, 1328, 1254, 1212, 1146, 
1096, 1031, 953, 884, 845, 753
Synthesis of 42
To a  solution of 40 (500 mg, 1.3 mmol) in DCM (20 mL) was added dropwise formic 
acid until the obtention of a pH=3 solution and leaved by stirring for 12 h. After a first 
addition of water (20 mL) the reaction was extracted with brine (x3) to obtain a 
colorless oil in quantitative yield (350 mg).
Characterizations were in accordance with literature.156b
1H-NMR (300 MHz, CDCl3): " 10.02 (bs, COOH) 4.42 (t, J = 6.4 Hz, 4H, OCH2) 3.20 (s, 
2H, O2CCH2CO2), 2.24 (t, J = 7.4 Hz, 4H, CH2COOH), 1.87 (tt, J = 6.9 Hz, J =6.8 Hz, 4H, 
(CH2CH2CH2).
Synthesis of 43
A solution of Boc anhydride (29.45 g, 0.14 mol) in dioxane (150 mL) was added 
dropwise to a solution of 2,2-(ethylen-dioxy) bis(ethylamine) (40.00 g, 0.27 mol) in 
dioxane (150 mL). After 12 h, the solvent was removed under reduced pressure and 
water was added to give a semisolid that was filtered over celite to remove the 
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bisprotected amine. The resulting oil was extracted from the filtrated aqueous solution 
with ethyl acetate (x3) and dried over Na2SO4 to give 43 (18.83 g, 56%).
Characterizations were in accordance with literature.157
1H-NMR (300 MHz, CDCl3): ! 5.15 (bs, 1H), 3.65-3.45 (m, 8H), 3.31 (t, J=5.2 Hz, 2H), 
2.85 (t, J=5.2 Hz, 2H), 1.42 (s, 9H).
Synthesis of 44
To a cooled solution of 42 (100 mg, 0.72 mmol), 43 (360 mg, 1.44 mmol), and DMAP 
(439 mg, 3.60 mmol) in DCM anhydrous under Ar atmosphere was added in one pot 
(742 mg, 3.60 mmol) and leaved by stirring for 2 hours at 0ºC and 12 additional hours 
at room temperature. The solvent was removed under reduced pressure to give a 
yellow oil that was purified by using silica column chromatography and an eluent 
mixture DCM/MeOH 9:1 to afford 44 as a colorless oil (317 mg, 60% yield).
1H-NMR (300 MHz, CDCl3): ! 4.56 (t, J = 6.4 Hz, 4H, OCH2), 3.76-3.62 (m, 16H), 3.36 (t, 
J=5.5 Hz, 4H, CH2-HNCO), 3.18 (s, 2H, O2CCH2CO2), 2.88 (t, J=5.5 Hz, 4H, BocHN-
CH2) 2.42 (t, J= 7.8 Hz, 4H, CH2COONH), 1.87 (tt, J= 6.9 Hz, J=6.8 Hz, 4H, 
(CH2CH2CH2), 1.60 (s, 18H, Boc).
13C-NMR (75 MHz, CDCl3): ! 173.02 (2C, CO2tBu) 156.42 (2C, OOCCH2COO), 155.91 
(2C, OCONH) 78.92 (2C, C(CH3)3), 68.06 (2C), 66.66 (2C) 64.63 (2C, OOC-CH2-
COOCH2), 50.77 (2C), 48.81 (2C), 41.51 (1C, O2CCH2CO2), 40.39 (2C), 40.31 (2C), 31.77 
(2C, CH2CONH), 28.46 (6C, C(CH3)3) , 24.03 (2C, CH2CH2CH2). 
MS-MALDI-TOF (matrix: (DCTB)): found 737.8 (M+1), expected 736.40. 
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IR (diamond): ! (cm-1) 3347, 2980, 2937, 2871, 1720, 1712, 1512, 1458, 1420, 1399, 1368, 
1248, 1175,966, 865, 747, 752, 701.
Synthesis of 45
A solution of C60 (14 mg, 0.02 mmol) in anhydrous o-dichlorobenzene (50 mL) was 
prepared and to the solution were added 44 (125 mg, 0.16 mmol), CBr4 (550 mg, 33.0 
mmol) and 1,8-diazabicyclo[5.4.0] undec-7-ene (DBU)( 45 µL, 0.33mmol). The mixture 
was stirred under N2 for 72 hours and purified by column chromatography on silica 
gel using CHCl3/pyridine 97:3, to provide the corresponding hexakisadduct 45 ( 34 
mg, 40%).
1H-NMR (400 MHz, CDCl3): " 4.86 (t, J = 6.4 Hz, 24H, OCH2), 4.02-3.83 (m, 96H), 3.42 
(bb,  24H, CH2-HNCO), 3.18 (bb, 24H, BocHN-CH2) 2.421 (t, J = 8.0 Hz, 24H, 
CH2COONH), 1.92 (tt, J = 6.9 Hz, J =6.8 Hz, 24H, (CH2CH2CH2), 1.60 (s, 108H, Boc). 
13C-NMR (100 MHz, CDCl3): " 169.05 (12C, CO2tBu) 168.40 (12C, OOCCH2COO), 
154.92 (12C, OCONH), 145.83 (sp2 C60), 141.03 (sp2 C60), 80.12 (12C, C(CH3)3), 70.01 (sp3 
C60), 68.13 (12C), 66.91 (12C) 64.72 (12C, OOC-CH2-COOCH2), 51.86 (12C), 48.89 (12C), 
41.57 (6C, O2CCH2CO2), 40.62 (12C), 39.98 (12C), 32.63 (12C, CH2CONH), 28.92 (36C, 
C(CH3)3) ,26.25 (12C, CH2CH2CH2). 
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MS-MALDI-TOF (matrix: pivalic acid): found 5127.8 (M+H), expected 5126.46.
Synthesis of 46
A solution of C60 (370 mg, 0.51 mmol) in anhydrous o-dichlorobenzene (250 mL) was 
prepared and to the solution were added 41 (2 g, 5.15 mmol), CBr4 (17 g, 51.5 mmol) 
and 1,8-diazabicyclo[5.4.0] undec-7-ene (DBU)( 155 µL, 10.3 mmol). The mixture was 
stirred under N2 for 24 hours and purified by column chromatography on silica gel 
using CHCl3/MeOH 95:5, to provide the corresponding hexakisadduct 46 ( 541 mg, 
35%).
1H-NMR (400 MHz, CDCl3): ! 4.77 (t, J = 6.8 Hz, 24H, OCH2), 2.80 (t, J = 8.1 Hz, 48H, 
CH2CO2tBu), 1.92 (tt, J = 7.9 Hz, J =7.8 Hz, 24H, CH2CH2CH2), 1.89 (s, 108H, C(CH3)).
13C-NMR (100 MHz, CDCl3): ! 168.09(12C, CO2tBu) 166.42 (12C, OOCCH2COO), 145.81 
(sp2 C60), 141.18 (sp2 C60), 79.21 (12C, C(CH3)3), 70.11 (sp3 C60) 65.68 (12C, OCH2), 33.02 
(12C, CH2CO2tBu), 29.40 (36C, C(CH3)3), 24.04 (12C, CH2CH2CH2). 
MS-MALDI-TOF (matrix: pivalic acid): found 3059.82 (M+Na), expected 3036.11
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Synthesis of 47
A solution of 46 (500 mg, 0.16 mmol) in 20 mL of a mixture of DCM/TFA 1:1 was 
stirred for 12 hours, the solvent removed under reduced pressure to give 47  in 
quantitative yield (375 mg).
1H-NMR (400 MHz, MeOD): ! 10.06 (bb, 1H, COOH), 4.55 (bb, 24H, OCH2), 2.67 (t, J = 
7.7 Hz, 48H, CH2CO2H), 1.90 (tt, J = 7.5 Hz, J =7.4 Hz, 24H, CH2CH2CH2).
13C-NMR (100 MHz, MeOD): ! 164.12 (12C, OOCCH2COO), 143.26 (sp2 C60), 141.10 (sp2 
C60),  69.86 (sp3 C60) 63.22 (12C, OCH2), 32.96 (12C, CH2CO2H), 23.99 (12C, 
CH2CH2CH2). 
MS-MALDI-TOF (matrix: CHCA): found 2363.86 (M-1H), expected 2364.65.
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To a cooled solution of 42 (40 mg, 0.14 mmol), 18 (140 mg, 0.28 mmol), and DMAP (34 
mg, 0.28 mmol) in DCM anhydrous under Ar atmosphere was added in one pot EDC 
(53 mg, 0.28 mmol) and leaved by stirring for 2 hours at 0ºC and 36 additional hours at 
room temperature. The solvent was removed under reduced pressure to give a yellow 
oil that was purified by using silica column chromatography and an eluent mixture 
DCM/MeOH 8:2 to afford 48 as a white solid (102 mg, 61% yield).
1H-NMR (300 MHz, CDCl3): !  3.78-3.62 (m, 20H, CH2-N-(CH2)2, HNCO-CH2 and 
tBuOCONH-CH2), ,  3.50 (t, J= 6.0 Hz, 8H, N-(CH2)2), 3.22 (s, 2H, O2CCH2CO2) 2.98-2.88 
(m, 8H, CH2CONH and CH2-CO-CH2-CO), 2.31 (t,  J= 7.2 Hz, 4H, CH2(CH2)2-CO-CH2-
CO), 1.80 (tt, 4H, CH2-CH2-CH2-CO-CH2-CO), 1.61 (s, 36 H, Boc). 
13C-NMR (75 MHz, CDCl3): ! 170.06, 162.76 (2C, OC-CH2-CO), 157.99 (4C, OCONH), 
79.94 (24C, C-(CH3)3 ),  65.73 (OOC-CH2-COO), 64.86, 52.99, 52.95, 48.21, 46.92,  28.72 
(12C, Boc), 23.62, 20.03. 
MALDI-TOF (no matrix): found 1218.2 (M+1H), expected 1216.73
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Synthesis of 49
A solution of C60 (15 mg, 0.02 mmol) in anhydrous o-dichlorobenzene (20 mL) was 
prepared and to the solution were added 48 (260 mg, 0.21 mmol), CBr4 (706 mg, 2.13 
mmol) and 1,8-diazabicyclo[5.4.0] undec-7-ene (DBU)( 62 µL, 0.42 mmol). The mixture 
was stirred under N2 for 8 days,and purified by column chromatography on silica gel 
using CHCl3/Pyridine 97:3, to provide the corresponding hexakisadduct 49 ( 24 mg, 
15%).
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1H-NMR (400 MHz, CDCl3): ! 5.26 (s, 24H, tBuOCONH), 3.68 (t, J= 6.6 Hz, 24H, CH2-N-
(CH2)2), 3.66 (t, J = 6.6 Hz, 48 H, HNCO-CH2) , 3.64-3.62 (m, 48 H, tBuOCONH-CH2), 
3.60 (t, t, J = 6.5 Hz 48H, N-(CH2)2), 3.02-2.96 (m, 48H, CH2CONH and CH2-CO-CH2-
CO), 2.31 (t, t, J = 7.9 Hz 24H, CH2(CH2)2-CO-CH2-CO), 2.28 (bs, 24H, CH2-CH2-CH2-
CO-CH2-CO), 1.52 (s, 216H, Boc).  
13C-NMR (100 MHz, CDCl3): ! 164.92, 162.86, 161.13, 158.20 (24 C, OCONH), 146.30 
(sp2 C60), 138.61 (sp2 C60), 79.94 (24C, C-(CH3)3 ), 73.21 (sp3 C60), 71.70, 64.92, 54.86, 
51.12, 48.52, 46.02, 41.03 (OOC-C-COO), 28.72 (72C, Boc), 24.85, 19.92. 
MALDI-TOF (matrix: pivalic acid): found 8005.7 (M+H), expected 8004.16.
Synthesis of 50
A solution of 45 (10 mg, 2.0 µmol) in5 mL of a mixture of DCM/TFA 1:1 was stirred for 
12 hours, the solvent removed under reduced pressure to give 50 in quantitative yield 
(9 mg).
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1H-NMR (400 MHz, D2O): ! 4.50 (bb, 24H, OCH2), 4.17-3.88 (m, 96H), 3.45 (bb,  24H, 
CH2-HNCO), 3.21 (bb, 24H, BocHN-CH2) 2.26 (bb, 24H, CH2COONH), 1.88 (m, 24H, 
(CH2CH2CH2). 
MS-MALDI-TOF (no matrix):  found 269.1, expected 269.19
Synthesis of 51
A solution of 49 (10 mg, 1.2 µmol) in 5 mL of a mixture of DCM/TFA 1:1 was stirred for 
12 hours and the solvent removed under reduced pressure to give 51 in quantitative 
yield (8 mg).
1H-NMR (400 MHz, D2O): ! 3.82-3.66 (m, 72H, CH2-N-(CH2)2 and HNCO-CH2) , 
3.34-3.22 (m, 48 H, tBuOCONH-CH2), 3.20 (m, 96H, N-(CH2)2), CH2CONH and CH2-
CO-CH2-CO), 2.31-2.28 (m, 48H, CH2(CH2)2-CO-CH2-CO and CH2-CH2-CH2-CO-CH2-
CO). 
MS-MALDI-TOF (no matrix):  found 137.2, expected 137.09
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Synthesis of 52a-f
A solution of methyl 4-formylbenzoate (1.13 g, 6.89 mmol) and distilled 
isonicotinaldehyde (2.03 mL, 2.10 mmol) in propionic acid (100 mL) was heated to 130 
ºC and subsequently added drop by drop pyrrole (1.94 mL, 27.99 mmol). The resulting 
dark solution was refluxed for 2 hours under darkness, when the solvent was removed 
to give a dark oil. When a minimum quantity of NEt3 and excess of MeOH was added 
a dark violet precipitated was observed after 2 days at -20ºC. Thus, the crude was 
filtered and extensively washed with cooled MeOH to give a violet solid containing 
mixture of all the isomers 55a-f. This mixture can be efficiently separated by using 
chromatographic column using as eluent CHCl3/MeOH (99:1). Each isolated isomer 
was finally  precipitated from a saturated solution in THf and addition of petroleum 
ether.
Characterizations were in agreement with literature.158
52a
1H-NMR (200 MHz, CDCl3): ! 8.85 (s, 8H), 8.48 (d, J =8.3 Hz, 8H) 8.32 (d, J=8.0 Hz, 8H), 
4.14 (s, 12H, CH), 2.80 (s, 2H). 
52b
1H-NMR (200 MHz, CDCl3): ! 9.07 (d, J=5.4 Hz, 2H)  8.85 (m, 8H) 8.48 (d, J=8.3) 8.32 (d, 
J=8.0 Hz, 6H),    8.18 (d, J=5.9 Hz, 2H), 4.14 (s, 9H), -2.83 (s, 2H).
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52c and 52d were obtained as a mixture, their separation is beyond the scope of this 
thesis
52e
1H-NMR (200 MHz, CDCl3): ! 9.06, 8.86 (8H, m), 8.47 (2H, d, J=8.1Hz) 8.30 (2H, d, 
J=8.1Hz), 8.30 (2H, d, J=8.1Hz), 8.16 (6H, m), 4.12 (3H, s), -2.89 (2H, s).
52f was obtained in very small quantities since quickly decompounds in silica, but its 
obtention is beyond the scope of this thesis.
Synthesis of 53
To a solution of 52e (50 mg, 0.06 mmol) in 24 mL of THF/MeOH 2:1 were added 3 mL 
of a 40% (w/v)  solution of KOH in water.. The mixture was heated to 40ºC and leaved 
under stirring for 40 hours. The reaction can be monitorized by means of TLC using 
CHCl3/EtOH 98:2 until the no trace of the ester is detected. The mixture was acidified 
with concentrated HCl  to pH 5 and then 20 mL of water were added to extract the 
organic phase with chloroform (20 mL). The organic phase obtained was further 
washed with 20 mL of water (x3). Later, the organic solvent was removed under 
reduced pression to obtain the desired acid 53 (24 mg, 51%)
The characterizations were in accordance with literature.159
1H-NMR (200 MHz, DMSO [d6]): ! 13.31 (bs, 3H, COOH), 9.05 (m, 2H, H2,6-pyridine), 
8.89 (m, 8H, Hß), 8.39 (m, 12H, H2,6 and H3,5-phenyl), 8.29 (m, 2H, H3,5-pyridine), -2.97 
(s, 2, NH).
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Synthesis of 54
To a solution of 52e (710 mg, 1.05 mmol) in 100 mL of anhydrous THF was added 
LiAlH4 (319 mg, 80.4 mmol) at room temperature. After being stirred for 30 min, 10 mL 
of AcOEt was added  and then poured into H2O (100 mL). The aqueous suspension 
was extracted with CHCl3 (300 mL), washed with brine, dried over MgSO4, and 
evaporated under reduced pressure to yield 54 (360 mg, 53%).
1H-NMR (200 MHz, CDCl3): ! 9.06 (d, 6H, J=4.4 Hz, 2,6-pyridyl), 8.86 (m, 8H, pyrrole 
ß), 8.19 (m, 8H, 2,6-phenyl and 3,5-pyridyl ), 7.80 (d, J=7.6 Hz, 2H, 3,5-phenyl), 5.10 (s, 
2H, -CH2OH), -2.88 (s, 2H, internal pyrrole)
Characterizations were in accordance with literature.159
Synthesis of 55
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To a solution of (COCl)2 (0.5 mL, 5.85 mmol) in anhydrous DCM (5 mL) was dropped 
DMSO (0.5 mL, 7.05 mmol) for 2 min at -60ºC. After being stirred for 15 min at the 
same temperature, 54 (99.4 mg, 0.15 mmol)  in DCM (50 mL) was dropped into the 
above mixture for 10 min. After being further stirred for 20 min at the same 
temperature, the reaction was completed by the addition of triethylamine (2.5 mL, 17.9 
mmol) and was stirred for 30 min longer at the same temperature. After being warmed 
to room temperature, the organic layer was washed with water, saturated NaHCO3, 
and then brine. After being dried over MgSO4 and evaporated under reduced pressure, 
the crude 55 was filtered through a plug of silica using CHCl3/MeOH 95:5 to afford 55 
as a purple solid (65.6 mg, 66%).
Characterizations were in accordance with literature.159
1H NMR (200 MHz, CDCl3): ! 10.43 (s, 1H, CHO), 9.05 (bs, 6H, 2,6-pyridyl), 8.84 (m, 
2H, pyrrole ß), 8.40 (m, 2H, 2,6-phenyl), 8.30 (d, J=8.2 Hz, 2H, 3,5-phenyl), 8.18 (d, 6H, 
J=4.8 Hz, 3,5-pyridyl)  -2.88 (s, 2H, internal pyrrole).
Synthesis of 56
A solution of 9 (200 mg, 0.98 mmol), p-nitro benzaldehyde (148 mg, 0.98 mmol) and C60 
(708 mg, 0.98 mmol) in  100 mL of o-dichlorobenzene  previously sonicated for 10 
minutes until complete disolution was refluxed for 30 min. The monoadduct was 
recovered by silica chromatographic column with toluene/ethylacetate 9:1. After 
precipitation with the addition of Petroleum eter to a saturated solution  56 was 
afforded as a brown solid. (100 mg, 86% yield respect to recovered C60).
1H-NMR (200 MHz, CDCl3): ! 7.92 (d, J=1.2 Hz, 2H, p-Ar), 7.01 (d, J=1.2 Hz, 2H, p-Ar), 
5.36 (d, J=8.9 Hz, 1H,  CH2pyrrolidine), 4.96 (s, 1H,  CH2pyrrolidine), 4.72 (d, J=8.9 Hz, 
N
O
O
NO2
NO2
OHC
C60O
O
N
H
O
OH
9
+
+
56
Chapter 4
129
1H,  CH2pyrrolidine), 3.90 (m, 2H, N-CH2),  3.22 (m, 2H, N-CH2-CH2-COO), 1.89 (s, 9H, 
tBu). 
13C-NMR (50 MHz, CDCl3): ! 170.23, 155.64, 154.42, 150.02 (Ar), 148.96, 147.23, 145.11, 
145.03, 144.96, 143.32, 143.06, 142.87, 142.55, 142.30, 141.89, 141.35, 140.65, 140.33, 136.62 
(Ar) 125.03 (Ar), 124.98 (Ar),  78.03(C-(CH3)3), 72.62 (1C), 70.45 (1C), 68.62, 68.61, 36.40, 
29.10, 28.11. 
MS ESI m/z : found 1013.2 (M+1); calculated 1012.14.
UV/vis (DCM, " nm) =  225, 250, 310, 689. 
FT-IR (KBr): # (cm-1) 3370, 2925, 2920, 2896, 1815, 1805, 1798, 1690, 1644, 1536, 1450, 
1410, 1363, 1200, 1159, 750 527. 
Synthesis of 57
A solution of sarcosine (62 mg, 0.69 mmol), p-nitro benzaldehyde (104 mg, 0.69 mmol) 
and C60 (500 mg, 0.609 mmol) previously sonicated for 10 minutes was refluxed in o-
dichlorobenzene for 20 min. The monoadduct was recovered by silica chromatographic 
column with toluene/ethylacetate 9:1. After precipitation by addition of Petroleum eter 
to a saturated solution  57 was afforded as a brown solid. (80 mg, 78% yield respect to 
recovered C60).
 1H-NMR (200 MHz, CDCl3): ! 8.22 (d, J=1.1 Hz, 2H, p-Ar), 8.11 (d, J=1.1 Hz, 2H, p-Ar), 
5.20-5.16 (m, 2H,  CH2pyrrolidine), 4.46, J=8.9 Hz, 1H,  CH2pyrrolidine)),2.98 (s, 3H, 
OCH3). 
13C-NMR (50 MHz, CDCl3): ! 169.11, 155.62, 153.97, 151.62 (Ar), 148.85, 140.21, 145.10, 
144.96, 144.93, 142.99, 142.96, 142.86, 142.61, 142.04, 141.92, 141.26, 140.85, 140.22, 137.52 
N
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(Ar) 132.08 (Ar), 125.55 (Ar),  79.22(C-(CH3)3), 73.06 (1C), 70.45 (1C), 70.36 (1C), 68.61, 
52.60. 
MS ESI m/z : found 899.02 (M+1); calculated 897.07, UV/vis (DCM, ! nm) =  226, 252, 
309, 690. 
FT-IR (KBr): " (cm-1) 3369, 2920, 2920,  1814, 1806, 1790, 1690, 1644,  1452, 1411, 1364, 
1199, 1159, 732 525.
Synthesis of 58
To a solution of 59 (50 mg, 0.05 mmol) in 10 mL of toluene previously degassed for 10 
minutes by bubbling N2 was added a catalytic amount of Pd/C (10% w/w). The 
reaction was leaved for 6 hours under H2 atmosphere to finally filtered it in celite and 
removed the solvent under reduced pressure, obtaining a brown solid in quantitative 
yield (42 mg).
1H-NMR (200 MHz, CDCl3): # 7.74 (d, J=1.0 Hz, 2H, p-Ar), 6.95 (d, J=1.0 Hz, 2H, p-Ar), 
5.10 (d, J=9.1 Hz, 1H,  CH2pyrrolidine), 4.96 (s, 1H,  CH2pyrrolidine), 4.45 (d, J=9.1 Hz, 
1H,  CH2pyrrolidine), 3.76 (bb, 2H, O-CH3), 2.96 (s, 3H, OCH3). 
MS-ESI: found 869.20 (M+1), expected: 868.10. 
N
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Synthesis of 59
A solution of 59 (25 mg, 0.02 mmol) in 5 mL of a mixture of DCM/TFA 1:1 was stirred 
for 12 hours, the solvent removed under reduced pressure to give 62  in quantitative 
yield (23 mg).
1H-NMR (200 MHz, pyridine [d5]): ! 7.76 (bb, 2H, p-Ar), 7.65 (bb,  2H, p-Ar), 5.36 (m 
2H,  CH2pyrrolidine), 4.81 (d, J=8.8 Hz, 1H,  CH2pyrrolidine), 3.62 (bb, 2H, N-CH2), 
3.30 (m, 2H, N-CH2-CH2-COO).
13C-NMR (50 MHz, CDCl3): ! 173.23, 152.60, 151.23, 150.00 (Ar), 148.95, 147.22, 146.84, 
145.01, 144.85, 144.02, 143.92, 142.86, 142.55, 142.30, 141.7, 141.02, 140.55, 140.11, 134.23 
(Ar) 125.46 (Ar), 124.21 (Ar),   73.00 (1C), 71.95 (1C), 69.03, 69.02, 36.12, 29.20.  
MS ESI m/z : found 925.0 (M-1); calculated 926.11.
UV/vis (CHCl3, " nm) =  230, 252, 311, 689. 
FT-IR (KBr): # (cm-1) 3400, 2986, 2915, 2920, 1801, 1760, 1686, 1632, 1525, 1406, 1400, 
1363, 740.
N
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Synthesis of 60
To a solution of 59 (10 mg, 0.01 mmol)  and EDC (19 mg, 0.10 mmol) in 1mL of CHCl3, 
was added drop by drop a mixture of 1G-PAMAM 18 (48.8 mg, 0.10 mmol) and DMAP 
(12 mg, 0.100 mmol) and the reaction was stirred under Ar atmosphere for 12 hours. 
The solvent was removed under reduced pressure to obtain a brown solid that was 
purified by silica column chromatography CHCl3/MeOH (90:10) as eluent. The 
product was precipitated from a highly concentrated solution in CHCl3 by adding 
ethyl ether to give 60 as a brown solid (13 mg, 90% yield)
1H-NMR (500 MHz, pyridine[d5]): ! 8.92 (bb, 1H, NH-CO), 8.46 (d, J=1.0 Hz, 2H, p-Ar), 
7.62 (d, J=1.0 Hz, 2H, p-Ar), 5.61 (d, 1H, d, J=9.2 Hz, 1H,  CH2pyrrolidine), 5.42 (s, 1H, 
CH2pyrrolidine), 4.36 (d, 1H, d, J=9.2 Hz, 1H,  CH2pyrrolidine), 4.01-3.42 (m, 12H, NH-
CH2, CH2-NHBoc, CH2-Npyrrolidine ) 3.08-3.01 (m, 4H, N-(CH2)2) 3.00-2.96 (m, 2H, 
Npyrrolidine-CH2-CH2) 2.86-2.42 (m, 4H, CH2-CONH), 1.51 (s, 18H, Boc).
13C-NMR (125 MHz, CDCl3): ! 172.62, 155.78, 153.69, 149.99 (Ar), 148.26, 146.52, 145.08, 
144.94, 144.23, 143.57, 143.05, 142.67, 142.14, 142.01, 141.90, 141.26, 140.46, 140.33, 136.28 
(Ar) 124.92 (Ar), 124.00 (Ar), 79.06 (C-(CH3)3), 71.58 (1C), 70.12 (1C), 68.76 (1C), 68.72 
(1C), 51.22 (1C), 50.77 (2C), 40.32 (1C), 40.01 (2C), 37.97 (1C), 35.02 (2C), 34.10 (1C), 
28.10 (6C).
MS ESI m/z : found 1397.5(M+1); calculated 1396.43.
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UV/vis (CHCl3, ! nm) =  231, 253, 311, 690.
FT-IR (KBr): " (cm-1) 3369, 3320, 3108, 2924, 1690, 1582, 1496, 1455, 1430, 1364, 1250, 
1210, 1169, 723, 525.
Synthesis of 61
To a solution of 60 (10 mg, 7 µmol) in 5 mL of toluene previously degassed for 10 
minutes by bubbling N2 was added a catalytic amount of Pd/C (10% w/w). The 
reaction was leaved for 36 hours under H2 atmosphere to finally filtered it and 
removed the solvent under reduced pressure, obtaining 61 as a brown solid in 
quantitative yield (10 mg). When the solid is filtered on celite, the dendrofullerene 64 
tends to adsorb on it. 
1H-NMR (200 MHz,CDCl3): # 7.86 (d, J=1.0 Hz, 2H, p-Ar), 7.72 (d, J=1.0 Hz, 2H, p-Ar), 
5.23 (d, J=9.2 Hz, 1H,  CH2pyrrolidine), 5.32 (s, 1H, CH2pyrrolidine), 4.51 (d, 1H, d, 
J=9.2 Hz, 1H,  CH2pyrrolidine), 4.22-3.42 (m, 15H, NH-CH2, CH2-NHBoc, CH2-N 
pyrrolidine, NH2) 3.26-3.12 (m, 4H, N-(CH2)2) 2.95-2.46 (m, 6H, Npyrrolidine-CH2-CH2 and CH2-
CONH), 1.51 (s, 18H, Boc).
13C-NMR (50 MHz,CDCl3): # 172.59, 155.77, 153.62, 148.92 (Ar+1C), 146.32, 146.01, 
145.63, 145.00, 144.32, 143.26, 142.96, 142.67, 141.88, 141.24, 140.96, 140.35, 140.2, 138.12 
(Ar), 128.13 (Ar), 123.99 (Ar), 80.02 (C-(CH3)3), 71.23 (2C), 68.73 (2C), 51.50 (1C), 50.50 
(1C), 40.48 (1C), 40.12 (2C), 37.99 (1C), 35.00 (2C), 34.62(1C), 28.90 (6C)
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UV/vis (CHCl3, ! nm) =  231, 254, 311, 690.
FT-IR (KBr): " (cm-1) 3420, 3369, 3321, 3108, 2924, 1689, 1582, 1496, 1455, 1430, 1364, 
1210, 1168, 722, 523.
Synthesis of 62
To a solution of 53 (10 mg, 15 µmol)  and EDC (21 mg, 0.15 mmol) in 1mL of DMF anh, 
was added drop by drop a mixture of 61  (21 mg, 15 µmol) and DMAP (12 mg, 0.15 
mmol) and the reaction was stirred under Ar atmosphere for 36 hours at 60ºC. The 
solvent was removed under reduced pressure to obtain a brown solid that was purified 
by silica column chromatography CHCl3/MeOH (95:5) as eluent. The product was 
precipitated from a highly concentrated solution in CHCl3 by adding  petroleum  ether 
to give 62 as a brown redish solid (3.8 mg, 12% yield).
1H-NMR (500 MHz,CDCl3): # 9.1(m, 6H, 2,6-pyridil), 8.91 (m, 8H, pyrrole ß), 8.25 (m, 
4H, Ar-P), 8.10 (m, 2H, 3,5-pyridyl ), 8.01 (bb, Npyrr-(CH2)2-CONH), 7.72 (m, 4H, 
CHPyrr-Ar), 7.01 (bb, 3H, CONH), 5.31 (bb, 2H, NHBoc), 5.25 (m, 2H, CH2pyrrolidine), 
3.86-3.22 (m, NH-CH2, CH2-NHBoc and CH2-N(CH2)2,  2.98-2.44 (m, CH2-N(CH2)2 and 
Npyrrolidine-CH2-CH2), (m, 4H, CH2CONH), 1.49 (s, 18H, Boc), -2.98 (s, 2H, internal 
pyrrole).
The low quantity obtained did not permit to record 13C-NMR spectra.
MS-MALDI-TOF (no matrix):  found 2057.2, expected 2056.64.
UV/vis (CHCl3, ! nm) =  417, 512, 547, 590, 645.
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Synthesis of 63
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A solution of 9 (10 mg, 49 µmol), 55 (104 mg, 49 µmol) and C60 (500 mg, 0.609 mmol) 
previously sonicated for 10 minutes was refluxed in o-dichlorobenzene anhydrous/
DMF anhydrous 1:1 for 2 hours under Ar. After removing the unreacted C60 by silica 
chromatographic colum with only toluene, the monoadduct was recovered with 
toluene/ethylacetate 9:1. After precipitation by addition of petroleum ether to a 
saturated solution  63 was afforded as a brown solid. (22 mg, 15% yield respect to 
recovered C60).
1H-NMR (500 MHz,CDCl3): ! 9.12 (m, 6H, 2,6-pyridil), 8.86 (m, 8H, pyrrole ß), 8.30 (m, 
J=1.0 Hz, 10H, Ar and  3,5-pyridyl ),  5.42 (m, 2H, CH2pyrrolidine), 4.40 (d, J=9.2 Hz 
1H, CH2pyrrolidine), 3.45 (t, J= 9.0 Hz 2H, N-CH2), 3.18 (t, J= 9.0 Hz, 2H, CH2-CO), 1.51 
(s, 9H, tBu), -2.90 (s, 2H, internal pyrrole).
13C-NMR (100 MHz,CDCl3): ! 172.60, 167.31, 155.76, 153.62, 150.22 (4’-py), 148.90, 
148.51 (2’,6’ pyr), 147.20 (broad, C" pyrrol), 146.40 (Ar-P), 146.32, 146.12, 145.60, 144.99, 
144.23, 143.18, 142.95, 142.66, 141.78, 141.15, 140.89, 140.33, 140.18, 138.23 (Ar), 134.61 
(Ar-P), 131.99 (broad, ß-pyrrole), 130.06 (Ar-P), 129.55 (3’,5’-pyr), 128.11, 128.08 (Ar-P), 
123.90, 120.00 (Cmeso), 118.25 (Cmeso), 79.82 (C-(CH3)3), 71.06 (2C), 68.88 (2C), 51.30 
(1C), 50.49 (1C), 41.46 (1C), 41.02 (2C), 38.02 (1C), 34.62 (2C), 34.22(1C), 28.88 (6C).
MS-ESI  found 1513.0 (M+4H), expected 1508.36
UV/vis (CHCl3, # nm) =  420, 510, 545, 588, 643.
Experimental Part
136
Synthesis of 64
A solution of 63 (20 mg, 13 µmol) in 5 mL of a mixture of DCM/TFA 1:1 was stirred for 
1 hour, the solvent removed under reduced pressure to give 64 in quantitative yield (18 
mg).
1H-NMR (200 MHz, DMF [d7]): ! 9.31 (bb, 6H, 2,6-pyridil), 8.72 (bb, 8H, pyrrole ß), 8.05 
(bb, overlaped with DMF signal,  10H, Ar and  3,5-pyridyl ),  5.50 (m, 2H, 
CH2pyrrolidine), 4.48 (bb, 1H, CH2pyrrolidine), 3.52 (bb, 2H, N-CH2), 3.18 (bb,  2H, 
CH2-CO),  -2.90 (s, 2H, internal pyrrole).
13C-NMR spectra could not be recorded due to the low solubility of 64.
MS-ESI  found 1436.8 (M+4H), expected 1432.30
UV/vis (DMF, " nm) = 520 (broad), 543, 590, 643.
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Synthesis of 65
A solution of 64 (10 mg, 7 µmol)  and EDC (13 mg, 70 µmol) in 5 mL of DMF anh (pH of 
the resultant solution! 8.2), was added drop by drop a mixture of 18 (35 mg, 70 µmol) 
and DMAP (8 mg, 70 µmol) and the reaction was stirred under Ar atmosphere for 36 
hours at r.t. The solvent was removed under reduced pressure to obtain a red oil that 
was purified by silica column chromatography CHCl3/MeOH (98:2) as eluent. The 
product was precipitated from a highly concentrated solution in CHCl3 by adding 
petroleum  ether to give 65 as a dark red solid (16 mg, 62% yield).
1H-NMR (400 MHz,CDCl3): ! 9.06 (m, 6H, 2,6-pyridil), 8.83 (m, 8H, pyrrole ß), 8.10-7.89 
(m,10H, Ar and  3,5-pyridyl ),  5.10 (bb, 1H, CH2pyrrolidine), 5.00 (s, 1H, 
CH2pyrrolidine), 4.80 (d, J=8.9 Hz, 1H,  CH2pyrrolidine), 4.10-3.26 (m, 15H, NH-CH2, 
CH2-NHBoc, CH2-N pyrrolidine, NH2) 3.05-2.80 (m, 10H, N-(CH2)2 and Npyrrolidine-CH2-CH2 
and CH2-CONH), 1.48 (s, 18H, Boc), -2.92 (s, 2H, internal pyrrole).
13C-NMR (75 MHz,CDCl3): ! 172.60, 167.28, 155.77, 153.60, 150.30 (4’-py), 148.99, 148.62 
(2’,6’ pyr), 146.52 (Ar-P), 146.41, 146.20, 145.66, 144.89, 144.22, 143.6, 142.93, 142.80, 
141.79, 141.25, 140.89, 140.32, 140.26, 138.57 (Ar), 134.86 (Ar-P), 132.00 (broad, ß-
pyrrole), 130.02 (Ar-P), 129.56 (3’,5’-pyr), 128.10, 128.18 (Ar-P), 123.89, 120.06 (Cmeso), 
117.10 (Cmeso), 79.99 (C-(CH3)3), 71.22 (2C), 69.25 (2C), 51.48 (1C), 50.46 (1C), 40.21 (1C), 
40.13 (2C), 37.52 (1C), 34.96 (2C), 33.78(1C), 28.88 (6C).
MS-ESI  found 1927.8 (M+H), expected 1926.62.
UV/vis (CHCl3, " nm) =  421, 510, 540, 580, 640.
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General procedure of methylation to obtain 66 and 67
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In a sealed vial, 5 mg of  62 (2.4 µmol) or 65 (2.5 µmol) were solved in the minimum 
volume of chloroform (1 mL) and then added an excess (4 mL) of  methyl iodide. The 
mixture was refluxed for 72 hours and the reaction followed by reversed-face HPLC 
until observation of a single peak. Thus, the reaction was stopped, cooled to 0ºC, and 
the solvent removed by reduced pressure to obtain a brown-redish solid in quantitative 
yield. Crude of reactions were used for the next step without further purification.
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Synthesis of 68 and 69
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To a suspension of the crudes of 66 and 67 in DMF was bubbled HCl gas for 5 minutes 
and leaved under stirring for additional 30 minutes. The solvent was removed and the 
crude was washed with distilled chloroform (x5) to obtain a brown-redish solid.
68 (6 mg, >99% yield respect to 62)
1H-NMR (500 MHz,DMSO): ! 9.14(bb, 6H, 2,6-pyridil), 8.88 (bb, 8H, pyrrole ß), 8.32 (m, 
4H, Ar-P), 8.24 (m, 2H, 3,5-pyridyl ), 7.88 (m, 4H, CHPyrr-Ar), 5.30-5.20 (m, 3H, 
CH2pyrrolidine), 4.82 (s, 9H, quaternary ammonium methyl), 4.18 (s, 3H, Npyr-Me), 
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3.86-3.22 (m, NH-CH2, CH2-NHBoc and CH2-N(CH2)2,  3.12-2.77 (m, CH2-N(CH2)2 and 
Npyrrolidine-CH2-CH2), (m, 4H, CH2CONH), 2.79 (s, 3H, N-CH3, partially overlapped)
UV/vis (H2O, ! nm) =  425, 510, 545, 588, 640
MS-ESI  found 374.8 (M/7), expected 374.71
69 (6 mg, 92% yield respect to 65)
1H-NMR (500 MHz, DMSO): " 9.15-8.80 (bb, 14H, 2,6-pyridil and pyrrole ß), 8.20-8.06 
(m, 10H, Ar and 3,5-pyridyl), 5.06 (s, 1H, CH2pyrrolidine), 4.84 (bb, 2H, 
CH2pyrrolidine), 4.81(s, 9H, quaternary ammonium methyl), 4.20(s, 3H, Npyr-Me), 
4.15-3.28 (m, 15H, NH-CH2, CH2-NHBoc, CH2-N pyrrolidine, NH2), 3.25-2.98 (m, 10H, N-
(CH2)2 and Npyrrolidine-CH2-CH2 and CH2-CONH), 2.85 (s, 3H, N-CH3)
UV/vis (H2O, ! nm) = 423, 508, 539, 577, 639
MS-ESI  found 357.6 (M/7), expected 357.44
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